 BUSINESS COMBINATION AGREEMENT,
DATED NOVEMBER 23, 2020      

Exhibit 2.1

  



  

 _Execution Version_

  



  



  



  



  



  



  



  



  



  



  



  



  

BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION

  



  

by and among

  



  

APEX TECHNOLOGY ACQUISITION CORP.,

  



  

ATHENA TECHNOLOGY MERGER SUB, INC.,

  



  

ATHENA TECHNOLOGY MERGER SUB 2, LLC,

  



  

and

  



  

AVEPOINT, INC.

  



  

Dated as of November 23, 2020

  



     



  



  



  



  



  



  



  

   



 



    



  

TABLE OF CONTENTS

  



       |   | Page 
---|---|--- 
     |   | 
   Article I. DEFINITIONS  | 3 
     |   | 
   Section 1.01  | Certain Definitions  | 3 
   Section 1.02  | Further Definitions  | 19 
   Section 1.03  | Construction  | 22 
     |   | 
   Article II. AGREEMENT AND PLAN OF MERGERs  | 23 
     |   | 
   Section 2.01  | The Merger  | 23 
   Section 2.02  | Effective Time; Closing  | 23 
   Section 2.03  | Effect of the Merger  | 24 
   Section 2.04  | Organizational Documents  | 24 
   Section 2.05  | Directors and Officers  | 25 
   Section 2.06  | Closing Deliverables  | 25 
     |   | 
   Article III. CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES  | 26 
     |   | 
   Section 3.01  | Conversion of Securities  | 26 
   Section 3.02  | Exchange of Securities  | 28 
   Section 3.03  | Contingent Consideration  | 31 
   Section 3.04  | Stock Transfer Books  | 32 
   Section 3.05  | Appraisal Rights  | 32 
     |   | 
   Article IV. REPRESENTATIONS AND WARRANTIES OF THE COMPANY  | 33 
     | 
   Section 4.01  | Organization and Qualification; Subsidiaries  | 33 
   Section 4.02  | Certificate of Incorporation and Bylaws  | 34 
   Section 4.03  | Capitalization  | 34 
   Section 4.04  | Authority Relative to this Agreement  | 36 
   Section 4.05  | No Conflict; Required Filings and Consents  | 37 
   Section 4.06  | Permits; Compliance  | 37 
   Section 4.07  | Financial Statements  | 38 
   Section 4.08  | Absence of Certain Changes or Events  | 40 
   Section 4.09  | Absence of Litigation  | 40 
   Section 4.10  | Employee Benefit Plans  | 40 
   Section 4.11  | Labor and Employment Matters  | 43 
   Section 4.12  | Real Property; Title to Assets  | 44 
   Section 4.13  | Intellectual Property  | 45 
   Section 4.14  | Data Privacy.  | 48 
   Section 4.15  | Taxes  | 50 
   Section 4.16  | Environmental Matters  | 52 
   Section 4.17  | Material Contracts  | 52 
   Section 4.18  | Insurance  | 55 
   Section 4.19  | Board Approval; Vote Required  | 55 
   



  

   

i

 



     



     Section 4.20  | Sanctions and International Trade Compliance  | 55 
---|---|--- 
   Section 4.21  | Customers and Suppliers  | 56 
   Section 4.22  | Certain Business Practices  | 56 
   Section 4.23  | Interested Party Transactions  | 56 
   Section 4.24  | Exchange Act  | 57 
   Section 4.25  | Brokers  | 57 
   Section 4.26  | Exclusivity of Representations and Warranties  | 57 
     |   | 
   Article V. REPRESENTATIONS AND WARRANTIES OF Apex AND MERGER SUBs  | 58 
     |   | 
   Section 5.01  | Corporate Organization  | 58 
   Section 5.02  | Organizational Documents  | 58 
   Section 5.03  | Capitalization  | 59 
   Section 5.04  | Authority Relative to This Agreement  | 61 
   Section 5.05  | No Conflict; Required Filings and Consents  | 61 
   Section 5.06  | Compliance  | 62 
   Section 5.07  | SEC Filings; Financial Statements; Sarbanes-Oxley  | 62 
   Section 5.08  | Absence of Certain Changes or Events  | 64 
   Section 5.09  | Absence of Litigation  | 64 
   Section 5.10  | Board Approval; Vote Required  | 65 
   Section 5.11  | No Prior Operations  | 65 
   Section 5.12  | Brokers  | 66 
   Section 5.13  | Apex Trust Fund  | 66 
   Section 5.14  | Employees  | 67 
   Section 5.15  | Taxes  | 67 
   Section 5.16  | Listing  | 69 
   Section 5.17  | PIPE Investment  | 69 
   Section 5.18  | Apex's and Merger Subs' Investigation and Reliance  |
70 
   Section 5.19  | Exclusivity of Representations and Warranties  | 70 
     |   | 
   Article VI. CONDUCT OF BUSINESS PENDING THE MERGERs  | 71 
     |   | 
   Section 6.01  | Conduct of Business by the Company Pending the Merger 
| 71 
   Section 6.02  | Conduct of Business by Apex and Merger Subs Pending the
Merger  | 74 
   Section 6.03  | Claims Against Trust Account  | 77 
     |   | 
   Article VII. ADDITIONAL AGREEMENTS  | 78 
     |   | 
   Section 7.01  | Proxy Statement  | 78 
   Section 7.02  | Apex Stockholders' Meeting; and First Merger Sub
Stockholder's Approval  | 80 
   Section 7.03  | Company Stockholders' Written Consent  | 81 
   Section 7.04  | Access to Information; Confidentiality  | 81 
   Section 7.05  | Exclusivity  | 82 
   Section 7.06  | Employee Benefits Matters  | 82 
   



  

   

ii

 



     



     Section 7.07  | Adoption of Equity Plan and ESPP  | 83 
---|---|--- 
   Section 7.08  | Directors' and Officers' Indemnification  | 84 
   Section 7.09  | Notification of Certain Matters  | 85 
   Section 7.10  | Further Action; Reasonable Best Efforts  | 85 
   Section 7.11  | Public Announcements  | 87 
   Section 7.12  | Stock Exchange Listing  | 87 
   Section 7.13  | Antitrust  | 87 
   Section 7.14  | Trust Account  | 88 
   Section 7.15  | Tax Matters  | 88 
   Section 7.16  | Directors  | 89 
   Section 7.17  | Audited Financial Statements  | 90 
   Section 7.18  | Affiliate Agreements  | 90 
   Section 7.19  | 280G Approval  | 90 
   Section 7.20  | Trust Account Proceeds and Related Available Equity  |
90 
   Section 7.21  | Employment Agreements  | 90 
     |   | 
   Article VIII. CONDITIONS TO THE MERGERs  | 91 
     |   | 
   Section 8.01  | Conditions to the Obligations of Each Party  | 91 
   Section 8.02  | Conditions to the Obligations of Apex and Merger Sub  |
92 
   Section 8.03  | Conditions to the Obligations of the Company  | 92 
   Section 8.04  | Frustration of Conditions  | 93 
     |   | 
   Article IX. TERMINATION, AMENDMENT AND WAIVER  | 93 
     |   | 
   Section 9.01  | Termination  | 93 
   Section 9.02  | Effect of Termination  | 94 
   Section 9.03  | Expenses  | 95 
   Section 9.04  | Amendment  | 95 
   Section 9.05  | Waiver  | 95 
     |   | 
   Article X. GENERAL PROVISIONS  | 96 
     |   | 
   Section 10.01  | Notices  | 97 
   Section 10.02  | Nonsurvival of Representations, Warranties and
Covenants  | 97 
   Section 10.03  | Severability  | 97 
   Section 10.04  | Entire Agreement; Assignment  | 97 
   Section 10.05  | Parties in Interest  | 97 
   Section 10.06  | Governing Law  | 97 
   Section 10.07  | Waiver of Jury Trial  | 98 
   Section 10.08  | Headings  | 98 
   Section 10.09  | Counterparts  | 98 
   Section 10.10  | Specific Performance  | 98 
   Section 10.11  | No Recourse  | 98 
   Section 10.12  | Conflicts and Privilege  | 99 
  



  

   

iii

 



     



     EXHIBIT  A  | Form  of Amended and Restated Registration Rights
Agreement 
---|--- 
   EXHIBIT  B  | Form  of Lock-Up Agreement 
   EXHIBIT  C  | Form  of Sponsor Insider Side Letter 
   EXHIBIT  D  | Form  of Certificate of Amendment to the Amended and
Restated Certificate of Incorporation of the Company 
   EXHIBIT  E  | Form  of Board Observer Letter 
   EXHIBIT  F  | Form  of Amended and Restated Certificate of
Incorporation of Surviving Corporation 
   EXHIBIT  G  | Form  of Amended and Restated Bylaws of Surviving
Corporation 
   EXHIBIT  H  | Form  of Amended and Restated Operating Agreement of
Surviving Entity 
   EXHIBIT  I  | Form  of Apex Amended and Restated Certificate of
Incorporation 
   EXHIBIT  J  | Form  of Apex Amended and Restated Bylaws 
   EXHIBIT  K  | Directors  and Officers of the Surviving Corporation,
Surviving Entity and Apex 
     | 
   SCHEDULE  A  | Company  Knowledge Parties 
   SCHEDULE  B  | Key  Company Stockholders 
   SCHEDULE  C  | Named  Executives 
   SCHEDULE  D  | Specified  Options 
   SCHEDULE  E  | Company  Employment Agreement Executives 
  



  

   

iv

 



    

  



     

BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION, dated as of
November 23, 2020 (this " _Agreement_ "), by and among Apex Technology
Acquisition Corp., a Delaware corporation (" _Apex_ "), Athena Technology
Merger Sub, Inc., a Delaware corporation (" _First Merger Sub_ "), Athena
Technology Merger Sub 2, LLC, a Delaware limited liability company (" _Second
Merger Sub_ " and, together with First Merger Sub, " _Merger Subs_ " and
each, a " _Merger Sub_ "), and AvePoint, Inc., a Delaware corporation (the "
_Company_ ").

  



  

WHEREAS, each Merger Sub is a wholly owned direct subsidiary of Apex;

  



  

WHEREAS, upon the terms and subject to the conditions of this Agreement, (a)
in accordance with the General Corporation Law of the State of Delaware,
Subchapter XV (the " _DGCL_ "), Apex and the Company will enter into a
business combination transaction pursuant to which First Merger Sub will
merge with and into the Company (the " _First Merger_ "), with the Company
surviving the First Merger as a wholly owned subsidiary of Apex, subject to
the conditions set forth herein, and (b) in accordance with the Limited
Liability Company Act of the State of Delaware, Subchapter XVIII (the "
_DLLCA_ "), promptly following the First Merger, but in any event on the same
day as the First Merger and as part of the same overall transaction as the
First Merger, the Surviving Corporation will merge with and into Second Merger
Sub (the " _Second Merger_ " and, together with the First Merger, the "
_Mergers_ "), with Second Merger Sub surviving the Second Merger as a wholly
owned subsidiary of Apex, subject to the conditions set forth herein;

  



  

WHEREAS, each of the parties intends that, for U.S. federal income Tax
purposes, (a) the First Merger, the Second Merger and the Named Executive
Transactions (as defined herein), taken together, shall be viewed as a single
integrated transaction that shall qualify as a "reorganization" within the
meaning of Section 368(a) of the United States Internal Revenue Code of
1986, as amended (the " _Code_ ") and (b) this Agreement is, and is hereby
adopted as, a "plan of reorganization" within the meaning of Section 368 of
the Code and Treasury Regulations Sections 1.368-2(g) and 1.368-3 (clauses
(a) and (b), the " _Intended Tax-Free Treatment_ ");

  



  

WHEREAS, the Board of Directors of the Company (the " _Company Board_ ") has
unanimously (a) determined that the Mergers are fair to, and in the best
interests of, the Company and its stockholders and has approved and adopted
this Agreement and declared its advisability and approved the Mergers and the
other transactions contemplated by this Agreement, and (b) has recommended
the approval and adoption of this Agreement and the Mergers by the
stockholders of the Company;

  



  

WHEREAS, the Board of Directors of Apex (the " _Apex Board_ ") has (a)
approved and adopted this Agreement and declared its advisability and
approved the payment of the Per Share Amount to stockholders of the Company
pursuant to this Agreement and the other transactions contemplated by this
Agreement, and (b) has recommended the approval and adoption of this Agreement
and the transactions contemplated by this Agreement by the stockholders of
Apex;

  



  

WHEREAS, the Board of Directors of First Merger Sub (the " _First Merger Sub
Board_ ") has (a) determined that the First Merger is fair to, and in the
best interests of, First Merger Sub and its sole stockholder and has approved
and adopted this Agreement and declared its advisability and approved the
First Merger and the other transactions contemplated by this Agreement, and
(b) recommended the approval and adoption of this Agreement and the First
Merger by the sole stockholder of First Merger Sub;

  



  

   

1

 



    



  

WHEREAS, Apex, in its capacity as the sole member and manager of Second
Merger Sub has (a) determined that the Second Merger is fair to, and in the
best interests of, Second Merger Sub and its sole member and has approved and
adopted this Agreement and declared its advisability and approved the Mergers
and the other transactions contemplated by this Agreement, and (b) approved
the adoption of this Agreement and the Second Merger;

  



  

WHEREAS, Apex, the Company and the Key Company Stockholders (as defined
herein), concurrently with the execution and delivery of this Agreement, are
entering into the Stockholder Support Agreement, dated as of the date hereof
(the " _Stockholder Support Agreement_ "), providing that, among other
things, the Key Company Stockholders will vote their shares of Company Common
Stock and Company Preferred Stock in favor of this Agreement, the Mergers and
the other transactions contemplated by this Agreement;

  



  

WHEREAS, concurrently with the execution and delivery of this Agreement, Apex
Technology Sponsor LLC (the " _Sponsor_ ") shall enter into a Sponsor Support
Agreement (the " _Sponsor Support Agreement_ ") providing that, among other
things, the Sponsor will (i) vote its shares of Apex Common Stock in favor of
this Agreement, the Mergers and the other transactions contemplated by this
Agreement, and (ii) place into escrow certain shares of Apex Common Stock held
by Sponsor, the release of which shall be contingent upon certain events and
conditions, all as set forth in the Sponsor Support Agreement;

  



  

WHEREAS, in connection with the Closing, Apex, certain Key Company
Stockholders and the parties to the Registration Rights Agreement shall enter
into an Amended and Restated Registration Rights Agreement (the "
_Registration Rights Agreement_ "), substantially in the form attached hereto
as _Exhibit A_;

  



  

WHEREAS, in connection with the Closing, certain Key Company Stockholders
shall enter into separate Lock-Up Agreements (each, a " _Lock-Up Agreement_
"), substantially in the form attached hereto as _Exhibit B_;

  



  

WHEREAS, concurrently with the execution and delivery of this Agreement, Jeff
Epstein and Brad Koenig shall enter into separate side letter agreements,
substantially in the form attached hereto as _Exhibit C_;

  



  

WHEREAS, Apex, concurrently with the execution and delivery of this
Agreement, is entering into subscription agreements (the "
_Subscription Agreements_ ") with certain investors pursuant to which such
investors, upon the terms and subject to the conditions set forth therein,
have agreed to purchase shares of Apex Common Stock at a purchase price of
$10.00 per share in one or more private placement transactions for an
aggregate purchase price equal to the PIPE Commitment identified herein, such
purchases to be consummated prior to or substantially concurrently with the
Closing (the " _Private Placements_ "), to be consummated concurrently with
the consummation of the transactions contemplated hereby;

  



  

WHEREAS, concurrently with the execution and delivery of this Agreement, each
Named Executive is entering into an agreement with Apex and the Company (the
" _Named Executive Equity Agreement_ ") pursuant to which such Named Executive
has agreed that on the Closing Date and immediately prior to the Effective
Time, such Named Executive shall exchange the Named Executive Shares for cash
and shares of Apex Common Stock, in accordance with the terms of the Named
Executive Equity Agreement (collectively, the " _Named Executive
Transactions_ ");

  



  

   

2

 



    



  

WHEREAS, the Company and its requisite stockholders have adopted and approved
a certificate of amendment to the Company Certificate of Incorporation in the
form attached hereto as _Exhibit D_ (the " _Company Certificate of Amendment_
") and the Company will cause such certificate of amendment to be filed with
the Delaware Secretary of State on the date of this Agreement.

  



  

WHEREAS, in connection with the Closing, Apex shall file with the Secretary
of State of the State of Delaware the Amended and Restated Apex Certificate
of Incorporation, pursuant to which all outstanding shares of Apex Class A
Common Stock and Apex Class B Common Stock shall be converted into shares of
Apex Common Stock.

  



  

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants
and agreements herein contained, and intending to be legally bound hereby,
the parties hereto hereby agree as follows:

  



  

Article I. 
 DEFINITIONS

  



  

Section 1.01 _Certain Definitions_. For purposes of this Agreement:

  



  

" _affiliate_ " of a specified person means a person who, directly or
indirectly through one or more intermediaries, controls, is controlled by, or
is under common control with, such specified person; _provided_ , _further_ ,
that in no event shall the Company or any Company Subsidiaries be considered
an affiliate of any portfolio company (other than the Company and Company
Subsidiaries) of any investment fund affiliated with any direct or indirect
equityholder of the Company.

  



  

" _Aggregate Available Cash_ " means the sum of (a) the Available Apex Cash,
_plus_ (b) the Company Cash.

  



  

" _Aggregate Cash Amount_ " means the sum of (a) the Baseline Cash Amount,
_plus_ (b) the Aggregate Options Exercise Price.

  



  

" _Aggregate Cash Consideration_ " means the sum of (a) (i) the Company
Preferred Stock Cash Amount, _minus_ (ii) the Preferred PIPE Fees _plus_ (b)
the Available Named Executive Cash Amount, _plus_ (c) (i) the Final Cash
Election Consideration,  _minus_ (ii) the Common Stockholder PIPE Fees.

  



  

" _Aggregate Cash Election Amount_ " means the aggregate amount of Cash
Election Consideration elected by all Electing Stockholders (before giving
effect to any adjustment pursuant to the proviso at the end of Section
3.01(a)(ii) _(y)_ ).

  



  

   

3

 



    



  

" _Aggregate Named Executive Cash-Settled Option Consideration_ " means an
amount in cash equal to: (a) the product of (i) Per Share Amount, _multiplied
by_ (ii) the number of shares of Company Common Stock issuable upon exercise
of the Named Executive Cash-Settled Options, _minus_ (b) the Aggregate Named
Executive Cash-Settled Options Exercise Price.

  



  

" _Aggregate Named Executive Cash-Settled Options Exercise Price_ " means the
aggregate exercise price of the Named Executive Cash-Settled Options.

  



  

" _Aggregate Option Consideration_ " means a number of shares of Apex Common
Stock equal to: (a) (i) Per Share Amount, _divided by_ (ii) $10.00,
_multiplied by_ (b) the number of shares of Company Common Stock issuable upon
exercise of all Company Options (other than Named Executive Cash-Settled
Options).

  



  

" _Aggregate Option Exercise Price_ " means the aggregate exercise price of
all Company Options.

  



  

" _Aggregate Preferred Stock Consideration_ " means a number of shares of
Apex Common Stock equal to (a) an amount equal to (i) the Company Preferred
Stock Converted Shares _multiplied by_ the Per Share Amount, _minus_ (ii) the
Company Preferred Stock Cash Amount, _divided by_ (b) $10.00.

  



  

" _Aggregate Stock Consideration_ " means a number of shares of Apex Common
Stock equal to (a) the Aggregate Preferred Stock Consideration,  _plus_ (b)
an amount equal to (i) the Named Executive Stock-Settled Shares _multiplied
by_ the Per Share Amount, _divided by_ (ii) $10.00 _plus_ (c) the Final Stock
Election Consideration.

  



  

" _Ancillary Agreements_ " means the Stockholder Support Agreement, the
Sponsor Support Agreement, the Registration Rights Agreement, the Lock-Up
Agreements, and all other agreements, certificates and instruments executed
and delivered by Apex, Merger Subs or the Company in connection with the
Transactions and specifically contemplated by this Agreement.

  



  

" _Apex Capital Stock_ " means, collectively, Apex Common Stock and Apex
Preferred Stock.

  



  

" _Apex Certificate of Incorporation_ " means the Amended and Restated Apex
Certificate of Incorporation dated September 16, 2019.

  



  

" _Apex Class A Common Stock_ " means Apex's Class A common stock, par value
$0.0001 per share, prior to the filing of the Amended and Restated Apex
Certificate of Incorporation.

  



  

" _Apex Class B Common Stock_ " means Apex's Class B common stock, par value
$0.0001 per share, prior to the filing of the Amended and Restated Apex
Certificate of Incorporation.

  



  

" _Apex Common Stock_ " means Apex's common stock, par value $0.0001 per
share, after the filing of the Amended and Restated Apex Certificate of
Incorporation.

  



  

" _Apex Initial Stockholders_ " means the Sponsor.

  



  

   

4

 



    



  

" _Apex IPO Financial Advisors_ " means Cantor Fitzgerald and Co. and William
Blair.

  



  

" _Apex IPO Underwriting Fees_ " means an aggregate of $13,500,000 of
underwriting commissions and capital markets advisory fees, costs and
expenses payable to the Apex IPO Financial Advisors.

  



  

" _Apex Material Adverse Effect_ " means any Effect that, individually or in
the aggregate with all other events, circumstances, changes and effects, (a)
is or is reasonably expected to be materially adverse to the business,
financial condition or results of operations of Apex; or (b) would prevent,
materially delay or materially impede the performance by Apex or Merger Subs
of their respective obligations under this Agreement or the consummation of
the Mergers or any of the other Transactions; _provided_ , _however_ , that
none of the following shall be deemed to constitute, alone or in combination,
or be taken into account in the determination of whether, there has been or
will be a Apex Material Adverse Effect pursuant to clause (a): (i) any change
or proposed change in or change in the interpretation of any Law or GAAP;
(ii) events or conditions generally affecting the industries or
geographic areas in which Apex operates; (iii) any downturn in general
economic conditions, including changes in the credit, debt,
securities, financial or capital markets (including changes in interest or
exchange rates, prices of any security or market index or commodity or any
disruption of such markets); (iv) any geopolitical conditions, outbreak of
hostilities, acts of war, sabotage, civil unrest, cyberterrorism, terrorism,
military actions, earthquakes, volcanic activity, hurricanes, tsunamis,
tornadoes, floods, mudslides, wild fires or other natural disasters, weather
conditions, epidemics, pandemics or other outbreaks of illness or public
health events and other force majeure events (including any escalation or
general worsening of any of the foregoing Effects); (v) any actions taken or
not taken by Apex as required by this Agreement or any Ancillary Agreement,
(vi) any Effect attributable to the announcement or execution, pendency,
negotiation or consummation of the Mergers or any of the other Transaction (
_provided_ , that this clause (vi) shall not apply to any representation or
warranty to the extent the purpose of such representation or warrant is to
address the consequences resulting from this Agreement or the consummation of
the transactions contemplated hereby), or (vii) any actions taken, or
failures to take action, or such other changes or events, in each case, which
the Company has requested or to which it has consented or which actions are
contemplated by this Agreement, except in the cases of clauses (i) through
(iv), to the extent that Apex is materially disproportionately affected
thereby as compared with other participants in the industry in which Apex
operates.

  



  

" _Apex Organizational Documents_ " means the Apex Certificate of
Incorporation, Apex bylaws, and Trust Agreement, in each case as
amended, modified or supplemented from time to time.

  



  

" _Apex Public Stockholder Redemption Rate_ " means the percentage of the
Trust Fund that is actually redeemed by Apex Public Stockholders upon
exercise of the Redemption Rights.

  



  

" _Apex Public Stockholders_ " means any stockholders of Apex other than the
Sponsor, Jeff Epstein, Brad Koenig or any of their respective affiliates or
any stockholder of Apex pursuant to that certain Letter Agreement, dated as of
September 16, 2019, by and among the Sponsor, Apex and the other stockholders
named therein.

  



  

   

5

 



    



  

" _Apex Sponsor Common Stock_ " means (a) Apex Class B Common Stock, prior to
the filing of the Amended and Restated Apex Certificate of Incorporation and
(b) Apex Common Stock upon and following the filing of the Amended and
Restated Apex Certificate of Incorporation.

  



  

" _Apex Transaction Expenses_ " means the following out-of-pocket fees and
expenses paid or payable by Apex or its affiliates (whether or not billed or
accrued for) as a result of or in connection with the negotiation,
documentation and consummation of the transactions contemplated hereby: (a)
all reasonable and documented fees, costs, expenses, brokerage fees,
commissions, finders' fees and disbursements of financial advisors,
investment banks, data room administrators, attorneys, accountants and other
advisors and service providers other than any Ineligible Apex IPO
Underwriting Fees, (b) Apex's allocated share of the fees and expenses as set
forth in _Section 7.01(a)_ , _Section 7.12_ and _Section 7.13_ in connection
with the transactions contemplated hereby and (c) repayment of any Working
Capital Loans, in each case of clauses (a) through (c) solely to the extent
such fees and expenses are incurred and unpaid as of 11:59 p.m. (New York
time) on the day immediately preceding the Closing Date.

  



  

" _Apex Units_ " means one share of Apex Class A Common Stock and one Apex
Warrant.

  



  

" _Apex Warrant Agreement_ " means that certain warrant agreement dated
September 16, 2019 by and between Apex and Continental.

  



  

" _Apex Warrants_ " means whole warrants to purchase shares of Apex Class A
Common Stock as contemplated under the Apex Warrant Agreement, with
each whole warrant exercisable for one share of Apex Class A Common Stock at
an exercise price of $11.50.

  



  

" _Available Apex Cash_ " means the total cash and cash equivalents of Apex
at the Effective Time, including (a) (i) the funds remaining in the Trust
Account, _plus_ (ii) the proceeds under the Subscription Agreements entered
into as of the date hereof (as amended in accordance with this Agreement) and
any additional Subscription Agreements entered into after the date hereof in
accordance with this Agreement, _plus_ (iii) the proceeds with respect to any
Additional Equity Amount actually purchased in accordance with this
Agreement, _minus_ (b) the sum of (i) the amount required to satisfy the
Redemption Rights, _plus_ (ii) any Taxes due on any accrued interest on the
Trust Account, _plus_ (iii) any unpaid Apex Transaction Expenses, _plus_
(iv) any unpaid Company Transaction Expenses.

  



  

" _Available Company Common Stock Cash Amount_ " means (a) the Company Common
Stock Cash Amount, _minus_ (b) the Company Common Stock Cash Cutback.

  



  

" _Available Named Executive Cash Amount_ " means (a) the Named Executive
Cash Amount, _minus_ (b) the Named Executive Cash Cutback, if any, _minus_
(c) the Named Executive PIPE Fees, if any.

  



  

" _Balance Sheet Cash Amount_ " means $90,000,000.

  



  

" _Baseline Cash Amount_ " means $261,026,922.09.

  



  

" _Baseline Share Amount_ " means $1,433,660,775.

  



  

   

6

 



    



  

" _Board Observer Agreement_ " means an agreement to be entered into between
Apex and Brad Koenig, substantially in the form attached hereto as _Exhibit
E._

  



  

" _Business Combination_ " has the meaning set forth in Article II of the
Apex Certificate of Incorporation.

  



  

" _Business Data_ " means all business information and data that is accessed,
collected, used, stored, shared, distributed, transferred, disclosed,
destroyed, disposed of or otherwise Processed by any of the Business Systems
or otherwise in the course of the conduct of the business of the Company
Group.

  



  

" _Business Day_ " means any day on which banks are not required or
authorized to close in New York, NY; _provided_ , that banks shall not be
deemed to be authorized or obligated to be closed due to a "shelter in place,"
"non-essential employee" or similar closure of physical branch locations at
the direction of any Governmental Authority if such banks' electronic funds
transfer systems (including for wire transfers) are open for use by customers
on such day.

  



  

" _Business Systems_ " means all Software, computer hardware (whether general
or special purpose), electronic data processors, databases, communications,
telecommunications, networks, interfaces, platforms, servers, peripherals, and
computer systems, including any outsourced systems and processes, that are
owned or used in the conduct of the business of the Company or any Company
Subsidiary.

  



  

" _Cash Consideration Shortfall Amount_ " means the amount, if any, by which
(a) the sum of (i) the Baseline Cash Amount _plus_ (ii) the Balance Sheet
Cash Amount, exceeds (b) the sum of (i) the Aggregate Available Cash, _plus_
(ii) the PIPE Fees; _provided_ , that such amount shall be deemed to be zero
if it is a negative number.

  



  

" _Closing Price_ " means, for each Trading Day, the closing price (based on
such Trading Day) of shares of Apex Common Stock on the Trading Market, as
reported on Nasdaq.com.

  



  

" _Common Stockholder PIPE Fees_ " means the product of (a) the product of
4.5% _multiplied by_ (i) the aggregate proceeds received by Apex under the
Subscription Agreements entered into as of the date hereof (as amended in
accordance with this Agreement) and any additional Subscription Agreements
entered into after the date hereof in accordance with this Agreement, _minus_
(ii) the Company Preferred Stock Cash Amount; _provided_ , that, if such
amount is less than zero, such amount shall be deemed to be zero, _multiplied
by_ (b) the quotient obtained by (i) the Final Cash Election Consideration,
_divided by_ (ii) the sum (x) of the Named Executive Cash Amount, _minus_ the
Named Executive Cash Cutback and (y) the Final Cash Election
Consideration, rounded down to the nearest cent.

  



  

" _Company Capital Stock_ " means the Company Common Stock and the Company
Preferred Stock.

  



  

" _Company Cash_ " means the total cash and cash equivalents of the Company
Group at the Effective Time.

  



  

   

7

 



    



  

" _Company Certificate of Incorporation_ " means the Third Amended and
Restated Certificate of Incorporation of the Company dated December 26, 2019,
as amended by the Company Certificate of Amendment.

  



  

" _Company Common Stock_ " means the Company's Common Stock, with a par value
of $0.001 per share.

  



  

" _Company Common Stock Cash Amount_ " means $91,026,922.09.

  



  

" _Company Common Stock Cash Cutback_ " means an amount in cash equal to (a)
the Cash Consideration Shortfall Amount, _multiplied by_ (b) the quotient
equal to (i) the Company Common Stock Cash Amount, _divided by_ (ii) the sum
of (A) the Named Executive Cash Amount, _plus_ (B) the Company Common Stock
Cash Amount, _plus_ (C) the Balance Sheet Cash Amount, rounded to the nearest
dollar.

  



  

" _Company Financial Advisors_ " means the persons listed on _Section 4.25_
of the Company Disclosure Schedule.

  



  

" _Company Group_ " means the Company and the Company Subsidiaries.

  



  

" _Company Group Member_ " means the Company or any Company Subsidiary.

  



  

" _Company IP_ " means, collectively, all Company-Owned IP and Company-
Licensed IP.

  



  

" _Company-Licensed IP_ " means all Intellectual Property rights owned or
purported to be owned by a third party and licensed to any Company Group
Member or to which any Company Group Member otherwise has a right to use.

  



  

" _Company Loan Agreement_ " means that certain Loan and Security Agreement,
dated April 7, 2020, by and between the Company, the Guarantors party thereto
and HSBC Ventures UA Inc.

  



  

" _Company Material Adverse Effect_ " means any event, circumstance, change
or effect (collectively " _Effect_ ") that, individually or in the aggregate
with all other events, circumstances, changes and effects, (a) is or would
reasonably be expected to be materially adverse to the business, financial
condition, or results of operations of the Company and the
Company Subsidiaries, taken as a whole or (b) would prevent, materially delay
or materially impede the performance by the Company of its obligations under
this Agreement or the consummation of the Mergers or any of the other
Transactions; _provided_ , _however_ , that none of the following shall be
deemed to constitute, alone or in combination, or be taken into account in the
determination of whether, there has been or will be a Company Material
Adverse Effect pursuant to clause (a): (i) any change or proposed change in
or change in the interpretation of any Law or GAAP; (ii) events or conditions
generally affecting the industries or geographic areas in which the Company
and the Company Subsidiaries operate; (iii) any downturn in general economic
conditions, including changes in the credit, debt, securities, financial or
capital markets (including changes in interest or exchange rates, prices of
any security or market index or commodity or any disruption of such markets);
(iv) any geopolitical conditions, outbreak of hostilities, acts of war,
sabotage, civil unrest, cyberterrorism, terrorism, military actions,
earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods,
mudslides, wild fires or other natural disasters, weather conditions,
epidemics, pandemics or other outbreaks of illness or public health events
and other force majeure events (including any escalation or general worsening
of any of the foregoing Effects); (v) any actions taken or not taken by any
Company Group Member as required by this Agreement or any
Ancillary Agreement, (vi) any Effect attributable to the announcement or
execution, pendency, negotiation or consummation of the Mergers or any of the
other Transactions (including the impact thereof on relationships with
customers, suppliers, employees or Governmental Authorities) ( _provided_ ,
that this clause (vi) shall not apply to any representations or warranty to
the extent the purpose of such representation or warranty is to address the
consequences resulting from this Agreement or the consummation of the
transactions contemplated hereby), (vii) any failure to meet any projections,
forecasts, guidance, estimates, milestones, budgets or financial or operating
predictions of revenue, earnings, cash flow or cash position, _provided_ ,
that this clause (vii) shall not prevent a determination that any Effect
underlying such failure has resulted in a Company Material Adverse Effect, or
(viii) any actions taken, or failures to take action, or such other changes
or events, in each case, which Apex has requested or to which it has
consented or which actions are contemplated by this Agreement, except in the
cases of clauses (i) through (iv), to the extent that the Company and the
Company Subsidiaries are as a whole materially disproportionately affected
thereby as compared with other participants in the industries in which the
Company and the Company Subsidiaries operate.

  



  

   

8

 



    



  

" _Company Option Plans_ " means the 2006 Equity Incentive Plan of the
Company and the 2016 Equity Incentive Plan of the Company, in each case, as
such may have been amended, supplemented or modified from time to time.

  



  

" _Company Optionholders_ " means the holders of Company Options as of
immediately prior to the Effective Time.

  



  

" _Company Options_ " means all unexpired and unexercised options to purchase
shares of Company Common Stock, whether or not exercisable and whether or not
vested, immediately prior to the Effective Time under either Company Option
Plan or otherwise.

  



  

" _Company Organizational Documents_ " means the Company Certificate of
Incorporation, and the bylaws of the Company, in each case as amended,
modified or supplemented from time to time.

  



  

" _Company Outstanding Shares_ " means the sum of (a) total number of shares
of Company Common Stock outstanding immediately prior to the Effective Time
(including the Named Executive Shares), _plus_ (b) the number of Company
Preferred Stock Converted Shares,  _plus_ (c) the number of shares of Company
Common Stock issuable upon the exercise of all Company Options (other than
Unvested Exchanged Options held by a Company Optionholder who does not remain
in continuous service to Apex or one of its subsidiaries as of the date of
the applicable Contingent Milestone).

  



  

" _Company-Owned IP_ " means all Intellectual Property rights owned or
purported to be owned by any Company Group Member.

  



  

" _Company Preferred Stock_ " means the Company Series C Preferred Stock.

  



  

" _Company Preferred Stock Cash Amount_ " means $135,000,000.

  



  

" _Company Preferred Stock Converted Shares_ " means total number of shares
of Company Common Stock that would be issuable upon the conversion of the
outstanding shares of Company Preferred Stock immediately prior to the
Effective Time.

  



  

" _Company Privacy Policies_ " means each written external or internal, past
or present, policy, notice, or statement of any Company Group Member
concerning the privacy, security, or Processing of Personal Information.

  



  

" _Company Series C Preferred Stock_ " means the shares of the Preferred
Stock of the Company, par value $0.001 per share, designated as Series C
Preferred Stock in the Company Certificate of Incorporation.

  



  

" _Company Stockholders_ " means the holders of Company Common Stock and
Company Preferred Stock, in each case as of immediately prior to the
Effective Time.

  



  

" _Company Subsidiary Organizational Documents_ " means with respect to each
Company Subsidiary, its certificate of formation and limited liability
company agreement, in each case as amended, modified or supplemented from time
to time.

  



  

   

9

 



    



  

" _Company Transaction Expenses_ " means the following out-of-pocket fees and
expenses paid or payable by any Company Group Member (whether or not billed
or accrued for) as a result of or in connection with the negotiation,
documentation and consummation of the transactions contemplated hereby: (a)
all reasonable and documented fees, costs, expenses, brokerage fees,
commissions, finders' fees and disbursements of financial advisors,
investment banks, data room administrators, attorneys, accountants and other
advisors and service providers, (b) change-in-control payments, transaction
bonuses, retention payments, severance or similar compensatory payments
payable by the any Company Group Member to any current or former employee
(including any amounts due under any consulting agreement with any such
former employee), independent contractor, officer, or director of any Company
Group Member as a result of the transactions contemplated hereby (and not
tied to any subsequent event or condition, such as a termination of
employment), including the employer portion of payroll Taxes arising
therefrom, but in each case excluding any payments in respect of
Named Executive Cash-Settled Options, (c) the Company's allocated share of
the fees and expenses as set forth in _Section 7.01(a)_ ,  _Section 7.12_ and
_Section 7.13_ in connection with the transactions contemplated hereby and (d)
repayment of loans made to the Company by any affiliate of the Company (other
than a wholly-owned subsidiary of the Company), in each case of clauses (a)
through (d) solely to the extent such fees and expenses are incurred and
unpaid as of 11:59 p.m. (New York time) on the day immediately preceding the
Closing Date.

  



  

" _Confidential Information_ " means any information, knowledge or data
concerning the businesses and affairs of the Company Group or any Suppliers
or customers of the Company Group or Apex or its subsidiaries (as applicable)
that is not already generally available to the public.

  



  

" _Continental_ " means Continental Stock Transfer and Trust Company, Apex's
transfer agent.

  



  

" _control_ " (including the terms " _controlled by_ " and " _under common
control with_ ") means the possession, directly or indirectly, or as trustee
or executor, of the power to direct or cause the direction of the
management and policies of a person, whether through the ownership of voting
securities, as trustee or executor, by contract or otherwise.

  



  

" _Disabling Devices_ " means Software viruses, time bombs, logic bombs,
Trojan horses, trap doors, back doors, or other computer instructions,
intentional devices or techniques that are designed to threaten, infect,
assault, vandalize, defraud, disrupt, damage, disable, maliciously encumber,
hack into, incapacitate, infiltrate or slow or shut down a computer system or
any component of such computer system, including any such device affecting
system security or compromising or disclosing user data in an
unauthorized manner, other than those incorporated by the Company
intentionally to protect Company IP from misuse.

  



  

" _Election Percentage_ " means with respect to any Electing Stockholder that
has properly made and not revoked or lost an Election in accordance with
Section 3.02, the percentage of cash (rounded to the nearest whole number)
elected by such holder in such Election;  _provided_ , that such percentage
shall not be greater than the Maximum Election Percentage.

  



  

" _Eligible Apex IPO Underwriting Fees_ " means (a) if the Apex Public
Stockholder Redemption Rate is equal to 10% or less, 100% of the Apex IPO
Underwriting Fees, (b) if the Apex Public Stockholder Redemption Rate is 40%
or more, none of the Apex IPO Underwriting Fees and (c) if the Apex Public
Stockholder Redemption Rate is greater than 10% but equal to or less than 40%,
a portion of the Apex IPO Underwriting Fees equal to (i) 40% _minus_ the Apex
Public Stockholder Redemption Rate _divided by_ (ii) 10%.

  



  

" _Employee Benefit Plan_ " means any plan that is an "employee benefit plan"
as defined in Section 3(3) of ERISA, any nonqualified deferred compensation
plan subject to Section 409A of the Code, bonus, stock option, stock purchase,
restricted stock, other equity-based compensation arrangement, performance
award, incentive, deferred compensation, retiree medical or life insurance,
death or disability benefit, supplemental retirement, severance, retention,
change in control, employment, consulting, fringe benefit, sick pay and
vacation plans or arrangements or other employee benefit plans, programs or
arrangements, whether written or unwritten and whether or not subject to
ERISA.

  



  

" _Environment_ " means any ambient air, surface water, drinking water,
groundwater, land surface (whether below or above water), subsurface
strata, sediment, plant or animal life, and natural resources.

  



  

" _Environmental Claim_ " means any claim, judicial or administrative
proceeding, investigation or notice by any person, including any Governmental
Authority, alleging potential liability (including potential liability for
investigatory costs, cleanup or remediation costs, governmental or third
party response costs, natural resource damages, property damage, personal
injuries, or fines or penalties) based on or resulting from (a) the presence
or Release of, or exposure to, any Hazardous Materials at any location,
whether or not owned or operated by the Company or Company Subsidiaries, as
applicable, or (b) any Environmental Law, including the alleged or actual
violation thereof.

  



  

   

10

 



    



  

" _Environmental Laws_ " means any law, statute, ordinance, regulation, order
or rule relating to: (a) the Environment, including pollution, contamination,
cleanup, preservation, protection and reclamation of the Environment, (b) the
protection of human health with respect to, or the exposure of employees or
third parties to, any Hazardous Materials, (c) any Release or threatened
Release of any Hazardous Materials, including investigation, assessment,
testing, monitoring, containment, removal, remediation and cleanup of any
such Release or threatened Release, (d) the management of any Hazardous
Materials, including the use, labeling, processing, disposal, storage,
treatment, transport, or recycling of any Hazardous Materials, or (e) the
presence of Hazardous Materials in any building, physical structure, product
or fixture.

  



  

" _Environmental Permits_ " means all franchises, grants, authorizations,
licenses, permits, easements, variances, exceptions, consents, certificates,
approvals and orders of any Governmental Authority required under
Environmental Laws for the conduct of the business and activities of the
Company and Company Subsidiaries, as currently conducted.

  



  

" _ERISA_ " means the Employee Retirement Income Security Act of 1974, as
amended.

  



  

" _Exchange Ratio_ " means the following ratio (rounded to four decimal
places): the quotient obtained by dividing (a) the Per Share Amount by (b)
$10.00.

  



  

" _Fully Diluted Number_ " means the sum of (i) total number of shares of
Company Common Stock outstanding immediately prior to the Effective Time
(including the Named Executive Shares) _plus_ (ii) the number of shares of
Company Common Stock issuable upon the conversion of the Company Preferred
Stock Converted Shares that are outstanding immediately prior to the Effective
Time,  _plus_ (iii) the number of shares of Company Common Stock issuable
upon exercise of all Company Options that are outstanding immediately prior
to the Effective Time.

  



  

" _Government Contract_ " shall mean any prime contract, subcontract, basic
ordering agreement, letter contract, purchase order, delivery order, change
order, arrangement, grant, cooperative agreement, other transaction authority
agreement, or other commitment of any kind between any Company Group Member,
on the one hand, and any Governmental Authority or prime contractor or
subcontractor to a Governmental Authority, on the other hand.

  



  

" _Governmental Authority_ " means (a) the United States, (b) any federal,
state, provincial, municipal, local or any governmental or quasi-governmental
authority of any nature, (c) any body exercising or entitled to exercise any
administrative, executive, judicial, legislative, police, standards,
regulatory or taxing authority, or (d) any subdivision, agency, department,
branch, official, bureau, commission, board, court, tribunal, judicial or
arbitral body or other instrumentality or authority of any of the foregoing.

  



  

" _Gross Merger Consideration_ " means (a) the Baseline Share Amount, _plus_
(b) the Aggregate Cash Amount.

  



  

" _Hazardous Materials_ " means all materials, chemicals, wastes, compounds
and substances in any form defined, regulated or characterized as a
pollutant, contaminant or toxic or hazardous substance or waste (or terms of
similar meaning) under Laws protecting the Environment and human health,
including petroleum, crude oil and any fraction thereof.

  



  

   

11

 



    



  

" _HSR Act_ " means the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended, and the rules and regulations promulgated thereunder.

  



  

" _Ineligible Apex IPO Underwriting Fees_ " means any Apex IPO Underwriting
Fees that are not Eligible Apex IPO Underwriting Fees.

  



  

" _Intellectual Property_ " means: (a) patents, patent applications and
patent disclosures, together with all renewals, reissues,
continuations, continuations-in-part, divisionals, revisions, extensions,
reexaminations, substitutions and foreign counterparts thereof and
industrial property rights; (b) trademarks and service marks, trade dress,
logos, trade names, corporate names, brands, slogans, and other source
identifiers together with all translations, adaptations, derivations,
combinations and other variants of the foregoing, and all applications,
registrations, and renewals in connection therewith, together with all of the
goodwill associated with the foregoing; (c) copyrights, Software, and other
works of authorship (whether or not copyrightable), and moral rights, and
registrations and applications for registration, renewals and extensions
thereof; (d) trade secrets and know-how (including ideas,
formulas, compositions, inventions (whether or not patentable or reduced to
practice)), customer and supplier lists, improvements, protocols, processes,
methods and techniques, research and development information, industry
analyses, algorithms, architectures, layouts, drawings, specifications,
documentation, technical manuals, designs, plans, methodologies, proposals,
industrial models, technical data, financial and accounting and all other
data, databases, database rights, pricing and cost information, business and
marketing plans and proposals, and customer and supplier lists (including
lists of prospects) and related information; (e) Internet domain names and
registrations thereof and rights to use social media accounts; (f) all other
intellectual property rights of any kind or description; (g) copies and
tangible embodiments of any of the foregoing, in whatever form or medium; and
(h) all legal rights arising from items (a) through (f), including the right
to prosecute, enforce and perfect such interests and rights to sue,
oppose, cancel, interfere, enjoin and collect damages based upon such
interests, including such rights based on past infringement, if any, in
connection with any of the foregoing.

  



  

" _International Trade Laws_ " means (a) all laws, regulations, and
restrictive measures imposed, administered, or enforced by the U.S.
government relating to the import, export, re-export, deemed export, deemed
re-export, or transfer of information, data, goods, and technology, including
but not limited to the Export Control Reform Act of 2018 (50 U.S.C. 
4801-4861), the Export Administration Regulations (15 C.F.R. Parts 730-774),
the Arms Export Control Act (22 U.S.C.  1778), the International Traffic in
Arms Regulations (22 C.F.R. Parts 120-130), customs and import laws
administered by the United States Customs and Border Protection, and any other
export or import controls administered by an agency of the United States
government, (b) the anti-boycott regulations administered by the United States
Department of Commerce and the United States Department of the Treasury, and
(c) any other applicable laws adopted by the governments or agencies of other
countries relating to the same subject matter as the United States laws and
regulations described above, except to the extent inconsistent with U.S. law.

  



  

" _Key Company Stockholders_ " means the persons and entities listed on
_Schedule B_.

  



  

" _Key Employee_ " means each of Xunkai Gong, Tianyi Jiang and Brian Brown.

  



  

   

12

 



    



  

" _knowledge_ " or " _to the knowledge_ " of a person shall mean in the case
of the Company, the actual knowledge of the persons listed on _Schedule A_
after reasonable inquiry (and for all purposes of _Section 4.13_ hereof,
"reasonable inquiry" shall not require Company to have conducted patent
clearance or similar freedom to operate searches, or other
Intellectual Property searches), and in the case of Apex, the actual
knowledge of Jeff Epstein and Brad Koenig after reasonable inquiry.

  



  

" _Laws_ " mean, collectively, all federal, state and local statutes,
treaties, rules, regulations, directives, ordinances, codes and
administrative or judicial precedents or authorities, including the
interpretation or administration thereof by any Governmental Authority
charged with the enforcement, interpretation or administration thereof, and
all applicable administrative orders, directed duties, requests, licenses,
authorizations and permits of, and agreements with, any Governmental
Authority, in each case whether or not having the force of law.

  



  

" _Leased Real Property_ " means the real property leased by any Company
Group Member as tenant, together with, to the extent leased by any Company
Group Member, all buildings and other structures, facilities or improvements
located thereon and all easements, licenses, rights and appurtenances of any
Company Group Member relating to the foregoing.

  



  

" _Lien_ " means any lien, security interest, mortgage, pledge, adverse claim
or other encumbrance of any kind that secures the payment or performance of
an obligation (other than those created under applicable securities laws).

  



  

" _Maximum Election Percentage_ " means 12.68%.

  



  

" _Merger Subs Organizational Documents_ " means (a) the certificate of
incorporation and bylaws of First Merger Sub, as amended, modified or
supplemented from time to time and (b) the certificate of formation and
operating agreement of Second Merger Sub, as amended, modified or
supplemented from time to time.

  



  

" _Minimum Cash Amount_ " means $300,000,000.

  



  

" _Named Executive Cash Amount_ " means an aggregate amount of $35,000,000.

  



  

" _Named Executive Cash Cutback_ " means an amount in cash equal to: (a) the
Cash Consideration Shortfall Amount, _multiplied by_ (b) the quotient equal
to (a) the Named Executive Cash Amount, _divided by_ (b) the sum of (i) the
Named Executive Cash Amount, _plus_ (ii) the Company Common Stock Cash
Amount, _plus_ (iii) the Balance Sheet Cash Amount, rounded to the nearest
dollar.

  



  

" _Named Executive Cash-Settled Options_ " means the Vested Company Options
held by the Named Executives designated as "Named Executive Cash-Settled
Options" in the amounts set forth on _Schedule C_ ; _provided_ , that if the
Named Executive Cash Cutback is greater than zero, such number of Vested
Company Options shall be decreased by multiplying the Named Executive Pro
Rata Cutback by the number of Named Executive Cash-Settled Options, rounded
down to the nearest whole number, and the Named Executive Cash-Settled
Options shall refer only to such lower number, and the remaining Vested
Company Options shall be assumed pursuant to _Section 3.01(a)(vi)_.

  



  

   

13

 



    



  

" _Named Executive Cash-Settled Shares_ " means the shares of Company Common
Stock held by the Named Executives designated as "Named Executive Cash-
Settled Shares" in the amounts set forth on _Schedule C_ ; _provided_ , that
if the Named Executive Cash Cutback is greater than zero, such number of
shares of Company Common Stock shall be decreased by multiplying the Named
Executive Pro Rata Cutback by the number of Named Executive Cash-Settled
Shares, rounded down to the nearest whole number, and the Named Executive
Cash-Settled Shares shall refer only to such lower number, and the remaining
shares of Company Common Stock held by the Named Executives shall be
converted into the right to receive the consideration payable pursuant to
_Section 3.01(a)(ii)_.

  



  

" _Named Executive PIPE Fees_ " means the product of (a) the product of 4.5%
_multiplied by_ (i) the aggregate proceeds received by Apex under the
Subscription Agreements entered into as of the date hereof (as amended in
accordance with this Agreement) and any additional Subscription Agreements
entered into after the date hereof in accordance with this Agreement, _minus_
(ii) the Company Preferred Stock Cash Amount, _provided_ , that, if such
amount is less than zero, such amount shall be deemed to be zero, _multiplied
by_ (b) the quotient obtained by (i) the Named Executive Cash Amount, _minus_
the Named Executive Cash Cutback _divided by_ (ii) the sum of (x) the Named
Executive Cash Amount, _minus_ the Named Executive Cash Cutback and (y) the
Final Cash Election Consideration, rounded down to the nearest cent.

  



  

" _Named Executive Pro Rata Cutback_ " means a quotient equal to (a) the
Named Executive Cash Cutback, _divided by_ (b) the Named Executive Cash
Amount.

  



  

" _Named Executive Shares_ " means all shares of Company Common Stock held by
the Named Executives.

  



  

" _Named Executive Stock-Settled Shares_ " means the Named Executive Shares
other than the Named Executive Cash-Settled Shares.

  



  

" _Named Executives_ " means the executives of the Company and their
affiliates named on _Schedule C_.

  



  

" _Open Source Software_ " means any Software that is licensed pursuant to:
(a) any license that is a license now or in the future approved by the open
source initiative and listed at http://www.opensource.org/licenses, which
licenses include all versions of the GNU General Public License (GPL), the
GNU Lesser General Public License (LGPL), the GNU Affero GPL, the MIT license,
the Eclipse Public License, the Common Public License, the CDDL, the Mozilla
Public License (MPL), the Artistic License, the Netscape Public License, the
Sun Community Source License (SCSL), and the Sun Industry Standards License
(SISL); (b) any license to Software that is considered "free" or "open source
software" by the open source foundation or the free software foundation; or
(c) any Reciprocal License, in each case whether or not source code is
available or included in such license.

  



  

" _PCAOB_ " means the Public Company Accounting Oversight Board and any
division or subdivision thereof.

  



  

" _Per Share Amount_ " means (a) an amount equal to the Gross Merger
Consideration, _divided by_ (b) the Fully Diluted Number.

  



  

   

14

 



    



  

" _Per Share Contingent Consideration_ " means a number of shares of Apex
Common Stock equal to: (a) the applicable Contingent Consideration  _divided
by_ (b) the Company Outstanding Shares.

  



  

" _Per Share Preferred Cash Consideration_ " means (a) (i) the Company
Preferred Stock Cash Amount, _minus_ (ii) the Preferred PIPE Fees, _divided
by_ (b) the Company Preferred Stock Converted Shares, rounded down to the
nearest cent.

  



  

" _Per Share Preferred Stock Consideration_ " means a number of shares of
Apex Common Stock equal to: (a) the Aggregate Preferred Stock Consideration,
_divided by_ (b) the Company Preferred Stock Converted Shares.

  



  

" _Permitted Liens_ " means: (a) such imperfections of title, easements,
encumbrances, Liens or restrictions that do not materially impair the current
use of the Company's or any Company Subsidiary's assets that are subject
thereto; (b) materialmen's, mechanics', carriers', workmen's, warehousemen's,
repairmen's, landlord's and other similar Liens arising in the ordinary
course of business, or deposits to obtain the release of such Liens; (c) Liens
for Taxes not yet delinquent, or if delinquent, being contested in good faith
and for which appropriate reserves have been made; (d) zoning,
entitlement, conservation restriction and other land use and environmental
regulations promulgated by Governmental Authorities, (e) non-
exclusive licenses (or sublicenses) of Company-Owned IP granted in the
ordinary course of business; (f) non-monetary Liens, encumbrances and
restrictions on real property (including easements, covenants, rights of way
and similar restrictions of record) that do not materially interfere with the
uses of such real property as presently conducted by the Company and Company
Subsidiaries, (g) Liens identified in the Annual Financial Statements and (h)
Liens on leases, subleases, easements, licenses, rights of use, rights
to access and rights of way arising from the provisions of such agreements or
benefiting or created by any superior estate, right or interest.

  



  

" _person_ " means an individual, corporation, partnership, limited
partnership, limited liability company, syndicate, person (including,
without limitation, a "person" as defined in Section 13(d)(3) of the Exchange
Act), trust, association or entity or government, political subdivision,
agency or instrumentality of a government.

  



  

" _Personal Information_ " means any information, in any form, that (a) is
identifiable to or could reasonably be used to identify a natural person,
including, to the extent the following information is identifiable or could
reasonably be used to identify a natural person, a financial account number,
online identifier, device identifier, IP address, online activity or usage
data, location data, or biometric data, or (b) is considered "personally
identifiable information," "personal information," or "personal data" by any
Law(s) or Privacy/Data Security Law(s).

  



  

" _PIPE Fees_ " means (a) the Preferred PIPE Fees, (b) the Named Executive
PIPE Fees and (c) the Common Stockholder PIPE Fees.

  



  

" _PIPE Pro Rata Share_ " means, with respect to an Electing Stockholder, the
quotient obtained by (a) the amount of Final Cash Election Consideration
payable to such Electing Stockholder (prior to any deduction for the Common
Stockholder PIPE Fees),  _divided by_ (b) the aggregate amount of Final Cash
Election Consideration payable to all Electing Stockholder (prior to any
deduction for the Common Stockholder PIPE Fees).

  



  

   

15

 



    



  

" _PRC Options_ " means all Company Options granted pursuant to a PRC Stock
Option Award.

  



  

" _Preferred PIPE Fees_ " means (a) the lesser of (i) the product of 4.5%
_multiplied by_ the Company Preferred Stock Cash Amount and (ii) the product
of 4.5% _multiplied by_ the aggregate proceeds received by Apex under the
Subscription Agreements entered into as of the date hereof (as amended in
accordance with this Agreement) and any additional Subscription Agreements
entered into after the date hereof in accordance with this Agreement, _minus_
(b) $2,000,000.

  



  

" _Privacy/Data Security Laws_ " means all applicable Laws governing the
privacy, security, or Processing of Personal Information, data breach and
notification, website and mobile application privacy policies and practices,
Social Security number protection, Processing and security of payment card
information (including, to the extent applicable, Payment Card Industry
Security Standards), and email, text message, or telephone communications.

  



  

" _Process_ " (and the corollary term " _Processing_ ") means any operations
or set of operations that are performed on data (including Personal
Information), or on sets of data, whether or not by automated means, including
collecting, storing, retrieving, deleting, or transmitting available data.

  



  

" _Products_ " mean any products or services, developed, owned, performed,
offered, marketed, out-licensed, sold, distributed or other otherwise made
available by or on behalf of any Company Group Member, (i) from which any
Company Group Member has derived in the three (3) years prior to the date of
this Agreement, is currently deriving, or is scheduled to derive, revenue from
the sale, license or provision thereof, including products or services under
development, or (ii) for which any Company Group Member has an
ongoing obligation to provide warranties services or other support or
maintenance services.

  



  

" _Reciprocal License_ " means a license of an item of Software that requires
or that conditions any rights granted in such license upon: (i) the
disclosure, distribution or licensing of any other Software (other than such
item of licensed Software as provided by a third party in its unmodified
form); (ii) a requirement that any disclosure, distribution or licensing of
any other Software (other than such item of licensed Software in its
unmodified form) be at no charge; (iii) a requirement that any other
licensee of the licensed Software be permitted to access the source code of,
modify, make derivative works of, or reverse-engineer any other Software;
(iv) a requirement that any other Software be redistributable by other
licensees; or (v) the grant of any patent rights (other than patent rights in
such item of licensed Software), including non-assertion or patent license
obligations (other than patent obligations relating to the use of such item
of licensed Software).

  



  

" _Redemption Rights_ " means the redemption rights provided for in Section
9.2 of the Apex Certificate of Incorporation.

  



  

" _Registered Intellectual Property_ " means all Intellectual Property that
is the subject of registration (or an application for registration),
including domain names.

  



  

   

16

 



    



  

" _Registration Rights Agreement_ " means that certain registration rights
agreement dated September 16, 2019 by and between Apex, Sponsor and Cantor
Fitzgerald and Co.

  



  

" _Release_ " means any release, spill, emission, leaking, pumping, emitting,
depositing, discharging, injecting, escaping, leaching, dispersing, dumping,
pouring, disposing or migrating into, onto or through the Environment.

  



  

" _Requisite Approval_ " means the affirmative vote of (a) the holders of at
least a majority of the shares of Company Common Stock and Company Preferred
Stock (on an as-converted basis) outstanding, voting together as a single
class, and (b) the holders of at least a majority of the Company Series C
Preferred Stock (on an as-converted basis) outstanding, voting together as a
single class.

  



  

" _Sanctioned Country_ " means at any time, a country or territory that is
itself the target of any country-wide or territory-wide Sanctions (at the
time of this Agreement, the Crimea region, Cuba, Iran, North Korea and Syria).

  



  

" _Sanctioned Person_ " means: (a) any person identified in any Sanctions-
related list of designated persons maintained by (i) the United States
Department of the Treasury's Office of Foreign Assets Control, the United
States Department of Commerce, or the United States Department of State; (ii)
Her Majesty's Treasury of the United Kingdom; (iii) any committee of the
United Nations Security Council; or (iv) the European Union or its member
states; (b) any person operating, organized, or resident in a Sanctioned
Country; (c) a government instrumentality or Governmental Authority of any
Sanctioned Country or Venezuela; and (d) any person directly or indirectly
50% or more owned, individually or in the aggregate, or otherwise controlled
by, or acting for the benefit or on behalf of, a person described in clauses
(a) - (c).

  



  

" _Sanctions_ " means those trade, economic and financial sanctions laws,
orders, regulations, embargoes and restrictive measures
imposed, administered, or enforced by (a) the United States (including the
Department of the Treasury's Office of Foreign Assets Control), (b) the
European Union and enforced by its member states, (c) the United Nations, or
(d) Her Majesty's Treasury of the United Kingdom.

  



  

" _Software_ " means all any and all computer programs, operating systems,
application systems, application programming interfaces, firmware or other
software code of any nature, whether in machine-readable form, source code or
a programming language or any other language or symbols, whether operational
or under development, and any derivations, updates, enhancements, and
customizations of any of the foregoing, whether stored, encoded, recorded or
written on disk, tape, film, memory device, paper or other media of any
nature.

  



  

" _Specified Option_ " means the Company Options set forth on _Schedule D_.

  



  

" _Specified Option Delivery Date_ " means the date specified by the Company
Board for the liquidation and settlement of the Specified Option in
connection with the Transactions, or, if earlier, the occurrence of any of the
Exercise Events as defined in the Stock Option Award Agreement for a
Specified Option.

  



  

   

17

 



    



  

" _Subsequent Transaction_ " means any transaction or series of related
transactions, including any sale, merger, liquidation, exchange offer or
other similar transaction, that is consummated after the Effective Time that
results (a) in any person or "group" (within the meaning of Section 13(d)(3)
of the Exchange Act) acquiring beneficial ownership of 50% or more of the
outstanding voting securities of Apex (or any successor to Apex), directly or
indirectly, immediately following such transaction, provided that
any transaction or series of related transactions which results in at least
50% of the combined voting power of the then outstanding shares of Apex
Common Stock (or at least 50% of the combined voting power of the then
outstanding shares of any successor to Apex or any parent company of Apex
issued in exchange for Apex Common Stock) immediately following the closing of
such transaction (or series of related transactions) being beneficially
owned, directly or indirectly, by individuals and entities who were the
beneficial owners of at least 50% of the shares of Apex Common Stock
outstanding immediately prior to such transaction (or series of
related transactions), shall not be deemed a "Subsequent Transaction" or (b)
a sale or disposition of all or substantially all of the assets of Apex and
its subsidiaries on a consolidated basis.

  



  

" _subsidiary_ " or " _subsidiaries_ " of the Company, the Surviving
Corporation, the Surviving Entity, Apex or any other person means an
affiliate controlled by such person, directly or indirectly, through one or
more intermediaries.

  



  

" _Supplier_ " means any person that supplies inventory or other materials or
personal property, components, or other goods or services that are utilized
in or comprise the Products of the Company Group.

  



  

" _Tax_ " or " _Taxes_ " means (a) any and all taxes (including any duties,
levies or other similar governmental assessments in the nature of taxes),
including, but not limited to, income, estimated, business, occupation,
corporate, capital, gross receipts, transfer, stamp, registration,
employment, payroll, unemployment, withholding, occupancy, license, severance,
capital, production, ad valorem, excise, windfall profits, customs duties,
real property, personal property, sales, use, turnover, value added and
franchise taxes, in each case imposed by any Governmental Authority, whether
disputed or not, together with all interest, penalties, and additions to tax
imposed with respect thereto, and (b) a liability for amounts of the type
described in clause (a) as a result Treasury Regulations Section 1.1502-6, as
a result of being a transferee or successor or otherwise by operation of law,
or as a result of a contract.

  



  

" _Tax Return_ " means any return, declaration, report, claim for refund, or
information return or statement relating to Taxes, including any schedule or
attachment thereto and any amendment thereof, in each case filed or required
to be filed with a Governmental Authority.

  



  

" _Trading Day_ " means any day on which shares of Apex Common Stock are
actually traded on the Trading Market.

  



  

" _Trading Market_ " means the stock market on which shares of Apex Common
Stock shall be trading at the time of determination of the Closing Price.

  



  

" _Transaction Documents_ " means this Agreement, including all Schedules and
Exhibits hereto, the Company Disclosure Schedule, the Ancillary Agreements,
and all other agreements, certificates and instruments executed and delivered
by Apex, Merger Subs or the Company in connection with the Transaction and
specifically contemplated by this Agreement.

  



  

   

18

 



    



  

" _Transactions_ " means the transactions contemplated by this Agreement and
the Transaction Documents, including the Mergers.

  



  

" _Treasury Regulations_ " means the United States Treasury regulations
issued pursuant to the Code.

  



  

" _Vested Company Option_ " means any Company Option (or portion thereof)
that is outstanding and vested as of immediately prior to the Effective Time.

  



  

" _Virtual Data Room_ " means the virtual data room established by the
Company, access to which was given to Apex in connection with its due
diligence investigation of the Company relating to the transactions
contemplated hereby.

  



  

" _Working Capital Loans_ " means any loan made to Apex by any of the
Sponsor, any affiliate, officer, manager or member of the Sponsor, or Apex's
officers or directors, and evidenced by a promissory note, for the purpose of
financing working capital or costs incurred in connection with a Business
Combination.

  



  

Section 1.02 _Further Definitions_. The following terms have the meaning
set forth in the Sections set forth below:

  



      

 

_Defined Term_

  |   | _Location of Definition_ 
---|---|--- 
   2020 Audited Financial Statements  |   | Section 7.17(b) 
   2020 Balance Sheet  |   | Section 4.07(b) 
   Action  |   | Section 4.09 
   Additional Equity Amount  |   | Section 7.20 
   Affiliate Agreement  |   | Section 7.18 
   Agreement  |   | Preamble 
   Amended and Restated Apex Certificate of Incorporation  |   | Section
2.04(d) 
   Annual Financial Statements  |   | Section 4.07(a) 
   Anti-Bribery Laws  |   | Section 4.22 
   Antitrust Laws  |   | Section 7.13(a) 
   Apex   |   | Preamble 
   Apex Board  |   | Recitals 
   Apex Business Combination Proposal  |   | Section 7.05(b) 
   Apex Disclosure Schedule  |   | Article V 
   Apex Equity Incentive Plan  |   | Section 7.01(a) 
   Apex Group   |   | Section 10.12(b) 
    Apex Preferred Stock  |   | Section 5.03(a) 
   Apex Proposals  |   | Section 7.01(a) 
   Apex SEC Reports  |   | Section 5.07(a) 
   Apex Stockholders' Meeting  |   | Section 7.01(a) 
    AvePoint Group  |   | Section 10.12(b) 
   



  

   

19

 



    



      

 

_Defined Term_

  |   | _Location of Definition_ 
---|---|--- 
    Blue Sky Laws  |   | Section 4.05(b) 
   Board Approvals  |   | Section 7.01(a) 
   CCPA  |   | Section 4.14(a) 
   Closing  |   | Section 2.02(b) 
   Closing Date  |   | Section 2.02(b) 
   Code  |   | Section 3.02(h) 
   Company  |   | Preamble 
   Company Board  |   | Recitals 
   Company Business Combination Proposal  |   | Section 7.05(a) 
   Company Certificate of Amendment  |   | Recitals 
   Company Disclosure Schedule  |   | Article IV 
   Company Group Organizational Documents  |   | Section 4.02 
   Company Permits  |   | Section 4.06 
   Company Personal Information  |   | Section 4.14(a) 
   Company Software  |   | Section 4.13(j) 
   Company Stockholder Approval  |   | Section 4.19 
   Company Stockholder Meeting  |   | Section 7.03 
   Company Subsidiary  |   | Section 4.01(a) 
   Compensation Report  |   | Section 7.01(a) 
   Confidentiality Agreements  |   | Section 7.04(b) 
   Contingent Consideration  |   | Section 3.03(a)(iii) 
   Contingent Milestones  |   | Section 3.03(a)(iii) 
   Contingent RSUs  |   | Section 3.03(c) 
   Continuing Employees  |   | Section 7.06(c) 
   Contracting Parties  |   | Section 10.11 
   Cooley  |   | Section 10.12(b) 
   Data Privacy Commitments  |   | Section 4.14(b) 
   Data Security Requirements  |   | Section 4.13(n) 
   Default Election Percentage  |   | Section 3.02(c) 
   DGCL  |   | Recitals 
   Dissenting Shares  |   | Section 3.05(a) 
   DLLCA  |   | Recitals 
   Effective Time  |   | Section 2.02(a) 
   Electing Stockholder  |   | Section 3.02(c) 
   Election  |   | Section 3.02(c) 
   Election Deadline  |   | Section 3.02(c) 
   Election Period  |   | Section 3.02(c) 
   Equity Proposals  |   | Section 7.01(a) 
   ERISA Affiliate  |   | Section 4.10(a) 
   Exchange Act  |   | Section 3.01(b) 
   Exchange Agent  |   | Section 3.02(a) 
   Exchange Fund  |   | Section 3.02(a) 
   Exchanged Option  |   | Section 3.01(a)(v) 
   Existing Security Agreements  |   | Section 4.17(a)(viii) 
   Export Approvals  |   | Section 4.20(a) 
   



  

   

20

 



    



      

 

_Defined Term_

  |   | _Location of Definition_ 
---|---|--- 
    Final Cash Election Consideration  |   | Section 3.01(a)(ii) 
   Final Stock Election Consideration  |   | Section 3.01(a)(ii) 
   First Certificate of Merger  |   | Section 2.02(a) 
   First Merger  |   | Recitals 
   First Merger Sub  |   | Preamble 
   First Merger Sub Board  |   | Recitals 
   First Milestone  |   | Section 3.03(a)(i) 
   First Milestone Contingent Consideration  |   | Section 3.03(a)(i) 
   Form of Election  |   | Section 3.02(c) 
   Fraud  |   | Section 10.11 
   GAAP  |   | Section 4.07(a) 
   Health Plan  |   | Section 4.10(k) 
   Intended Tax-Free Treatment  |   | Recitals 
   Interim Financial Statements  |   | Section 4.07(b) 
   Interim Period  |   | Section 6.01(a) 
   IT Systems  |   | Section 4.13(l) 
   Latham  |   | Section 10.12(b) 
   Lease  |   | Section 4.12(b) 
   Lease Documents  |   | Section 4.12(b) 
   Letter of Transmittal  |   | Section 3.02(b) 
   Lock-Up Agreement  |   | Recitals 
   Mailing Date  |   | Section 3.02(c) 
   Malicious Code  |   | Section 4.13(k) 
   Material Contracts  |   | Section 4.17(a) 
   Material Customer  |   | Section 4.21(a) 
   Material Vendor  |   | Section 4.21(b) 
   Merger Subs  |   | Preamble 
   Merger Sub Common Stock  |   | Section 5.03(b) 
   Merger Sub Units  |   | Section 5.03(d) 
   Mergers  |   | Recitals 
   Named Executive Equity Agreement  |   | Recitals 
   Named Executive Option-Based Cash Merger Consideration  |   | Section
3.01(a)(v) 
   Named Executive Transactions  |   | Recitals 
   Nonparty Affiliates  |   | Section 10.11 
   Outside Date  |   | Section 9.01(b) 
   PIPE Commitment  |   | Section 5.17 
   PIPE Investors  |   | Section 5.17 
   Plans  |   | Section 4.10(a) 
   PPACA  |   | Section 4.10(k) 
   Private Placements  |   | Recitals 
   Prospectus  |   | Section 6.03 
   Proxy Statement  |   | Section 7.01(a) 
    Registration Rights Agreement  |   | Recitals 
   Registration Statement  |   | Section 7.01(a) 
   



  

   

21

 



    



      

 

_Defined Term_

  |   | _Location of Definition_ 
---|---|--- 
    Remedies Exceptions  |   | Section 4.04 
   Representatives  |   | Section 7.04(a) 
   Requisite 280G Vote  |   | Section 7.19 
   SEC  |   | Section 5.07(a) 
   Second Certificate of Merger  |   | Section 2.02(a) 
   Second Effective Time  |   | Section 2.02(a) 
   Second Merger  |   | Recitals 
   Second Merger Sub  |   | Preamble 
   Second Milestone  |   | Section 3.03(a)(ii) 
   Second Milestone Contingent Consideration  |   | Section 3.03(a)(ii) 
   Securities Act  |   | Section 5.07(a) 
   Security Incident  |   | Section 4.14(f) 
   Sponsor  |   | Recitals 
   Sponsor Support Agreement  |   | Recitals 
   Stockholder Notice  |   | Section 7.03 
   Stockholder Support Agreement  |   | Recitals 
   Subscription Agreements  |   | Recitals 
   Surviving Corporation  |   | Section 2.01(a) 
   Surviving Entity  |   | Section 2.01(b) 
   Surviving Provisions  |   | Section 9.02 
   Terminating Apex Breach  |   | Section 9.01(g) 
   Terminating Company Breach  |   | Section 9.01(f) 
   Third Milestone  |   | Section 3.03(a)(iii) 
   Third Milestone Contingent Consideration  |   | Section 3.03(a)(iii) 
   Trust Account  |   | Section 5.13 
   Trust Agreement  |   | Section 5.13 
   Trust Fund  |   | Section 5.13 
   Trustee  |   | Section 5.13 
   Unvested Exchanged Options  |   | Section 3.03(c) 
   Updated Annual Financial Statements  |   | Section 7.17(a) 
   Updated Audited Interim Financial Statements  |   | Section 7.17(b) 
   Written Consent  |   | Section 7.03 
  



  

Section 1.03 _Construction_.

  



  

(a) Unless the context of this Agreement otherwise requires, (i) words of any
gender include each other gender, (ii) words using the singular or plural
number also include the plural or singular number, respectively, (iii) the
definitions contained in this agreement are applicable to the other
grammatical forms of such terms, (iv) the terms "hereof," "herein,"
"hereby," "hereto" and derivative or similar words refer to this entire
Agreement, (v) the terms "Article," "Section," "Schedule" and "Exhibit" refer
to the specified Article, Section, Schedule or Exhibit of or to this
Agreement, (vi) the word "including" means "including without limitation,"
(vii) the word "or" shall be disjunctive but not exclusive, (viii) references
to agreements and other documents shall be deemed to include all
subsequent amendments and other modifications thereto, (ix) references to
statutes shall include all regulations promulgated thereunder and references
to statutes or regulations shall be construed as including all statutory and
regulatory provisions consolidating, amending or replacing the statute or
regulation, the phrases "provide to," "made available" and "deliver to" and
phrases of similar import mean that a true, correct and complete paper or
electronic copy of the information or material referred to has been delivered
to the party to whom such information or material is to be provided and the
phrases "provided to Apex" or "made available to Apex" and phrases of similar
import means, with respect to any information, document or other material of
the Company or its affiliates, that such information, document or material was
made available for review and properly indexed by the Company and its
Representatives in the Virtual Data Room at least 48 hours prior to the
execution of this Agreement or actually delivered (whether by physical or
electronic delivery) to Apex or its Representatives at least 48 hours prior to
the execution of this Agreement, (x) the symbol "$" refers to United States
Dollars and (xi) the term "or" is not exclusive and shall be deemed to be
"and/or."

  



  

   

22

 



    



  

(b) The language used in this Agreement shall be deemed to be the language
chosen by the parties to express their mutual intent and no rule of strict
construction shall be applied against any party.

  



  

(c) Whenever this Agreement refers to a number of days, such number shall
refer to calendar days unless Business Days are specified. If any action is
to be taken or given on or by a particular calendar day, and such calendar day
is not a Business Day, then such action may be deferred until the next
Business Day.

  



  

(d) All accounting terms used herein and not expressly defined herein shall
have the meanings given to them under GAAP.

  



  

Article II. 
  _AGREEMENT AND PLAN OF MERGERs_

  



  

Section 2.01 _The Mergers_.

  



  

(a) Upon the terms and subject to the conditions set forth in _Article
VIII_, and in accordance with the DGCL, at the Effective Time, First Merger
Sub shall be merged with and into the Company. As a result of the First
Merger, the separate corporate existence of First Merger Sub shall cease and
the Company shall continue as the surviving corporation of the First Merger
(the " _Surviving Corporation_ ").

  



  

(b) Upon the terms and subject to the conditions set forth in _Article
VIII_, and in accordance with the DGCL and the DLLCA, at the Second Effective
Time, the Surviving Corporation shall be merged with and into the Second
Merger Sub. As a result of the Second Merger, the separate corporate
existence of the Surviving Corporation shall cease and the Second Merger Sub
shall continue as the surviving entity of the Second Merger (the " _Surviving
Entity_ ").

  



  

Section 2.02 _Effective Time; Closing_.

  



  

(a) As promptly as practicable, but in no event later than three Business
Days, after the satisfaction or, if permissible, waiver of the conditions set
forth in _Article VIII_ (other than those conditions that by their nature are
to be satisfied at the Closing, it being understood that the occurrence of
the Closing shall remain subject to the satisfaction or, if permissible,
waiver of such conditions at the Closing), the Company, Apex and First Merger
Sub shall cause the First Merger to be consummated by filing a certificate of
merger (the " _First Certificate of Merger_ ") with the Secretary of State of
the State of Delaware, in such form as is required by, and executed in
accordance with, the relevant provisions of the DGCL and mutually agreed by
the parties (the date and time of the filing of the First Certificate of
Merger (or such later time as may be agreed by each of the parties hereto and
specified in the First Certificate of Merger) being the " _Effective Time_ ").
Promptly following the Effective Time, but in any event on the same day as
the Effective Time, the Surviving Corporation, Apex and Second Merger
Sub shall cause the Second Merger to be consummated by filing a certificate
of merger (the " _Second Certificate of Merger_ ") with the Secretary of
State of the State of Delaware, in such form as is required by, and executed
in accordance with, the relevant provisions of the DLLCA and mutually agreed
by the parties (the date and time of the filing of such Second Certificate of
Merger (or such later time as may be agreed by each of the parties hereto and
specified in such Second Certificate of Merger) being the " _Second Effective
Time_ ").

  



  

(b) Immediately prior to such filing of the First Certificate of Merger in
accordance with _Section 2.02(a)_, a closing (the " _Closing_ ") shall be
held by electronic exchange of deliverables and release of signatures for the
purpose of confirming the satisfaction or waiver, as the case may be, of the
conditions set forth in _Article VIII_. The date on which the Closing shall
occur is referred to herein as the " _Closing Date_."

  



  

   

23

 



    



  

Section 2.03 _Effect of the Mergers_.

  



  

(a) At the Effective Time, the effect of the First Merger shall be as
provided in the applicable provisions of the DGCL. Without limiting the
generality of the foregoing, and subject thereto, at the Effective Time, all
the property, rights, privileges, immunities, powers, franchises, licenses
and authority of the Company and First Merger Sub shall vest in the Surviving
Corporation, and all debts, liabilities, obligations, restrictions,
disabilities and duties of each of the Company and First Merger Sub shall
become the debts, liabilities, obligations, restrictions, disabilities and
duties of the Surviving Corporation.

  



  

(b) At the Second Effective Time, the effect of the Second Merger shall be as
provided in the applicable provisions of the DGCL and the DLLCA. Without
limiting the generality of the foregoing, and subject thereto, at the Second
Effective Time, all the property, rights, privileges, immunities, powers,
franchises, licenses and authority of the Surviving Corporation and Second
Merger Sub shall vest in the Surviving Entity, and all debts, liabilities,
obligations, restrictions, disabilities and duties of each of the
Surviving Corporation and Second Merger Sub shall become the debts,
liabilities, obligations, restrictions, disabilities and duties of
the Surviving Entity.

  



  

Section 2.04 _Organizational Documents_.

  



  

(a) At the Effective Time, the Company Certificate of Incorporation, as in
effect immediately prior to the Effective Time, shall be amended and restated
in its entirety to read as set forth on _Exhibit F_ attached hereto and, as so
amended and restated, shall be the certificate of incorporation of the
Surviving Corporation until thereafter amended as provided by the DGCL and
such certificate of incorporation (subject to _Section 7.08_).

  



  

(b) At the Effective Time, the bylaws of the Company, as in effect
immediately prior to the Effective Time, shall be amended and restated in
their entirety to read as set forth on _Exhibit G_ and, as so amended and
restated, shall be the bylaws of the Surviving Corporation until thereafter
amended as provided by the DGCL, the certificate of incorporation and such
bylaws (subject to _Section 7.08_).

  



  

(c) At the Second Effective Time, the certificate of formation of Second
Merger Sub, as in effect immediately prior to the Second Effective Time,
shall be amended to change the name of the Surviving Entity to such name as is
determined by the Company no later than five Business Days prior to the
Closing Date, but shall otherwise remain the same, and the operating agreement
of Second Merger Sub, as in effect immediately prior to the Second Effective
Time, shall be amended and restated in its entirety to read as set forth on
_Exhibit H_ attached hereto and, as so amended and restated, shall be the
operating agreement of the Surviving Entity until thereafter amended as
provided by the DLLCA and such operating agreement (subject to _Section
7.08_).

  



  

(d) At the Closing, Apex shall amend and restate, effective immediately prior
to the Effective Time, the Apex Certificate of Incorporation to be as set
forth on _Exhibit I_ attached hereto (the " _Amended and Restated Apex
Certificate of Incorporation_ ") and, as so amended and restated, shall be
the certificate of incorporation of Apex until thereafter amended as provided
by the DGCL and such certificate of incorporation.

  



  

(e) At the Closing, Apex shall amend and restate, effective as of the
Effective Time, the Apex bylaws to be as set forth on _Exhibit J_ attached
hereto and, as so amended and restated, shall be the bylaws of Apex until
thereafter amended as provided by the DGCL, the certificate of incorporation
and such bylaws.

  



  

   

24

 



    



  

Section 2.05 _Directors and Officers_.

  



  

(a) The parties will take all requisite actions such that the initial
directors of the Surviving Corporation and the initial officers of the
Surviving Corporation immediately after the Effective Time shall be the
individuals set forth on _Exhibit K_ attached hereto, each to hold office in
accordance with the provisions of the DGCL and the certificate of
incorporation and bylaws of the Surviving Corporation and until their
respective successors are, in the case of the initial directors, duly elected
or appointed and qualified and, in the case of the initial officers, duly
appointed. The parties will take all requisite actions such that Apex shall
be the sole member and manager of the Surviving Entity and the initial
officers of the Surviving Entity immediately after the Second Effective Time
shall be the individuals set forth on _Exhibit K_ attached hereto, each to
hold office in accordance with the provisions of the DLLCA and the operating
agreement of the Surviving Entity and until their respective successors
are, in the case of the initial managers, duly elected or appointed and
qualified and, in the case of the initial officers, duly appointed.

  



  

(b) The parties shall cause the Apex Board and the officers of Apex as of
immediately following the Effective Time to be comprised of the individuals
set forth on _Exhibit K_ attached hereto, each to hold office in accordance
with the DGCL and the Apex Certificate of Incorporation and the bylaws of
Apex and until their respective successors are, in the case of the directors,
duly elected or appointed and qualified and, in the case of the officers,
duly appointed.

  



  

Section 2.06 _Closing Deliverables_.

  



  

(a) At the Closing, the Company will deliver or cause to be delivered:

  



  

(i) to Apex, the written resignations of all of the directors of the Company
(other than any such persons identified as initial directors of the Surviving
Corporation, in accordance with _Section 2.05_ ), effective as of the
Effective Time;

  



  

(ii) to Apex, the Registration Rights Agreement duly executed by duly
authorized representatives of each party thereto (other than Apex and the
Apex Initial Stockholders party thereto);

  



  

(iii) to Apex, the Lock-Up Agreements duly executed by duly authorized
representatives of each party thereto (other than Apex and the Sponsor); and

  



  

(iv) to Apex, a certification, in a form reasonably acceptable to Apex, dated
as of the Closing Date, that shares of the Company are not "U.S. real
property interests" within the meaning of Section 897 of the Code, in
accordance with Treasury Regulation Section 1.1445-2(c)(3), together with an
executed notice to the IRS (which shall be filed by Apex with the IRS
following the Closing) in accordance with the provisions of Section
1.897-2(h)(2) of the Treasury Regulations, together with written authorization
for Apex to deliver such documentation to the Internal Revenue Service on
behalf of the Company after the Closing.

  



  

(b) At the Closing, Apex will deliver or cause to be delivered:

  



  

(i) to the Company, the Registration Rights Agreement, duly executed by duly
authorized representatives of Apex and the Apex Initial Stockholders party
thereto; and

  



  

(ii) to the Company, the written resignations of all of the directors and
officers of Apex and First Merger Sub (other than those persons identified as
the initial directors and officers, respectively, of Apex after the Effective
Time, in accordance with _Section 2.05_ ), effective as of the Effective
Time.

  



  

(c) On the Closing Date, concurrently with the Effective Time, Apex shall pay
or cause to be paid by wire transfer of immediately available funds, (i) all
accrued and unpaid Apex Transaction Expenses set forth on a written statement
to be delivered to the Company not less than two Business Days prior to the
Closing Date and (ii) all accrued and unpaid Company Transaction Expenses as
set forth on a written statement to be delivered to Apex by or on behalf of
the Company not less than two Business Days prior to the Closing Date, which
shall include the respective amounts and wire transfer instructions for the
payment thereof, together with corresponding invoices for the foregoing;
_provided_ , that any Company Transaction Expenses due to current or
former employees, independent contractors, officers, or directors of the
Company or any of its subsidiaries shall be paid to the Company for further
payment to such employee, independent contractor, officer or director through
the Company's payroll.

  



  

   

25

 



    



  

Article III. 
 CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES

  



  

Section 3.01 _Conversion of Securities_.

  



  

(a) At the Effective Time, by virtue of the First Merger and without any
action on the part of Apex, First Merger Sub, the Company or the holders of
any of the following securities:

  



  

(i) each Company Preferred Stock Converted Share (other than any Dissenting
Shares), shall be canceled and converted into the right to receive the
following: (x) the number of shares of Apex Common Stock equal to the Per
Share Preferred Stock Consideration; (y) an amount in cash equal to the Per
Share Preferred Cash Consideration; and (z) the number of shares of Apex
Common Stock equal to the Per Share Contingent Consideration (if any);

  



  

(ii) each share of Company Common Stock issued and outstanding immediately
prior to the Effective Time (excluding any Dissenting Shares and Named
Executive Shares which shall be treated in accordance with _Section 3.05_ and
the terms of the Named Executive Equity Agreements respectively) with respect
to which an Election has been made or deemed to be made pursuant to _Section
3.02(c)_  shall be canceled and converted into the right to receive the
following: (x) an amount in cash equal to (1) the Per Share Amount, 
_multiplied by_ (2) the applicable Election Percentage, without interest (the
" _Cash Election Consideration_ ") subject to withholding from the Final Cash
Election Consideration payable to each Electing Stockholder such Election
Holder's PIPE Pro Rata Share of the Common Stockholder PIPE Fees; (y) the
number of shares of Apex Common Stock equal to (1) (A) the Per Share Amount,
_multiplied by_ (B) the difference obtained by subtracting the applicable
Election Percentage from one, _divided by_ (2) $10.00 (the " _Stock Election
Consideration_ "); _provided_ that if the Aggregate Cash Election Amount
prior to any adjustment pursuant to this proviso exceeds the Available Company
Common Stock Cash Amount because of the Company Common Stock Cash Cutback,
the applicable Election Percentage used to determine the Cash Election
Consideration and the Stock Election Consideration shall be _multiplied by_
the quotient of (a) the Available Company Common Stock Cash Amount, _divided
by_  (b) the Aggregate Cash Election Amount (the Cash Election Consideration
and Stock Election Consideration following such adjustment (if any) is
referred to as the " _Final Cash Election Consideration_ " and the " _Final
Stock Election Consideration_ "); and (z) the number of shares of Apex Common
Stock equal to the Per Share Contingent Consideration (if any);

  



  

(iii) all shares of Company Common Stock and Company Preferred Stock held in
the treasury of the Company or by Apex shall be canceled without any
conversion thereof and no payment or distribution shall be made with respect
thereto;

  



  

(iv) each share of common stock of First Merger Sub issued and outstanding
immediately prior to the Effective Time shall be converted into and exchanged
for one validly issued, fully paid and non-assessable share of common stock,
par value $0.001 per share, of the Surviving Corporation;

  



  

   

26

 



    



  

(v) each Named Executive Cash-Settled Option that is outstanding immediately
prior to the Effective Time, shall be converted into the right to receive (A)
an amount of cash equal to: the product of (1) the number of Named Executive
Cash-Settled Options _multiplied by_ (2) the Per Share Amount, _minus_ (y)
the aggregate exercise price attributable to such Named Executive Cash-
Settled Options (the " _Named Executive Option-Based Cash Merger
Consideration_ "); and (B) the contingent right to receive a number of shares
Contingent Consideration following the Closing in accordance with _Section
3.03_ ; and

  



  

(vi) each Company Option that is outstanding immediately prior to the
Effective Time, whether vested or unvested (other than the Named
Executive Cash-Settled Options and PRC Options), shall be converted into (1)
an option to purchase a number of shares of Apex Common Stock (such option,
an " _Exchanged Option_ ") equal to the product (rounded down to the nearest
whole number) of (x) the number of shares of Company Common Stock subject to
such Company Option immediately prior to the Effective Time and (y) the
Exchange Ratio, at an exercise price per share (rounded up to the nearest
whole cent) equal to (A) the exercise price per share of such Company Option
_immediately_ prior to the Effective Time divided by (B) the Exchange Ratio;
_provided_ ,  _however_ , that the exercise price and the number of shares of
Apex Common Stock purchasable pursuant to the Exchanged Options shall be
determined in a manner consistent with the requirements of Section 409A of the
Code (to the extent applicable to an Exchanged Option); _provided_ ,
_further_ , that in the case of any Exchanged Option to which Section 422 of
the Code applies, the exercise price and the number of shares of Apex Common
Stock purchasable pursuant to such option shall be determined in accordance
with the foregoing, subject to such adjustments as are necessary in order to
satisfy the requirements of Section 424(a) of the Code; _provided_ ,
_further_ , that, following the Effective Time, each Exchanged Option shall
continue to be governed by the same terms and conditions (including vesting
and exercisability terms) as were applicable to the corresponding former
Company Option immediately prior to the Effective Time and (2) the Per Share
Contingent Consideration multiplied by the number of shares of Company Common
Stock into which such Company Option is exercisable immediately prior to the
Effective Time, subject to _Section 3.03(c)_ in respect of Unvested Exchanged
Options. The PRC Options will not be continued or assumed by the Company, Apex
or the Merger Subs as part of the Mergers. The cancelled PRC Options will be
replaced and substituted for as of the Effective Time with the award of a new
stock option to purchase a number of shares of Apex Common Stock pursuant to
Apex Equity Incentive Plan equal to the product (rounded down to the nearest
whole number) of (x) the number of shares of Company Common Stock subject to
such PRC Option immediately prior to the Effective Time and (y) the Exchange
Ratio, at an exercise price (rounded up to the nearest whole cent) equal to
(A) the exercise price per share of such PRC Option prior to the Effective
Time divided by (B) the Exchange Ratio. The replacement stock options will
be credited with vesting to the same extent as the existing PRC Options being
replaced, and the new replacement awards will be subject to same vesting
schedule and exercisability provisions. In other respects, the terms and
conditions of the replacement stock options will be as set forth in the new
equity incentive plan and form of option agreement. 

  



  

   

27

 



    



  

In no event shall the aggregate amount of consideration payable pursuant to
_Section 3.01(a) _and the Named Executive Equity Agreements exceed the
amount of the Gross Merger Consideration.

  



  

(b) In connection with the assumption of the Exchanged Options pursuant to
_Section 3.01(a)_, Apex may assume the Company Option Plan as of the
Effective Time with respect to the Aggregate Option Consideration. Prior to
the Effective Time, Apex and the Company, shall adopt any resolutions and
take any actions that are necessary to effectuate the treatment of the Company
Options pursuant to this _Section 3.01_ , or to cause any disposition or
acquisition of equity securities of Apex pursuant to this _Section 3.01_ by
each individual who is subject to the reporting requirements of Section 16(a)
of the Securities Exchange Act of 1934, as amended (the " _Exchange Act_ "),
with respect to Apex or who will (or is reasonably expected to) become
subject to such reporting requirements with respect to Apex to be exempt under
Rule 16b-3 under the Exchange Act. Apex shall use commercially reasonable
efforts to prepare and file with the SEC, as soon as reasonably practicable,
and in any event not more than 60 days following the Closing Date, a Form S-8
(or any successor form) registering the shares of Apex Common Stock
subject to such Exchanged Options and shall use commercially reasonable
efforts to maintain the effectiveness of such registration statement (and
maintain the current status of the prospectus or prospectuses contained
therein) for so long as such awards remain outstanding.

  



  

(c) At the Second Effective Time, by virtue of the Second Merger and without
any action on the part of Apex, Second Merger Sub, the Surviving Corporation
or the holders of any of the following securities, each share of common stock
of the Surviving Corporation issued and outstanding immediately prior to the
Second Effective Time shall be converted into and become one newly issued,
fully paid and non-assessable common membership unit of the Surviving Entity.

  



  

Section 3.02 _Exchange of Securities_.

  



  

(a) _Exchange Agent_. On the Closing Date, Apex shall deposit, or shall
cause to be deposited, with a bank or trust company that shall be Continental
(the " _Exchange Agent_ "), for the benefit of the holders of Company Capital
Stock, for exchange in accordance with this _Article III_, (i) the Aggregate
Cash Consideration _minus_ the Aggregate Named Executive Cash-Settled Option
Consideration, and (ii) the Aggregate Stock Consideration (such shares of Apex
Common Stock, together with any dividends or distributions with respect
thereto and the Aggregate Cash Consideration _minus_ the Aggregate Named
Executive Cash-Settled Option Consideration being hereinafter referred to as
the " _Exchange Fund_ "). Apex shall cause the Exchange Agent, pursuant to
irrevocable instructions, to pay the Aggregate Cash Consideration and the
Aggregate Stock Consideration out of the Exchange Fund in accordance with this
Agreement. Apex shall cause the Named Executive Option-Based Cash Merger
Consideration to be paid to the holders of Named Executive Cash-
Settled Options through the Surviving Entity's or its applicable subsidiary's
payroll system no later than the second regular payroll following the
Closing.

  



  

(b) _Exchange Procedures_. As soon as reasonably practicable following the
Effective Time and in any event within two Business Days following the
Effective Time (but in no event prior to the Effective Time), Apex shall cause
the Exchange Agent to deliver to each holder of Company Capital Stock, as of
immediately prior to the Effective Time, whose Company Capital Stock was
converted pursuant to  _Section 3.01(a)_ into the right to receive, or
contributed to Apex pursuant to the Named Executive Equity Agreements in
exchange for the right to receive, the Per Share Amount and the Per Share
Contingent Consideration, if any, a letter of transmittal and instructions
for use in such exchange (the " _Letter of Transmittal_ "). The Letter of
Transmittal shall permit each holder of Company Common Stock to allocate for
tax purposes, on a share by share or "block" basis, (i) those shares of
Company Common Stock exchanged in the First Merger for shares of Apex Common
Stock that constitute such holder's portion of the Aggregate Stock
Consideration, and (ii) those shares of Company Common Stock exchanged in the
First Merger for such holder's portion of the Aggregate Cash Consideration.
Each holder of Company Capital Stock that has been converted pursuant to
_Section 3.01(a)_ into the right to receive, or contributed to Apex pursuant
to the Named Executive Equity Agreements in exchange for the right to
receive, the Per Share Amount and the Per Share Contingent Consideration, if
any, shall be entitled to receive such consideration represented by book-
entry upon receipt by the Exchange Agent of a duly completed and validly
executed Letter of Transmittal, a stock certificate (if any) representing
such Company Capital Stock and an IRS Form W-9 or the appropriate version of
IRS Form W-8, as applicable.

  



  

   

28

 



    



  

(c) _Election_. Each holder of record of shares of Company Common Stock
(excluding any Dissenting Shares and Named Executive Shares) (each, an "
_Electing Stockholder_ ") shall have the right, subject to the limitations set
forth in this _Article III_ , to submit an Election in accordance with this
_Section 3.02(c)_ on or prior to the Election Deadline. The Company shall not
waive the Election Deadline unless such Election Deadline is waived with
respect to all Electing Stockholders, the new election deadline is disclosed
by the Company to all Electing Stockholders on a date agreed to by Apex, and
Apex has otherwise given its prior written consent (not to be unreasonably
withheld, conditioned or delayed) to such waiver. " _Election Deadline_ "
means 5:00 p.m. (New York time) on the date that is five Business Days prior
to the Closing Date or such other date as Apex and the Company shall, prior
to the Closing, mutually agree (the period between the Mailing Date and the
Election Deadline, the " _Election Period_ "). At any time prior to the
Election Deadline, each Electing Stockholder may specify in a request made in
accordance with the provisions of this _Section 3.02(c)_ (an " _Election_
") the Election Percentage desired by such Electing Stockholder. An Election
made by any Electing Stockholder shall apply to all shares of Company Common
Stock held by such Electing Stockholder. Apex shall prepare a form of election
that is reasonably acceptable to the Company (the " _Form of Election_ "),
and the Company shall mail and deliver or cause to be mailed and delivered,
together with the Registration Statement, the Form of Election to Electing
Stockholders, for purposes of obtaining the Elections (the " _Mailing Date_
"). The Company shall use reasonable best efforts to make available one or
more Forms of Election as may reasonably be requested from time to time by all
persons who become Electing Stockholders during the period following the
Mailing Date and prior to the Election Deadline. Any Election shall have been
made properly only if the Company shall have received, by the Election
Deadline, (A) a Form of Election properly completed and signed in accordance
with the instructions therein, and (B) the properly completed and executed
documents required to be delivered by such Electing Stockholder pursuant to
the other provisions of this Section 3.02. Any Electing Stockholder that (i)
acquires shares of Company Common Stock pursuant to an exercise of Company
Options following the Mailing Date or (ii) does not make a valid Election by
the Election Deadline shall be deemed to have made an Election equal to 0%
(the " _Default Election Percentage_ "). Any Electing Stockholder may, at any
time during the Election Period, revoke or revise his, her or its Election by
written notice to the Company prior to the Election Deadline, together with a
properly completed and signed revised Form of Election. Any subsequent
transfer of such Electing Stockholder's shares of Company Common Stock after
such Electing Stockholder has made an Election shall not automatically revoke
such Election and such Election shall continue to be deemed effective unless a
written notice of revision is delivered to the Company. The Company shall not
permit any holder of a Company Option to exercise such Company Options
commencing on the date that is five Business Days prior to the Closing Date
and until the earlier of the Effective Time or the termination of this
Agreement. Notwithstanding anything to the contrary in this Agreement, all
Elections shall be automatically deemed revoked upon termination of this
Agreement by the Company or Apex in accordance with _Article IX_. The Company
shall have reasonable discretion to determine if any Election is not properly
made, revised or revoked with respect to any shares of Company Common
Stock (none of the Company, Apex, First Merger Sub, Second Merger Sub or the
Company being under any duty to notify any Electing Stockholder of any
applicable defect). In the event the Company makes a reasonable determination
that an Election was not properly made (including as a result of the Company
not receiving an Election by the Election Deadline), such Election shall be
deemed to be ineffective, and the shares of Company Common Stock covered by
such Election shall, for purposes hereof, be deemed to have made an
Election with an Election Percentage equal to the Default Election
Percentage. The Company shall provide a copy of each Form of
Election received by it to Apex and the Exchange Agent within two Business
Days following the receipt of such Form of Election.

  



  

   

29

 



    



  

(d) _No Further Rights in Company Capital Stock_. The Per Share Amount
payable upon conversion of the Company Capital Stock in accordance with the
terms hereof or contribution to Apex pursuant to the Named Executive Equity
Agreements shall be deemed to have been paid and issued in full satisfaction
of all rights pertaining to such Company Capital Stock.

  



  

(e) _Adjustments to Per Share Amount_. The Per Share Amount shall be
adjusted to reflect appropriately the effect of any stock split,
reverse stock split, stock dividend, reorganization, recapitalization,
reclassification, combination, exchange of shares or other like change with
respect to Apex Common Stock occurring on or after the date hereof and prior
to the Effective Time.

  



  

(f) _Termination of Exchange Fund_. Any portion of the Exchange Fund that
remains undistributed to the holders of Company Capital Stock for one year
after the Effective Time shall be delivered to Apex, upon demand, and any
holders of Company Capital Stock who have not theretofore complied with this
_Section 3.02_ shall thereafter look only to Apex for the portion of the Gross
Merger Consideration payable to them. Any portion of the Exchange Fund
remaining unclaimed by holders of Company Capital Stock as of a date which is
immediately prior to such time as such amounts would otherwise escheat to or
become property of any government entity shall, to the extent permitted by
applicable law, become the property of Apex free and clear of any claims or
interest of any person previously entitled thereto.

  



  

(g) _No Liability_. None of the Exchange Agent, Apex, the Surviving
Corporation or the Surviving Entity shall be liable to any holder of Company
Capital Stock (including shares of Company Capital Stock contributed to Apex
pursuant to the Named Executive Equity Agreements) for any Apex Common Stock
(or dividends or distributions with respect thereto) or cash delivered to a
public official pursuant to any abandoned property, escheat or similar Law in
accordance with this _Section 3.02_.

  



  

(h) _Withholding_. Notwithstanding anything in this Agreement to the
contrary, each of the Company, the Surviving Corporation, the Surviving
Entity, Merger Subs, Apex, and the Exchange Agent shall be entitled to deduct
and withhold from amounts otherwise payable pursuant to this Agreement and
the Named Executive Equity Agreements such amounts as it is required to deduct
and withhold with respect to the making of such payment under the Code or any
provision of state, local or non-U.S. Tax Law. To the extent that amounts are
so deducted or withheld, such deducted or withheld amounts shall be treated
for all purposes of this Agreement as having been paid to the person in
respect of which such deduction and withholding was made.

  



  

(i) _Fractional Shares_. No certificates or scrip or shares representing
fractional shares of Apex Common Stock shall be issued upon the exchange of
Company Capital Stock and such fractional share interests will not entitle the
owner thereof to vote or to have any rights of a stockholder of Apex or a
holder of shares of Apex Common Stock. In lieu of any fractional share of Apex
Common Stock to which each holder of Company Capital Stock would otherwise be
entitled, the Exchange Agent shall round up or down to the nearest
whole share of Apex Common Stock, with a fraction of 0.5 rounded up. No cash
settlements shall be made with respect to fractional shares eliminated by
rounding.

  



  

   

30

 



    



  

Section 3.03 _Contingent Consideration_.

  



  

(a) Following the Closing, in addition to the consideration to be received
pursuant to _Section 3.01(a)_ , the Company Stockholders and
Company Optionholders shall be issued additional shares of Apex Common Stock,
as follows:

  



  

(i) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time
prior to or as of the seventh anniversary of the Closing, (x) the Closing
Price is greater than or equal to $12.50 over any 20 Trading Days within any
30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which
results in the stockholders of Apex having the right to exchange their shares
for cash, securities or other property having a value equaling or exceeding
$12.50 per share (the " _First Milestone_ ") (such 1,000,000 shares of Apex
Common Stock, the " _First Milestone Contingent Consideration_ ").

  



  

(ii) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time
prior to or as of the seventh anniversary of the Closing, (x) the Closing
Price is greater than or equal to $15.00 over any 20 Trading Days within any
30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which
results in the stockholders of Apex having the right to exchange their shares
for cash, securities or other property having a value equaling or exceeding
$15.00 per share (the " _Second Milestone_ ") (such 1,000,000 shares of Apex
Common Stock, the " _Second Milestone Contingent Consideration_ ").

  



  

(iii) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time
prior to or as of the seventh anniversary of the Closing, (x) the Closing
Price is greater than or equal to $17.50 over any 20 Trading Days within any
30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which
results in the stockholders of Apex having the right to exchange their shares
for cash, securities or other property having a value equaling or exceeding
$17.50 per share (the " _Third Milestone_ " and together with the First
Milestone and the Second Milestone, the " _Contingent Milestones_ ") (such
1,000,000 shares of Apex Common Stock, the " _Third Milestone Contingent
Consideration_ " and together with the First Milestone Contingent
Consideration and the Second Milestone Contingent Consideration, the "
_Contingent Consideration_ "). For the avoidance of doubt, the maximum amount
of the Contingent Consideration is 3,000,000 shares of Apex Common Stock, in
the aggregate.

  



  

(b) If any of the Contingent Milestones set forth in _Section 3.03(a)_ shall
have been achieved, within five Business Days following the achievement of
the applicable Contingent Milestone, Apex shall, or shall cause the Exchange
Agent or any replacement transfer agent engaged by Apex to, issue the
applicable Per Share Contingent Consideration to each Company Stockholder and
Company Optionholder.

  



  

(c) Notwithstanding anything in _Section 3.03(b)_ to the contrary, to the
extent that any portion of the Contingent Consideration that would
otherwise be issued to a Company Optionholder hereunder relates to a Company
Option exchanged for an Exchanged Option that remains unvested as of such
Contingent Milestone (each such Exchanged Option, an " _Unvested Exchanged
Option_ "), then in lieu of issuing the applicable Contingent Consideration,
Apex shall instead issue, as soon as practicable following the later of (i)
the occurrence of such Contingent Milestone and (ii) Apex's filing of a Form
S-8 Registration Statement, to each holder of an Unvested Exchanged Option,
an award of restricted stock units of Apex for a number of shares of Apex
Common Stock equal to such portion of the Contingent Consideration issuable
with respect to the Unvested Exchanged Option (the " _Contingent RSUs_ "). A
holder of an Unvested Exchanged Option shall only be granted Contingent RSUs
if such holder remains in continuous service to Apex or one of its
subsidiaries as of the applicable Contingent Milestone and the applicable
grant date of the Contingent RSUs. Such Contingent RSUs shall vest in equal
amounts (or as close as possible, with any excess shares vesting on the last
vesting date) over the remaining vesting schedule of the applicable Unvested
Exchanged Option and shall be subject to the same vesting conditions as
applied to the applicable Unvested Exchanged Option. All Contingent RSUs to be
issued hereunder shall be issued under and pursuant to the terms of the Apex
Equity Incentive Plan and shall cover a number of shares in addition to the
share reserve approved for all other awards under _Section 7.01(a)_ under such
Apex Equity Incentive Plan.

  



  

   

31

 



    



  

(d) Notwithstanding anything in Section 3.03(b) to the contrary, to the
extent that any portion of the Contingent Consideration that relates to a
Specified Option exchanged for an Exchanged Option would otherwise be issued
to a holder of a Specified Option before the Specified Option Delivery Date,
then such Contingent Consideration shall instead be issued on the Specified
Option Delivery Date.

  



  

(e) Notwithstanding anything in Section 3.03(b) to the contrary, no
Contingent Consideration shall be issued in respect of any PRC Option, and
instead cash payment equal to the value of the Contingent Consideration as of
the close of the Trading Day on which the applicable Contingent Milestone is
achieved that otherwise would have been issuable in respect of such PRC Option
shall be made to the holder thereof in lieu of the applicable Contingent
Consideration.

  



  

(f) If any of the Contingent Milestones set forth in _Section 3.03(a)_ shall
not have been achieved on or prior to the seventh anniversary of the Closing,
the Company Stockholders and Company Optionholders shall have no further right
to receive the applicable Contingent Consideration.

  



  

(g) The Closing Price targets and any determination with respect to the
achievement of the Contingent Milestones and the amount of
Contingent Consideration and the Contingent RSUs shall be adjusted to reflect
appropriately the effect of any stock split, reverse stock split, stock
dividend (including any dividend or distribution of securities convertible
into shares of Apex Common Stock), reorganization, recapitalization,
reclassification, combination, merger, sale or exchange of shares or other
like change with respect to shares of Apex Common Stock, occurring on or
after the date hereof and prior to the time any such Contingent Consideration
is delivered to the Company Stockholders and Company Optionholders, if any.

  



  

(h) The right of a Company Stockholder or Company Optionholder to receive the
Per Share Contingent Consideration pursuant to this _Section 3.03_ (or
Contingent RSUs, if applicable) shall not be transferrable or assignable to
any other person except by will or intestacy upon the death of a Company
Stockholder or Company Optionholder that is a natural person and any shares of
Apex Common Stock issuable under this _Section 3.03_ shall be issued solely
in the name of, or for the benefit of, such Company Stockholder or
Company Optionholder or its permitted transferee in accordance with this
_Section 3.03(h)_.

  



  

(i) For the avoidance of doubt, if the condition for more than one Contingent
Milestone is achieved, the Contingent Consideration to be earned in
connection with such Contingent Milestone shall be cumulative with any
Contingent Consideration earned prior to such time in connection with the
achievement of any other Contingent Milestone; _provided_ that, for
avoidance of doubt, Contingent Consideration in respect of each Contingent
Milestone will be issued and earned only once and the aggregate
Contingent Consideration issued shall in no event exceed 3,000,000 shares of
Apex Common Stock.

  



  

Section 3.04 _Stock Transfer Books_. At the Effective Time, the stock
transfer books of the Company shall be closed and there shall be no further
registration of transfers of Company Capital Stock thereafter on the records
of the Company. From and after the Effective Time, holders of Company Capital
Stock outstanding immediately prior to the Effective Time shall cease to have
any rights with respect to such Company Capital Stock, except as
otherwise provided in this Agreement or by Law.

  



  

Section 3.05 _Appraisal Rights_.

  



  

(a) Notwithstanding any provision of this Agreement to the contrary and to
the extent available under the DGCL, shares of Company Capital Stock that are
outstanding immediately prior to the Effective Time and that are held by
stockholders of the Company who shall have neither voted in favor of the
Mergers nor consented thereto in writing and who shall have demanded properly
in writing appraisal for such Company Capital Stock in accordance with
Section 262 of the DGCL and otherwise complied with all of the provisions of
the DGCL relevant to the exercise and perfection of dissenters' rights ("
_Dissenting Shares_ ") shall not be converted into, and such stockholders
shall have no right to receive, the consideration payable pursuant to _Section
3.01(a)(ii)_  unless and until such stockholder fails to perfect or withdraws
or otherwise loses his, her or its right to appraisal and payment under the
DGCL. Any stockholder of the Company who fails to perfect or who effectively
withdraws or otherwise loses his, her or its rights to appraisal of such
shares of Company Capital Stock under Section 262 of the DGCL shall thereupon
be deemed to have been converted into, and to have become exchangeable for,
as of the Effective Time, the right to receive the consideration payable
pursuant to _Section 3.01(a)(ii)_ , without any interest thereon, upon
surrender, if applicable, in the manner provided in _Section 3.02(b)_ , of
the Certificate or Certificates that formerly evidenced such shares of Company
Capital Stock (as the case may be).

  



  

   

32

 



    



  

(b) Prior to the Closing, the Company shall give Apex (i) prompt notice of
any demands for appraisal received by the Company and any withdrawals of such
demands, and (ii) the opportunity to participate in all negotiations and
proceedings with respect to demands for appraisal under the DGCL. The Company
shall not, except with the prior written consent of Apex (which consent shall
not be unreasonably withheld), make any payment with respect to any demands
for appraisal or offer to settle or settle any such demands.

  



  

Article IV. 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  



  

Except as set forth in the correspondingly numbered Section of the Company's
disclosure schedule delivered by the Company in connection with this
Agreement (the " _Company Disclosure Schedule_ ") ( _provided_ , that such
disclosure shall be deemed to qualify or provide disclosure in response to
the section of this _Article IV_ under which such disclosure is made and
any other section of this _Article IV_ to the extent its relevance is
reasonably apparent from the face of such disclosure; _provided_ ,  _further_
, that any matter required to be disclosed for purposes of _Section 4.01_,
_Section 4.02_, _Section 4.03_, or _Section 4.04_ shall only be disclosed
by specific disclosure in the corresponding section of the Company
Disclosure Schedule), the Company hereby represents and warrants to Apex and
Merger Subs as follows:

  



  

Section 4.01 _Organization and Qualification; Subsidiaries_.

  



  

(a) The Company, is a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware and has the requisite
corporate or other organizational power and authority and all necessary
governmental approvals to own, lease and operate its properties and to carry
on its business as it is now being conducted. Each subsidiary of the Company
(each a " _Company Subsidiary_ ") is a corporation, company, or other
organization duly organized, validly existing and in good standing (if such
concept exists in the applicable jurisdiction) under the laws of the
jurisdiction of its incorporation or organization, and has the requisite
corporate or other organizational power and authority and all necessary
governmental approvals to own, lease and operate its properties and to carry
on its business as it is now being conducted, except as would not individually
or in the aggregate reasonably be expected to have a Company Material Adverse
Effect. The Company and each Company Subsidiary is duly qualified or licensed
as a foreign corporation or other organization to do business, and is in good
standing (in each case, if such concept exists in the applicable
jurisdiction), in each jurisdiction where the character of the properties
owned, leased or operated by it or the nature of its business makes such
qualification or licensing necessary, except for such failures to be so
qualified or licensed and in good standing that would not individually or in
the aggregate reasonably be expected to have a Company Material Adverse
Effect.

  



  

   

33

 



    



  

(b) A true and complete list of all the Company Subsidiaries, together with
the jurisdiction of incorporation or organization of each Company Subsidiary
and the percentage of the equity interest of each Company Subsidiary owned by
the Company and each other Company Subsidiary, is set forth in _Section
4.01(b)_ of the Company Disclosure Schedule. Other than with respect to any
Company Subsidiary, the Company does not directly or indirectly own, and has
never owned, any equity or similar interest in, or any interest
convertible into or exchangeable or exercisable for any equity or similar
interest in, any other corporation, partnership, joint venture or business
association or other entity.

  



  

Section 4.02 _Certificate of Incorporation and Bylaws_. The Company has
prior to the date of this Agreement made available to Apex in the Virtual Data
Room complete and correct copies of the Company Organizational Documents and
the Company Subsidiary Organizational Documents (such Company Organizational
Documents and the Company Subsidiary Organizational Documents collectively,
the " _Company Group Organizational Documents_ "). The Company Group
Organizational Documents are in full force and effect. No Company Group Member
is in violation of any of the provisions of its respective Company Group
Organizational Documents.

 



  

Section 4.03 _Capitalization_.

  



  

(a) As of the date hereof, the authorized capital stock of the Company
consists of 28,000,000 shares of Company Common Stock, of which 25,000,000
shares are voting Company Common Stock and 3,000,000 shares are non-voting
Company Common Stock and 12,612,502 shares of Company Preferred Stock, of
which 547,283 shares are designated as Series A-1 Convertible Preferred Stock,
124,050 are designated as Series A-2 Convertible Preferred Stock, 3,326,340
are designated as Series B-1 Convertible Preferred Stock, 2,736,477 are
designated as Series B-2 Convertible Preferred Stock, 1,045,943 are
designated as Series C Prime Convertible Preferred Stock and 4,832,409 are
designated as Company Series C Preferred Stock. As of the date hereof, (i)
9,652,236 shares of voting Company Common Stock are issued and outstanding,
(ii) 1,851,900 shares of non-voting Company Common Stock are outstanding,
(iii) 4,832,409 shares of Company Series C Preferred Stock are issued and
outstanding, (iv) no shares of any other series of Company Capital Stock are
outstanding, (v) no shares of Company Common Stock or Company Preferred Stock
are held in the treasury of the Company, (iv) 4,007,268 shares of Company
Common Stock are issuable pursuant to outstanding Company Options granted
pursuant to the Company Option Plans or otherwise, and (v) 2,223,577 shares
of Company Common Stock are available for future issuance pursuant to the
Company Option Plans. As of the date hereof, each share of Company Preferred
Stock is convertible into one share of Company Common Stock pursuant to
Section 4.1.1 of Part B of Article Fourth of the Company Certificate of
Incorporation.

  



  

   

34

 



    



  

(b) Other than the Company Options and the Company Preferred Stock, there are
no options, warrants, preemptive rights, calls, convertible securities,
conversion rights or other rights, agreements, arrangements or commitments of
any character relating to the issued or unissued capital stock of any Company
Group Member or obligating any Company Group Member to issue or sell any
shares of capital stock of, or other equity or voting interests in, or any
securities convertible into or exchangeable or exercisable for shares of
capital stock, or other equity or other voting interests in, any Company Group
Member. As of the date hereof, except as set forth on _Section 4.03(b)_ of
the Company Disclosure Schedule, no Company Group Member is a party to, or
otherwise bound by, and no Company Group Member has granted, any equity
appreciation rights, participations, phantom equity, restricted shares,
restricted share units, performance shares, contingent value rights or
similar securities or rights that are derivative of, or provide
economic benefits based, directly or indirectly, on the value or price of,
any capital stock of, or other securities or ownership interests in, any
Company Group Member, in each case, other than the Company Options and the
Company Preferred Stock. There are no voting trusts, voting agreements,
proxies, shareholder agreements or other agreements to which any Company Group
Member is a party, or to the Company's knowledge, among any holder of Company
Common Stock, Company Preferred Stock or any other equity interests or other
securities of any Company Group Member to which any Company Group Member is
not a party, with respect to the voting or transfer of the Company Common
Stock, Company Preferred Stock or any of the equity interests or other
securities of any Company Group Member.

  



  

(c) _Section 4.03(c)_ of the Company Disclosure Schedule sets forth, the
following information with respect to each Company Option outstanding: (i)
the name of the Company Option holder; (ii) the Company Option Plan, if any,
pursuant to which such Company Option was granted; (iii) the number of shares
of the Company subject to such Company Option; (iv) the exercise or purchase
price of such Company Option; (v) the date on which such Company Option was
granted; (vi) the date on which such Company Option expires; (vii) the vesting
schedule of such Company Option; (viii) any accelerated vesting provisions
applicable to such Company Option; (ix) whether such Company Option is
exercisable prior to vesting and (x) the type of Company Option (incentive
stock option or nonqualified stock option). The Company has made available to
Apex in the Virtual Data Room accurate and complete copies of the Company
Option Plans pursuant to which Company has granted the Company Options that
are currently outstanding and the form of all stock option agreements
evidencing such Company Options. No Company Option was granted with an
exercise price per share less than the fair market value of a share of
Company Common Stock on the date such Company Option was granted. All shares
of the Company subject to issuance as aforesaid, upon issuance on the terms
and conditions specified in the instruments pursuant to which they are
issuable, will be duly authorized, validly issued, fully paid and non-
assessable.

  



  

(d) Except for the Company Subsidiaries and as set forth on _Section 4.03(d)_
of the Company Disclosure Schedule, the Company does not own any equity
interests in any person or have any rights to acquire, directly or indirectly,
any equity interests of, or otherwise control, any person. There are no
outstanding contractual obligations of the Company or any Company Subsidiaries
to provide funds to, or make any investment (in the form of a loan, capital
contribution or otherwise) in, any person that is not a Company Subsidiary.

  



  

(e) There are no outstanding contractual obligations of any Company Group
Member to repurchase, redeem or otherwise acquire any shares of any Company
Group Member or to provide funds to or make any investment (in the form of a
loan, capital contribution or otherwise) in any person other than a Company
Subsidiary.

  



  

   

35

 



    



  

(f) (i) There are no commitments or agreements of any character to which the
Company is bound obligating the Company to accelerate the vesting of any
Company Option as a result of the proposed transactions herein, and (ii) all
outstanding shares of Company Common Stock and Company Preferred Stock, all
outstanding Company Options, and all outstanding shares of capital stock or
other equity securities (as applicable) of each Company Subsidiary have been
issued and granted in compliance with (A) all applicable securities laws and
other applicable laws and (B) all preemptive rights and other requirements set
forth in applicable contracts to which any Company Group Member is a party
and the applicable Company Group Organizational Documents. There are no
securities or instruments issued by or to which a Company Group Member is a
party containing anti-dilution or similar provisions that will be triggered
by the consummation of the Transactions or the Private Placements.

  



  

(g) The stockholders and optionholders of the Company collectively own
directly and beneficially and of record, all of the equity of the Company
(which are represented by the issued and outstanding shares of Company Common
Stock and Company Preferred Stock and the Company Options). Except for the
shares of Company Common Stock and Company Preferred Stock held by the
stockholders of the Company and the Company Options, no shares or other
equity or voting interest of the Company, or options, warrants or other rights
to acquire any such shares or other equity or voting interest, of the Company
is authorized or issued and outstanding.

  



  

(h) Each outstanding share of capital stock of the Company is duly
authorized, validly issued, fully paid and non-assessable, and each
such share is free and clear of all Liens, options, rights of first refusal
and limitations on the Company's or any Company Subsidiary's voting rights,
other than transfer restrictions under applicable securities Laws and their
applicable Company Group Organizational Documents. Each outstanding share of
capital stock of each Company Subsidiary is duly authorized, validly issued,
fully paid and non-assessable, and each such share is owned 100% by the
Company or another Company Subsidiary free and clear of all Liens,
options, rights of first refusal and limitations on the Company's or any
Company Subsidiary's voting rights, other than transfer restrictions under
applicable securities Laws and their applicable Company Group Organizational
Documents.

  



  

Section 4.04 _Authority Relative to this Agreement_. The Company has all
necessary power and authority to execute and deliver this Agreement and any
Ancillary Agreement to which it is a party, to perform its obligations
hereunder and thereunder, and subject to receiving the Company Stockholder
Approval, to consummate the Transactions. The execution and delivery of this
Agreement and any Ancillary Agreement to which it is a party by the Company
and the consummation by the Company of the Transactions have been duly and
validly authorized by all necessary corporate action and no other corporate
proceedings on the part of the Company are necessary to authorize this
Agreement, any Ancillary Agreement to which it is a party or to consummate
the Transactions (other than, with respect to the Mergers, the Company
Stockholder Approval, which the Written Consent shall satisfy, and the filing
and recordation of appropriate merger documents as required by the DGCL and
the DLLCA). This Agreement has been duly and validly executed and delivered by
the Company and, assuming the due authorization, execution and delivery by
Apex and Merger Subs, constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, except
as limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors'
rights generally, by general equitable principles (the " _Remedies
Exceptions_ "). The Company Board has approved this Agreement and the
Transactions, and such approvals are sufficient so that the restrictions on
business combinations set forth in Section 203 of the DGCL shall not apply to
the Mergers, this Agreement, the Stockholder Support Agreement, any Ancillary
Agreement to which it is a party or any of the other Transactions. To the
knowledge of the Company, no other state takeover statute is applicable to the
Mergers or the other Transactions.

  



  

   

36

 



    



  

Section 4.05 _No Conflict; Required Filings and Consents_.

  



  

(a) The execution and delivery of this Agreement and the Ancillary Agreements
to which it is a party by the Company does not, and subject to receipt of the
filing and recordation of appropriate merger documents as required by the DGCL
and the DLLCA, and of the consents, approvals, authorizations or permits,
filings and notifications, expiration or termination of waiting periods after
filings and other actions contemplated by _Section 4.05(b)_ and assuming all
other required filings, waivers, approvals, consents, authorizations and
notices disclosed in _Section 4.05(a)_ of the Company Disclosure Schedule,
including the Written Consent, and other notifications provided in the
ordinary course of business have been made, obtained or given, the performance
of this Agreement by the Company will not (i) conflict with or violate the
Company Group Organizational Documents, (ii) conflict with or violate any
United States or non-U.S. Law applicable to any Company Group Member or by
which any property or asset of any Company Group Member is bound or affected,
or (iii) require the consent, notice or other action by any person under,
result in any breach of or constitute a default (or an event which, with
notice or lapse of time or both, would become a default) under, or give
to others any right of termination, amendment, acceleration or cancellation
of, or result in the creation of a Lien (other than any Permitted Lien) on
any material property or asset of any Company Group Member pursuant to, any
Material Contract or Company Permit, except, with respect to _clauses (ii)_
and _(iii)_ , for any such conflicts, violations, breaches, defaults or other
occurrences which would not have or reasonably be expected to have a Company
Material Adverse Effect.

  



  

(b) The execution and delivery of this Agreement and the Ancillary Agreements
to which it is a party by the Company does not, and the performance of this
Agreement and the Ancillary Agreements to which it is a party by the Company
will not, require any consent, approval, authorization or permit of, or
filing with or notification to, or expiration or termination of any waiting
period by, any Governmental Authority, except (i) for applicable
requirements, if any, of the Exchange Act, state securities or "blue sky" laws
(" _Blue Sky Laws_ ") and state takeover laws, the pre-merger notification
requirements of the HSR Act, and filing and recordation of appropriate merger
documents as required by the DGCL and the DLLCA, and (ii) where the failure to
obtain such consents, approvals, authorizations or permits, or to make such
filings or notifications, would not have or would not reasonably be expected
to have a Company Material Adverse Effect.

  



  

Section 4.06 _Permits; Compliance_. Each of the Company and the Company
Subsidiaries is in possession of all material franchises, grants,
authorizations, licenses, permits, easements, variances, exceptions, consents,
certificates, approvals and orders of any Governmental Authority necessary
for each of the Company or the Company Subsidiaries to own, lease and operate
its properties or to carry on its business as it is now being conducted (the
" _Company Permits_ "), except where the failure to have such Company Permits
would not reasonably be expected to have a Company Material Adverse Effect.
No suspension or cancellation of any of the Company Permits is pending or, to
the knowledge of the Company, threatened in writing. No Company Group Member
is in conflict with, or in default, breach or violation of, (a) any Law
applicable to such Company Group Member or by which any property or asset of
such Company Group Member is bound or affected, or (b) any Material Contract
or Company Permit, except, in each case, for any such conflicts, defaults,
breaches or violations that would not have or would not reasonably be
expected to have a Company Material Adverse Effect.

  



  

   

37

 



    



  

Section 4.07 _Financial Statements._

  



  

(a) The Company has made available to Apex in the Virtual Data Room true and
complete copies of the audited consolidated balance sheets of the Company
Group as of December 31, 2019, December 31, 2018 and December 31, 2017 and the
related audited statements of operations and cash flows of the Company Group
for each of the years then ended (together with the Updated Annual
Financial Statements and the 2020 Audited Financial Statements delivered
pursuant to _Section 7.17_ , the " _Annual Financial Statements_ "), which
are attached as _Section 4.07(a)_ of the Company Disclosure Schedule. Each of
the Annual Financial Statements (including the notes thereto) (i) was
prepared in accordance with United States generally accepted
accounting principles (" _GAAP_ ") applied on a consistent basis throughout
the periods indicated (except as may be indicated in the notes thereto) and
(ii) fairly presents, in all material respects, the financial position,
results of operations and cash flows of the Company Group as at the date
thereof and for the period indicated therein, except as otherwise noted
therein.

  



  

(b) The Company has made available to Apex in the Virtual Data Room true and
complete copies of the consolidated unaudited balance sheet of the Company
Group as of June 30, 2020 (the balance sheet as of June 30, 2020, the " _2020
Balance Sheet_ "), and the related unaudited statements of operations and
cash flows of the Company and the Company Subsidiaries for the six
months then ended (together with the Updated Audited Interim Financial
Statements delivered pursuant to _Section 7.17_ , the " _Interim Financial
Statements_ "), which are attached as _Section 4.07(b)_ of the Company
Disclosure Schedule. The Interim Financial Statements were prepared in
accordance with GAAP applied on a consistent basis throughout the periods
indicated (except for the omission of footnotes and subject to year-end
adjustments) and fairly present, in all material respects, the
financial position, results of operations and cash flows of the Company Group
as at the date thereof and for the period indicated therein, except as
otherwise noted therein and subject to normal and recurring year-end
adjustments and the absence of notes.

  



  

(c) Except as and to the extent set forth on the 2020 Balance Sheet and the
Company Transaction Expenses, no Company Group Member has any liability or
obligation of a nature (whether accrued, absolute, contingent or otherwise)
required to be reflected on a balance sheet prepared in accordance with GAAP,
except for: (i) liabilities that were incurred in the ordinary course of
business since June 30, 2020 and that do not involve the incurrence of
indebtedness for money borrowed, except for indebtedness permitted in
accordance with _Section 6.01_ hereof, (ii) obligations for future
performance under any contract to which any Company Group Member is a party
or (iii) such other liabilities and obligations which are not, individually or
in the aggregate, expected to result in a Company Material Adverse Effect.

  



  

(d) In the past three years, (i) no Company Group Member nor, to the
Company's knowledge, any director, officer, employee, auditor, accountant or
Representative of any Company Group Member, has received or otherwise had or
obtained knowledge of any complaint, allegation, assertion or claim, whether
written or, to the knowledge of the Company, oral, regarding the accounting or
auditing practices, procedures, methodologies or methods of any Company Group
Member or their respective internal accounting controls, including any such
complaint, allegation, assertion or claim that any Company Group Member has
engaged in accounting or auditing practices in breach of any applicable Laws
and (ii) there have been no internal investigations regarding accounting or
revenue recognition discussed with, reviewed by or initiated at the direction
of the chief executive officer, chief financial officer, general counsel, the
Company Board or any committee thereof.

  



  

   

38

 



    



  

(e) To the knowledge of the Company, no employee of any Company Group Member
has provided or is providing information to any law enforcement agency
regarding the commission or possible commission of any crime or the violation
or possible violation of any applicable Law. None of the Company, any Company
Subsidiary or, to the knowledge of the Company, any officer, employee,
contractor, subcontractor or agent of any Company Group Member has
discharged, demoted, suspended, threatened, harassed or in any other manner
discriminated against an employee of any Company Group Member in the terms
and conditions of employment because of any act of such employee described in
18 U.S.C. sec. 1514A(a).

  



  

(f) All accounts receivable of the Company and the Company Subsidiaries
reflected on the 2020 Balance Sheet or arising thereafter have arisen from
bona fide transactions in the ordinary course of business consistent with past
practices and in accordance with GAAP and are collectible, subject to bad
debts reserved in the Interim Financial Statements. To the knowledge of the
Company, such accounts receivables are not subject to valid defenses, setoffs
or counterclaims, other than routine credits granted for errors in
ordering, shipping, pricing, discounts, rebates, returns in the ordinary
course of business and other similar matters. The Company's reserve for
contractual allowances and doubtful accounts is adequate in all material
respects and has been calculated in a manner consistent with past practices.
Since June 30, 2020, no Company Group Member has modified or changed in any
material respect its sales practices or methods including, without
limitation, such practices or methods in accordance with which any Company
Group Member sells goods, fills orders or records sales.

  



  

(g) Except as would not, individually or in the aggregate, be material to any
Company Group Member, all accounts payable of the Company Group reflected on
the 2020 Balance Sheet or arising thereafter are the result of bona fide
transactions in the ordinary course of business and have been paid or are not
yet due or payable. Since the date of the 2020 Balance Sheet, no Company Group
Member has altered in any material respects its practices for the payment of
such accounts payable, including the timing of such payment.

  



  

(h) The Company maintains systems of internal control over financial
reporting that are designed to provide, in all material respects, reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements in accordance with GAAP, including policies and
procedures sufficient to provide reasonable assurance: (i) that the Company
maintains records that in reasonable detailed accurately and fairly reflect
the transactions and dispositions of assets, (ii) that all transactions are
recorded as necessary to permit the preparation of financial statements in
conformity with GAAP; (iii) that receipts and expenditures are being made
only in accordance with authorizations of management and its board of
directors; and (iv) regarding prevention or timely detection of unauthorized
acquisition, use or disposition of its assets that could have a material
effect on its financial statements. The Company has delivered to Apex a true
and complete copy of any disclosure (or, if unwritten, a summary thereof) by
any representative of the Company to the Company's independent auditors
relating to any material weaknesses in internal controls and any significant
deficiencies in the design or operation of internal controls that would
adversely affect the ability of the Company to record, process, summarize and
report financial data. The Company has no knowledge of any fraud or whistle-
blower allegations, whether or not material, that involve management or other
employees or consultants who have or had a significant role in the internal
control over financial reporting of the Company.

  



  

   

39

 



    



  

Section 4.08 _Absence of Certain Changes or Events_. Since December 31, 2019
and prior to the date of this Agreement, except as otherwise reflected in the
Annual Financial Statements or Interim Financial Statements, or as expressly
contemplated by this Agreement, (a) the Company and the Company Subsidiaries
have conducted their respective businesses in all material respects in the
ordinary course and in a manner consistent with past practice, other than due
to any actions taken due to a "shelter in place," "non-essential employee" or
similar direction of any Governmental Authority, (b) no Company Group Member
has sold, assigned, transferred, permitted to lapse, abandoned, or otherwise
disposed of any right, title, or interest in or to any of its material assets
(including Company-Owned IP) other than revocable non-exclusive licenses (or
sublicenses) of Company-Owned IP granted in the ordinary course of business,
(c) there has not been a Company Material Adverse Effect, and (d) no Company
Group Member has taken any action that, if taken after the date of this
Agreement, would constitute a material breach of any of the covenants set
forth in _Section 6.01_.

  



  

Section 4.09 _Absence of Litigation_. There is no material litigation, suit,
claim, action, proceeding, arbitration, hearing, inquiry or investigation by
or before or involving any Governmental Authority or any arbitrator or
arbitration panel (an " _Action_ ") pending or, to the knowledge of the
Company, threatened against any Company Group Member, or any property or
asset of any Company Group Member, before any Governmental Authority. Except
as would not, individually or in the aggregate, be material to any Company
Group Member, no Company Group Member nor any material property or asset of
any Company Group Member is, subject to any continuing order of, consent
decree, settlement agreement or other similar written agreement with, or, to
the knowledge of the Company, continuing investigation by, any Governmental
Authority, or any order, writ, judgment, injunction, decree, determination or
award of any Governmental Authority. _Section 4.09_ of the Company Disclosure
Schedule sets forth a description of each Action by or against the Company
that is pending as of the date hereof.

  



  

Section 4.10 _Employee Benefit Plans._

  



  

(a) _Section 4.10(a)_ of the Company Disclosure Schedule lists, as of the
date of this Agreement, all employment and individual consulting contracts or
agreements that are compensatory in nature to which any Company Group Member
is a party, with respect to which any Company Group Member has any obligation
(other than customary employee or officer (or similar) indemnification
obligations under employment and consulting agreements that have terminated
and as to which no indemnity claim is presently outstanding or unpaid). 
_Section 4.10(a)_ of the Company Disclosure Schedule also lists, as of the
date of this Agreement, Employee Benefit Plans which are maintained,
contributed to or sponsored by any Company Group Member or any ERISA Affiliate
for the benefit of any current or former employee, officer, director or
consultant of any Company Group Member (or their respective beneficiaries or
dependents), or under which any Company Group Member has or could reasonably
be expected to incur any liability (contingent or otherwise)
(collectively, the " _Plans_ "). For purposes of this Agreement, " _ERISA
Affiliate_ " shall mean any entity that together with any Company Group
Member would be deemed a "single employer" for purposes of Section
4001(b)(1) of ERISA or Sections 414(b), (c) or (m) of the Code.

  



  

   

40

 



    



  

(b) With respect to each Plan, the Company has made available to Apex in the
Virtual Data Room, if applicable (i) a true and complete copy of the current
plan document and all amendments thereto and each trust or other funding
arrangement, (ii) copies of the most recent summary plan description and any
summaries of material modifications, (iii) a copy of the most recently filed
Form 5500 annual report and accompanying schedules, (iv) copies of the most
recently received IRS determination, opinion or advisory letter for each such
Plan, and (v) any material non-routine correspondence from any Governmental
Authority with respect to any Plan within the past three years. No Company
Group Member has any express commitment to modify, change or terminate any
Plan that may result in additional material liability to such Company Group
Member, other than with respect to a modification, change or
termination required by ERISA or the Code, or other applicable Law.

  



  

(c) No Company Group Member nor any ERISA Affiliate maintains, sponsors,
contributes to or reasonably expects to have any liability or obligation
under, or within the past six years has maintained, sponsored or contributed
to or had any liability or obligation under (i) a multiemployer plan (within
the meaning of Section 3(37) or 4001(a)(3) of ERISA), (ii) a single employer
pension plan (within the meaning of Section 4001(a)(15) of ERISA) subject to
Section 412 of the Code or Title IV of ERISA, (iii) a multiple employer plan
subject to Section 413(c) of the Code, or (iv) a multiple employer welfare
arrangement under ERISA.

  



  

(d) No Company Group Member is or will be obligated, whether under any Plan
or otherwise, to pay separation, severance, termination or similar benefits
to any person directly as a result of any Transaction contemplated by this
Agreement, nor will any such transaction accelerate the time of payment or
vesting, or increase the amount, of any benefit or other compensation due to
any individual. The Transactions shall not be the direct or indirect cause of
any amount paid or payable by any Company Group Member being classified as an
"excess parachute payment" under Section 280G of the Code.

  



  

(e) None of the Plans provides, nor does any Company Group Member have or
reasonably expect to have, any obligation to provide retiree medical to any
current or former employee, officer, director or consultant of any Company
Group Member after termination of employment or service except as may be
required under Section 4980B of the Code and Parts 6 and 7 of Title I of ERISA
and the regulations thereunder.

  



  

(f) Each Plan is and has been within the past six years in compliance, in all
material respects, in accordance with its terms and the requirements of all
applicable Laws including, without limitation, ERISA and the Code. Each
Company Group Member and the ERISA Affiliates have performed, in all material
respects, all obligations required to be performed by them under, are not in
any material respect in default under or in violation of, and have no
knowledge of any default or violation in any material respect by any party to
any Plan. No Action is pending or, to the knowledge of the Company,
threatened with respect to any Plan (other than claims for benefits in the
ordinary course) and, to the knowledge of the Company, no fact or event exists
that could reasonably be expected to give rise to any such Action.

  



  

   

41

 



    



  

(g) Each Plan that is intended to be qualified under Section 401(a) of the
Code or Section 401(k) of the Code has (i) timely received a favorable
determination letter from the IRS covering all of the provisions applicable to
the Plan for which determination letters are currently available that the
Plan is so qualified and each trust established in connection with such Plan
is exempt from federal income Taxation under Section 501(a) of the Code or
(ii) is entitled to rely on a favorable opinion letter from the IRS, and to
the knowledge of Company, no fact or event has occurred since the date of such
determination or opinion letter or letters from the IRS that could reasonably
be expected to adversely affect the qualified status of any such Plan or the
exempt status of any such trust.

  



  

(h) There has not been any prohibited transaction (within the meaning of
Section 406 of ERISA or Section 4975 of the Code) nor any reportable events
(within the meaning of Section 4043 of ERISA) with respect to any Plan that
could reasonably be expected to result in material liability to any Company
Group Member. There have been no acts or omissions by any Company Group Member
or any ERISA Affiliate that have given or could reasonably be expected to
give rise to any material fines, penalties, Taxes or related charges under
Sections 502 or 4071 of ERISA or Section 511 or Chapter 43 of the Code for
which the Company, any Company Subsidiary, or any ERISA Affiliate may be
liable.

  



  

(i) All material contributions, premiums or payments required to be made with
respect to any Plan have been timely made to the extent due or properly
accrued on the financial statements of the Company Group.

  



  

(j) Each Company Group Member and each ERISA Affiliate have each complied in
all material respects with the notice and continuation coverage requirements,
and all other requirements, of Section 4980B of the Code and Parts 6 and 7 of
Title I of ERISA, and the regulations thereunder, with respect to each Plan
that is, or was during any Tax year for which the statute of limitations on
the assessment of federal income Taxes remains open, by consent or otherwise,
a group health plan within the meaning of Section 5000(b)(1) of the Code.

  



  

(k) Each Company Group Member, and each Plan that is a "group health plan" as
defined in Section 733(a)(1) of ERISA (each, a " _Health Plan_ ") is and has
been in compliance, in all material respects, with the Patient Protection and
Affordable Care Act of 2010 (" _PPACA_ "), and no event has occurred, and no
condition or circumstance exists, that could reasonably be expected to
subject the Company, any Company Subsidiary, any ERISA Affiliate, or any
Health Plan to any material liability for penalties or excise Taxes under
Code Section 4980D or 4980H or any other provision of the PPACA.

  



  

(l) Each Plan that constitutes a nonqualified deferred compensation plan
subject to Section 409A of the Code has been administered and operated in
compliance in all material respects with the provisions of Section 409A of the
Code and the Treasury Regulations thereunder, and no additional Tax under
Section 409A(a)(1)(B) of the Code has been or could reasonably be expected to
be incurred by a participant in any such Plan.

  



  

   

42

 



    



  

Section 4.11 _Labor and Employment Matters_.

  



  

(a) The Company has made available to Apex a true, correct and complete list
of all employees of the Company Group as of the date hereof, including any
employee who is on a leave of absence of any nature, authorized or
unauthorized, and sets forth for each such individual the following: (i)
name; (ii) title or position (including whether full or part time); (iii) hire
date; (iv) current annual base compensation rate; and (v) commission, bonus
or other incentive based compensation. As of the date hereof, all
compensation, including wages, commissions and bonuses, due and payable to
all employees of the Company Group for services performed on or prior to
the date hereof have been paid in full (or accrued in full in the Company's
financial statements), except as would not, individually or in the aggregate,
be material to any Company Group Member.

  



  

(b) (i) There are no material Actions pending or, to the knowledge of the
Company, threatened against any Company Group Member by any of its current or
former employees, which Actions would be material to any Company Group Member;
(ii) no Company Group Member is, nor has been for the past five years, a
party to, bound by, or negotiating any collective bargaining agreement or
other contract with a union, works council or labor organization applicable
to persons employed by any Company Group Member, nor, to the knowledge of the
Company, are there any activities or proceedings of any labor union to
organize any such employees; (iii) there are no unfair labor practice
complaints pending against any Company Group Member before the National Labor
Relations Board; and (iv) there has never been, nor, to the knowledge of the
Company, has there been any threat of any strike, slowdown, work stoppage,
lockout, concerted refusal to work overtime or other similar labor disruption
or dispute affecting, or, to the knowledge of the Company, threat thereof, by
or with respect to any employees of any Company Group Member.

  



  

(c) Since January 1, 2017, the Company Group is and has been in compliance in
all material respects with all applicable Laws and any guidelines or
recommendations promulgated by any Governmental Authority related to COVID-19
relating to the employment, employment practices, employment discrimination,
terms and conditions of employment, mass layoffs and plant closings (including
the Worker Adjustment and Retraining Notification Act of 1988, as amended, or
any similar state or local Laws), immigration, meal and rest breaks,
pay equity, workers' compensation, family and medical leave, wages and hours
(including the classification of independent contractors and exempt and non-
exempt employees) and occupational safety and health requirements, including
those related to collective bargaining and is not liable for any arrears of
wages, penalties or other sums for failure to comply with any of the foregoing
except.

  



  

(d) Since January 1, 2017, there has not been, nor are there currently, any
Action or internal investigation or inquiry conducted by the Company Group,
the Company's Board of Directors or any committee thereof (or any person at
the request of any of the foregoing) concerning any financial, accounting,
Tax, conflict of interest, illegal activity, fraudulent or deceptive conduct,
whistleblowing or other misfeasance or malfeasance issues with respect to any
current or former director, officer, advisor, consultant or employee of the
Company Group (in each case, in relation to his or her work with the Company
Group), in each case, except as would not reasonably be expected to be
material to the Company Group, taken as a whole.

  



  

   

43

 



    



  

(e) Since January 1, 2017, there has not been any Action relating to any act
or allegation of or relating to, sex-based discrimination, sexual harassment
or sexual misconduct, or breach of any policy of the Company Group relating to
the foregoing, in each case involving the Company or any current or former
employee, director, officer or independent contractor (in each case, in
relation to his or her work with the Company Group) of the Company Group, nor
has there been any settlements or similar out-of-court or pre-
litigation arrangement relating to any such matters nor, to the knowledge of
the Company, has any such Action been threatened, in each case, except as
would not reasonably be expected to be material to the Company Group, taken as
a whole.

  



  

Section 4.12 _Real Property; Title to Assets_.

  



  

(a) No Company Group Member owns any real property.

  



  

(b) _Section 4.12(b)_ of the Company Disclosure Schedule lists, as of the
date of this Agreement, the street address of each parcel of Leased Real
Property, and sets forth a list of each lease, sublease, and license pursuant
to which any Company Group Member leases, subleases or licenses any real
property (each, a " _Lease_ "), with the name of the lessor and the date of
the Lease in connection therewith and each material amendment to any of the
foregoing (collectively, the " _Lease Documents_ "). True, correct and
complete copies of all Lease Documents have been made available to Apex in the
Virtual Data Room: (i) other than the Lease Documents, there are no leases,
subleases, sublicenses, concessions or other contracts granting to any
Company Group Member the right to use or occupy any real property, and (ii)
all such Leases are in full force and effect, are valid and enforceable in
accordance with their respective terms, subject to the Remedies Exceptions,
and there is not, under any of such Leases, any existing material default or
event of default (or event which, with notice or lapse of time, or both,
would constitute a default) by any Company Group Member or, to the Company's
knowledge, by the other party to such Leases, except as would not,
individually or in the aggregate, be material to any Company Group Member.

  



  

(c) Other than due to any actions taken due to a "shelter in place," "non-
essential employee" or similar direction of any Governmental Authority, there
are no contractual or legal restrictions that preclude or restrict the ability
of any Company Group Member to use any Leased Real Property by such party for
the purposes for which it is currently being used, except as would not,
individually or in the aggregate, be material to any Company Group Member.
There are no latent defects or adverse physical conditions affecting the
Leased Real Property, and improvements thereon, other than those that would
not have a Company Material Adverse Effect.

  



  

(d) The Company Group has legal and valid title to, or, in the case of Leased
Real Property and assets, valid leasehold or subleasehold interests in, all
of their respective properties and assets, tangible and intangible, real,
personal and mixed, used or held for use in its business, free and clear of
all Liens other than Permitted Liens, except as would not, individually or in
the aggregate, be material to any Company Group Member.

  



  

   

44

 



    



  

Section 4.13 _Intellectual Property_.

  



  

(a) _Section 4.13(a)_ of the Company Disclosure Schedule contains a true,
correct and complete list, as of the date of this Agreement, of all of the
following that are owned or purported to be owned, used or held for use by any
Company Group Member: (i) Registered Intellectual Property constituting
Company-Owned IP (showing in each, as applicable, the filing date, date of
issuance, and registration or application number, and registrar), (ii) all
contracts or agreements to use any Company-Licensed IP, including for the
Software or Business Systems of any other person (other than (A) Open Source
Software and (B) unmodified, commercially available, "off-the-shelf" Software
with aggregate annual license and maintenance fees of less than $50,000); and
(iii) any Software or Business Systems constituting Company-Owned IP that are
either (x) incorporated into or used in connection with the Products, or (y)
otherwise material to the business of the Company Group as conducted as of
the date hereof. The Company IP constitutes all Intellectual Property rights
used in, or necessary for, the operation of the business of the Company Group
and is sufficient for the conduct of such business as currently conducted as
of the date hereof.

  



  

(b) The Company Group exclusively owns and possesses, free and clear of all
Liens (other than Permitted Liens), all right, title and interest in and to
the Company-Owned IP and has the right to use pursuant to a written license,
all Company-Licensed IP. All Company-Owned IP is subsisting and (excluding
any pending applications), to the knowledge of the Company, is valid and
enforceable. No loss or expiration of any of the Company-Owned IP is
threatened in writing or pending. No third person has ownership rights in any
derivative works created by or on behalf of such third person of the Company-
Owned IP included in the Products.

  



  

(c) Since January 1, 2017, the Company Group has taken and takes reasonable
actions to maintain, protect and enforce Company-Owned IP and the secrecy,
confidentiality and value of its trade secrets and other Confidential
Information, except as would not, individually or in the aggregate, be
material to any Company Group Member. In the past five years, no Company Group
Member has disclosed any trade secrets or other Confidential Information that
relates to the Products or is otherwise material to the business of the
Company Group to any other person other than pursuant to a written
confidentiality agreement under which such other person agrees to
maintain the confidentiality and protect such Confidential Information.

  



  

(d) Since January 1, 2017, (i) there have been no claims filed and served, or
threatened in writing (including email), against any Company Group Member, by
any person (A) contesting the validity, use, ownership, enforceability,
patentability or registrability of any of the Company IP, or (B) alleging any
infringement or misappropriation of, or other violation of, any Intellectual
Property rights of other persons (including any unsolicited demands or offers
to license any Intellectual Property rights from any other person); (ii) the
operation of the business of any Company Group Member (including the Products)
has not and does not infringe, misappropriate or violate, any Intellectual
Property rights of other persons; (iii) to the Company's knowledge, no other
person has infringed, misappropriated or violated any of the Company-Owned
IP; and (iv) no Company Group Member has received written notice of any
of the foregoing or received any formal written opinion of counsel regarding
the foregoing.

  



  

(e) All persons who have contributed, developed or conceived any Company-
Owned IP that is material to the Company Group have executed valid and
enforceable written agreements with a Company Group Member, substantially in
one of the forms made available to Apex in the Virtual Data Room, and
pursuant to which such persons assigned to a Company Group Member all of their
entire right, title, and interest in and to any Intellectual Property
created, conceived or otherwise developed by such person in the course of and
related to his, her or its relationship with such Company Group Member,
without further consideration or any restrictions or obligations whatsoever,
including on the use or other disposition or ownership of such Intellectual
Property.

  



  

   

45

 



    



  

(f) No Company Group Member, nor, to the Company's knowledge, any other
person is in material breach or in material default of any agreement
specified in _Section 4.13(a)(ii)_ of the Company Disclosure Schedule.

  



  

(g) _Section 4.13(g)_ of the Company Disclosure Schedule sets forth a list
of all Open Source Software that has been used in, incorporated into,
integrated or bundled with any Products, and for each such item of Open Source
Software: (i) the name and version number of the applicable license under
which each such item of Open Source Software has been licensed to the
applicable Company Group Member; (ii) whether such Open Source Software has
been modified by any Company Group Member; and (iii) whether such Open
Source Software has been distributed by any Company Group Member.

  



  

(h) No Company Group Member has used any Open Source Software in a manner
that requires (i) the disclosure, licensing, or distribution of any source
code for any Company Software or any portion thereof, (ii) the granting to
licensees of the right to reverse engineer or make derivative works or other
modifications to any Company Software or portions thereof, (iii) licensing or
otherwise distributing or making available any Company Software or any
portion thereof for a nominal or otherwise limited fee or charge, (iv)
granting any Intellectual Property rights in any Company Software to any
licensee or other third party, or (v) could otherwise impose any limitation,
restriction, or condition on the right or ability of any Company Group Member
to use, license distribute or charge for any Company Software or any
Intellectual Property therein.

  



  

(i)  To the Company's knowledge, none of the Products (i) contains any bug,
defect, or error that materially and adversely affects the use,
functionality, or performance of such Product or any product or system
containing or used in conjunction with such Product or (ii) fails to comply
with any applicable warranty or other contractual commitment relating to the
use, functionality, or performance of such Product or any product or system
containing or used in conjunction with such Product, in each case, except as
would not result in material liability to the Company Group, taken as a
whole.

  



  

(j) No source code for any Software included in the Company-Owned IP ("
_Company Software_ ") has been delivered, licensed, or made available to any
escrow agent or other person who is not, as of the date of this Agreement, an
employee or contractor of any Company Group Member who needs such source code
to perform his or her job duties. No Company Group Member has any duty
or obligation (whether present, contingent, or otherwise) to deliver,
license, or make available the source code for any Company Software to any
escrow agent or other person.

  



  

(k) To the knowledge of the Company, no Company Software contains any "back
door," "drop dead device," "time bomb," "Trojan horse," "virus," "worm,"
"malware," "vulnerability," "spyware" or "adware" (as such terms are commonly
understood in the software industry) or any other code designed or intended
to have any of the following functions: (i) disrupting, disabling, harming, or
otherwise impeding in any manner the operation of, or providing unauthorized
access to, a computer system or network or other device on which such code is
stored or installed; or (ii) compromising the privacy or security of any data
or damaging or destroying any data or file without consent (collectively, "
_Malicious Code_ "). Each Company Group Member implements industry standard
measures designed to prevent the introduction of Malicious Code into Company
Software, including firewall protections and regular virus scans.

  



  

   

46

 



    



  

(l) With respect to Business Systems, which do not constitute Products (the "
_IT Systems_ "), a Company Group Member owns, leases, licenses, or otherwise
has the legal right to use all such IT Systems, and such IT Systems are
sufficient for the current needs of the business of the Company Group
Members. The Company Group Members maintain commercially reasonable
disaster recovery, business continuity and risk assessment plans, procedures
and facilities and each Company Group Member has taken reasonable steps and
implemented reasonable procedures to ensure its Business Systems under its
control are free from Malicious Code. To the Company's knowledge, in the past
three years, there has not been any material failure with respect to any of
the Business Systems that has not been remedied or replaced in all material
respects.

  



  

(m) In the past three years, the Company Group has implemented commercially
reasonable data security safeguards designed to protect the security and
integrity of the Business Systems and Business Data. The employees and
contractors of the Company Group receive commercially reasonable training on
information security issues. To the knowledge of the Company, there is no
Disabling Device in any of the Business Systems or Product components, except
as would not, individually or in the aggregate, be material to any Company
Group Member. In the past three years, no Company Group Member has, to the
Company's knowledge, experienced any material (i) data security breaches,
(ii) unauthorized access or use of any of the Business Systems, or (iii)
unauthorized acquisition, destruction, damage, disclosure, loss, corruption,
alteration, or use of any Business Data.

  



  

(n) The Company Group (i) exclusively owns and possesses all right, title and
interest in and to the Business Data constituting Company-Owned IP, free and
clear of any Liens other than Liens granted under the Existing Security
Agreements or (ii) has the right to use, exploit, publish, reproduce,
distribute, license, sell, and create derivative works of the Business Data,
in whole or in part, in the manner in which the Company and the Company
Subsidiaries receive and use such Business Data prior to the Closing Date. No
Company Group Member is subject to any contractual requirements, privacy
policies, or other legal obligations, including based on the
Transactions contemplated hereunder, that would materially prohibit Merger
Subs or Apex from receiving or using Personal Information or other Business
Data after the Closing Date, in the manner in which the Company receives and
uses such Personal Information and other Business Data immediately prior to
the Closing Date or, to the knowledge of the Company, result in material
liabilities in connection with all contractual commitments that any Company
Group Member has entered into with respect to privacy or data security
(collectively, the " _Data Security Requirements_ ").

  



  

(o) No funding, facilities, or personnel of any Governmental Authority were
used, to develop or create, in whole or in part, any Company-Owned IP. To the
knowledge of the Company, no Company Group Member is a party to any Government
Contract that grants a Governmental Authority any right or license with
respect to any Company-Owned IP beyond "limited rights" or "restricted
rights" as those terms are defined in the Federal Acquisition Regulation or
the Defense Federal Acquisition Regulation Supplement.

  



  

   

47

 



    



  

(p) No Company Group Member is, nor has it ever been, a member or promoter
of, or a contributor to, any industry standards body or similar standard
setting organization that could require or obligate any Company Group Member
to grant or offer to any other person any license or right to any Company-
Owned IP.

  



  

Section 4.14 _Data Privacy_.

  



  

(a) All Personal Information in the possession, custody or control of any
Company Group Member or of any third party authorized to process such
Personal Information on behalf of any Company Group Member (" _Company
Personal Information_ ") is an asset that will be transferred as part of the
Mergers, as contemplated by section 1798.140(t)(2)(D) of the California
Consumer Privacy Act (" _CCPA_ ") to the extent the CCPA applies to any
Company Group Member.

  



  

(b) Each Company Group Member and, to the Company's knowledge, all vendors,
processors, or other third parties Processing or otherwise with authorization
to access Company Personal Information in the course of their respective
performance of services to any Company Group Member, comply and, since
January 1, 2017, have complied with (i) all Privacy/Data Security Laws, (ii)
all applicable Company Privacy Policies, and (iii) all contractual
commitments that any Company Group Member has entered into with respect to the
Processing of Personal Information (collectively, the " _Data Privacy
Commitments_ "), except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect. To the
extent required by Privacy/Data Security Laws, the Company Group Members have
in place written agreements with all of their customers regarding the Company
Group Members' Processing of any Personal Information on behalf of such
customers, except as would not be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. Since January 1, 2017, except as
would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, none of the Company Group Members has
transferred or, to the knowledge of the Company, permitted the transfer of
Personal Information originating in the European Economic Area outside
the European Economic Area, except where such transfers have complied with
the Data Privacy Commitments.

  



  

(c) Except as would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect, the execution, delivery,
and performance of this Agreement and the consummation of the transactions
contemplated hereby do not and will not: (i) conflict with or result in a
violation or breach of any Data Privacy Commitments; (ii) require the consent
of or notice to any person concerning such person's Personal Information;
(iii) give rise to any right of termination or other right to impair or limit
Apex's or its subsidiaries' rights to own and Process any Company Personal
Information used in or necessary for the operation of the Company Group's
business; or (iv) otherwise prohibit the transfer of Personal Information in
the possession or control of a Company Group Member to Apex.

  



  

(d) The Company Group has delivered or made available to Apex true, complete,
and correct copies of all Company Privacy Policies that are currently in
place. All Company Privacy Policies are and since January 1, 2017 have been
accurate, consistent and complete and not misleading or deceptive (including
by omission), except as would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect.

  



  

   

48

 



    



  

(e) The Company Group Members routinely engage in due diligence of vendors,
processors, or other third parties before allowing them to access, receive or
Process Personal Information, and monitor them to verify fulfillment of their
contractual obligations regarding Personal Information. To the extent
required by the Data Privacy Commitments, each Company Group Member has and,
since January 1, 2017 has, had agreements in place with all affiliates,
vendors, processors, third parties or other persons whose relationship with
such Company Group Member involves the Processing of Personal Information
provided by or on behalf of such Company Group Member, which agreements
require such persons to protect such Personal Information in a manner
consistent with the Data Privacy Commitments, except as would not reasonably
be expected to have, individually or in the aggregate, a Company Material
Adverse Effect.

  



  

(f) The Company Group has implemented and, since January 1, 2017, maintained,
and required all vendors, processors, or other third parties authorized to
Process any Personal Information for or on behalf of any Company Group Members
to implement and maintain commercially reasonable security measures, plans,
procedures, controls, and programs (including a written information security
program with respect to the Company Group), to (i) protect and maintain the
security of any Personal Information which the Company Group Processes and to
protect such Personal Information against any accidental or unauthorized
access, use, loss, disclosure, alteration, destruction, compromise, or other
unauthorized Processing of Personal Information owned, used, maintained,
received, or controlled by or on behalf of any Company Group Member (a "
_Security Incident_ "); (ii) identify and address internal and external risks
to the privacy and security of Personal Information in their possession or
control; (iii) implement, monitor, and maintain administrative, technical,
and physical safeguards to protect such Personal Information and its software,
systems, applications, and websites involved in the Processing of Personal
Information; and (iv) provide prompt notification in compliance with
Privacy/Data Security Laws in the case of any Security Incident, except, in
each case, as would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect.

  



  

(g) Except as would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect, since January 1, 2017, the
Company Group has not experienced any Security Incidents. To the Company's
knowledge, since January 1, 2017, no Company Group Member has (i) been
required pursuant to any Data Privacy Commitment to notify customers,
consumers, employees, Governmental Authority, or any other person of any
Security Incident, (ii) been the subject of any inquiry, investigation or
enforcement action of any Governmental Authority with respect to compliance
with any Privacy/Data Security Law, or (iii) received any written notice,
request, claim, complaint, correspondence, or other communication from any
Governmental Authority or other person relating to any Security Incident or
violation of any Data Privacy Commitments.

  



  

(h) The Company maintains insurance coverage containing commercially
reasonable policy terms and limits to respond to the risk of
liability relating to any Security Incidents or unauthorized Processing of
Personal Information.

  



  

   

49

 



    



  

Section 4.15 _Taxes_.

  



  

(a) Each Company Group Member: (i) has duly and timely filed all income and
other material Tax Returns required to be filed by it (taking into account
validly obtained extensions of the due date for filing a Tax Return), and all
such filed Tax Returns are complete and accurate in all material respects;
(ii) has paid all material Taxes that are required to have been paid by it;
(iii) has not waived (or requested a waiver of) any statute of limitations
with respect to Taxes or agreed to any extension of time with respect to a
Tax assessment or deficiency; and (iv) does not have any deficiency,
assessment, claim, audit, examination, investigation, litigation or other
proceeding in respect of Taxes or Tax matters pending, asserted, proposed or
threatened in writing. The Company has made available to Apex in the Virtual
Data Room true, correct and complete copies of the Tax Returns filed by the
Company and the Company Subsidiaries for tax years ending on or after
December 31, 2017.

  



  

(b) No Company Group Member is a party to, bound by or has any obligation
under any Tax sharing agreement, Tax indemnification agreement, Tax
allocation agreement or similar contract or arrangement (including any
agreement, contract or arrangement providing for the sharing or ceding of
credits or losses), or has a liability or obligation to any person as a result
of or pursuant to any such agreement, contract, arrangement or commitment, in
each case, other than customary indemnification provisions in commercial
agreements the primary subject matter of which is not Taxes.

  



  

(c) No Company Group Member will be required to include any material item of
income in, or exclude any material item of deduction from, taxable income for
any Tax period (or portion thereof) ending after the Closing Date as a result
of any: (i) adjustment under Section 481 of the Code (or any corresponding or
similar provision of state, local or non-U.S. income Tax law) by reason of a
change in method of accounting on or prior to the Closing Date; (ii) "closing
agreement" as described in Section 7121 of the Code (or any corresponding or
similar provision of state, local or non-U.S. income Tax Law) executed on or
prior to the Closing Date; (iii) installment sale or open transaction
disposition made on or prior to the Closing Date, (iv) intercompany
transaction or any excess loss account described in Treasury Regulations
under Section 1502 of the Code (or any corresponding or similar provision of
state, local or non-U.S. Tax Law) arising from a transaction occurring on or
prior to the Closing Date, (v) prepaid amount received on or prior to the
Closing Date outside of the ordinary course of business; (vi) adjustment under
Section 482 of the Code (or any similar provision of applicable state, local
or foreign Law) with respect to a Tax period (or portion thereof) ending
on or prior to the Closing Date; (vii) election under Section 108(i) of the
Code made on or prior to the Closing Date; (viii) application of Section 965
of the Code; or (ix) Section 951 of the Code (or any corresponding or similar
provision of state, local, or foreign Tax law) with respect to amounts earned
on or before the Closing Date.

  



  

(d) Each Company Group Member has withheld and paid to the appropriate Tax
authority all material Taxes required to have been withheld and paid in
connection with amounts paid or owing to any current or former employee,
independent contractor, creditor, shareholder or other third party.

  



  

   

50

 



    



  

(e) No Company Group Member has been a member of an affiliated group filing a
consolidated, combined or unitary U.S. federal, state, local or non-U.S.
income Tax Return, other than a group the common parent of which was or is the
Company.

  



  

(f) No Company Group Member has any liability for the Taxes of any person
(other than the Company or the Company Subsidiaries) under
Treasury Regulation Section 1.1502-6 (or any similar provision of state,
local or non-U.S. law), as a transferee or successor, or otherwise by
operation of law.

  



  

(g) No Company Group Member (i) has any request for a ruling in respect of
Taxes pending between any Company Group Member and any Tax authority, and
(ii) has entered into any closing agreements, private letter rulings,
technical advice memoranda or similar agreements with a Taxing authority.

  



  

(h) No Company Group Member has distributed stock of another person, or had
its stock distributed by another person, in a transaction that was purported
or intended to be governed in whole or in part by Section 355 or Section 361
of the Code.

  



  

(i) No Company Group Member has engaged in or entered into a "listed
transaction" within the meaning of Treasury Regulation Section
1.6011-4(b)(2).

  



  

(j) No Taxing authority or agency has asserted in writing or, to the
knowledge of the Company, has threatened to assert against any Company Group
Member any deficiency or claim for any Taxes or interest thereon or penalties
in connection therewith.

  



  

(k) There are no Tax Liens upon any assets of any Company Group Member except
for Permitted Liens.

  



  

(l) No Company Group Member has been a United States real property holding
corporation within the meaning of Section 897(c)(2) of the Code during the
applicable period specified in Section 897(c)(1)(A)(ii) of the Code. No
Company Group Member has a permanent establishment (within the meaning of an
applicable Tax treaty) or an agency, office or fixed place of business or
other Tax presence in a country other than the country in which it is
organized.

  



  

(m) No written claim has ever been received by any Company Group Member from
a Taxing authority in a jurisdiction in which no Company Group Member files
Tax Returns that any Company Group Member is or may be subject to taxation in
such jurisdiction.

  



  

(n) No Company Group Member is currently the beneficiary of any extension of
time within which to file any Tax Return other than customary extensions of
the due date for filing a Tax Return obtained in the ordinary course of
business.

  



  

(o) None of the Company Group Members which are organized outside the United
States has made an election under U.S. law with respect to its classification
for U.S. tax purposes.

  



  

(p) Except as set forth in Section 4.15(p) of the Company Disclosure
Schedule, the Company does not own shares of any controlled foreign
corporations as described in Section 957 of the Code or passive foreign
investment companies as described in Section 1297 of the Code with respect to
the Company.

  



  

   

51

 



    



  

(q) No Company Group Member, after consultation with their respective tax
advisors, is aware of the existence of any fact, or any action it has taken
(or failed to take) or agreed to take, that would reasonably be expected to
prevent or impede the Mergers from qualifying for the Intended Tax-Free
Treatment.

  



  

Section 4.16 _Environmental Matters_.

  



  

(a) Except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect: (i) each
Company Group Member (A) is and has been in compliance with applicable
Environmental Laws and (B) holds and is and has been in compliance with all
Environmental Permits; and (ii) all Environmental Permits were validly issued
and are in full force and effect, and all applications, notices or other
documents have been timely filed to effect timely renewal, issuance or
reissuance of such Environmental Permits.

  



  

(b) No Company Group Member has been or is the subject of any Environmental
Claim, and no Environmental Claim is pending or to the knowledge of the
Company, threatened against any Company Group Member or against any person
whose liability for the Environmental Claim was or may have been retained or
assumed by contract or by operation of Law or pursuant to any order by any
Governmental Authority by any Company Group Member, except for any such
Environmental Claims that have not had and would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect.

  



  

Section 4.17 _Material Contracts_.

  



  

(a) _Section 4.17(a)_ of the Company Disclosure Schedule lists, as of the
date of this Agreement, the following types of contracts and agreements to
which any Company Group Member is a party or otherwise bound and which has not
been fully performed by the parties thereto on the date hereof (such
contracts and agreements as are required to be set forth on _Section 4.17(a)_
of the Company Disclosure Schedule along with any Plan listed on _Section
4.10(a)_ of the Company Disclosure Schedule being the " _Material Contracts_
"):

  



  

(i) each contract and agreement with consideration paid or payable to the
Company of more than $500,000, in the aggregate, during fiscal year 2019 or
2020;

  



  

(ii) each contract and agreement with a Material Vendor and suppliers,
manufacturers, or contractors to any Company Group Member for
expenditures paid or payable by the Company Group of more than $500,000, in
the aggregate, during fiscal year 2019 or 2020;

  



  

(iii) each contract and agreement with a Material Customer and customers or
distributors of the Company Group for amounts paid or payable to the Company
Group of more than $500,000, in the aggregate, during fiscal year 2019 or
2020;

  



  

   

52

 



    



  

(iv) all agency, sales promotion, market research, marketing consulting and
advertising contracts and agreements to which any Company Group Member is a
party with an annual contract value of more than $200,000;

  



  

(v) all management contracts (excluding contracts for employment) and
contracts with other management consultants;

  



  

(vi) all bonus and commission plans of any Company Group Member for the 2020
fiscal year or under which any Company Group Member has any material
outstanding liability with respect to any bonuses or commissions granted
thereunder that are then unpaid;

  



  

(vii) all contracts or agreements involving the payment or payment of
royalties or other amounts calculated based upon the revenues or income of
any Company Group Member or income or revenues related to any Product of any
Company Group Member to which any Company Group Member is a party;

  



  

(viii) all contracts and agreements evidencing indebtedness for borrowed
money in an amount greater than $100,000, and any pledge agreements, security
agreements or other collateral agreements in which any Company Group Member
granted to any person a security interest in or Lien on any of the property
or assets of any Company Group Member (such pledge, security and other
collateral agreements, the " _Existing Security Agreements_ ");

  



  

(ix) all partnership, joint venture or similar agreements involving the
sharing of revenues, profits, losses, costs or other liabilities or for joint
research or development;

  



  

(x) all Government Contracts to which any Company Group Member is a party, in
each case other than any Company Permits, provided, that for Government
Contracts in which a Company Group Member solely licenses or makes available
its standard Products or develops technology or Intellectual Property rights
(that are not derivative works of the Company's Products), only such contracts
with an annual recurring revenue Government Contract value based on
subscription and maintenance revenues during fiscal year 2019 or 2020 in
excess of $200,000 or with an expected annual recurring revenue Government
Contract value based on subscription and maintenance revenues for fiscal year
2020 in excess of $200,000, in each case with an individual total contract
value in excess of $500,000;

  



  

(xi) all contracts and agreements that limit, or purport to limit, the
ability of any Company Group Member to (A) compete in any line of business or
with any person or entity or in any geographic area or during any period of
time, excluding customary confidentiality agreements and agreements that
contain customary confidentiality clauses, (B) acquire any product, service,
Intellectual Property or other asset from any other person or to sell any
Product, Company-Owned IP or other asset or to perform any services for
any other person, or to transact business or deal in any other manner with
any other person, or (C) develop or distribute any Company-Owned IP;

  



  

   

53

 



    



  

(xii) all contracts or arrangements that result in any person or entity
holding a power of attorney from any Company Group Member that relates to the
Company or its business;

  



  

(xiii) all agreements or instruments guarantying the debts or other
obligations of any person;

  



  

(xiv) all contracts involving use of any Company-Licensed IP required to be
listed in _Section 4.13(a)_ of the Company Disclosure Schedule;

  



  

(xv) all contracts involving the license, sale, assignment, or other
provision of Company-Owned IP to a third party, or granting a third party a
covenant not to assert or similar right with respect to Company-Owned IP,
other than licenses of Products to customers, resellers and distributors and
non-exclusive licenses of Company-Owned IP in which the license is ancillary
to the primary purpose of the contract, in each case in the ordinary course
of business consistent with past practice;

  



  

(xvi) all contracts which involve the license or grant of rights of any
Company-Owned IP from a Company Group Member to any other Company Group
Member;

  



  

(xvii) all contracts or agreements under which any Company Group Member has
agreed to purchase goods or services from a vendor, supplier or other person
on a preferred supplier or "most favored supplier" basis;

  



  

(xviii) all contracts or agreements under which any Company Group Member has
agreed to treat any customer on a "most favored" basis; and

  



  

(xix) agreement for the development of Company-Owned IP by any third party
for the benefit of any Company Group Member.

  



  

(b) (i) each Material Contract is a legal, valid and binding obligation of
the applicable Company Group Member and, to the knowledge of the Company, the
other parties thereto, and no Company Group Member is in material breach or
violation of, or material default under, any Material Contract nor has any
Material Contract been canceled by the other party; (ii) to the Company's
knowledge, no other party is in material breach or violation of, or material
default under, any Material Contract; and (iii) no Company Group Member has
received any written, or to the knowledge of the Company, oral claim of
default under any such Material Contract. The Company has, in all material
respects, furnished or made available to Apex in the Virtual Data Room true
and complete copies of all Material Contracts, including amendments thereto
that are material in nature.

  



  

(c) With respect to any Government Contract, during the past three years, (i)
no Company Group Member has conducted an internal investigation for which it
engaged outside counsel or a forensic accounting firm or made any voluntary or
mandatory disclosure to any Governmental Authority with respect to or
concerning any actual, alleged, or potential violation of Laws under or
relating to any Government Contract, except as would not reasonably be
expected to, individually or in the aggregate, result in a Company Material
Adverse Effect; (ii) no Company Group Member has had a Government Contract
terminated for cause or default with respect to any such Government Contract;
(iii) no Company Group Member has been notified of any material claim,
dispute, or protest; and (iv) no Company Group Member nor any of their
Principals (as defined in 48 C.F.R.  2.101) or employees has been suspended
or debarred from doing business with any Governmental Authority or has been
declared non-responsible or ineligible for government contracting.

  



  

   

54

 



    



  

Section 4.18 _Insurance_.

  



  

(a) _Section 4.18(a)_ of the Company Disclosure Schedule sets forth, with
respect to each material insurance policy under which any Company Group
Member is an insured, a named insured or otherwise the principal beneficiary
of coverage as of the date of this Agreement (i) the names of the insurer,
the principal insured and each named insured, (ii) the policy number, (iii)
the period, scope and amount of coverage and (iv) the premium most recently
charged.

  



  

(b) With respect to each such insurance policy, except as would not be
expected to result in a Company Material Adverse Effect: (i) the policy is
legal, valid, binding and enforceable in accordance with its terms (subject to
the Remedies Exceptions) and, except for policies that have expired under
their terms in the ordinary course, is in full force and effect; (ii) no
Company Group Member is in material breach or default (including any such
breach or default with respect to the payment of premiums or the giving
of notice), and no event has occurred which, with notice or the lapse of
time, would constitute such a breach or default, or permit termination or
modification, under the policy; and (iii) to the knowledge of the Company, no
insurer on the policy has been declared insolvent or placed in receivership,
conservatorship or liquidation.

  



  

Section 4.19 _Board Approval; Vote Required_. The Company Board, by
resolutions duly adopted by unanimous vote of those voting at a meeting duly
called and held and not subsequently rescinded or modified in any way, or by
unanimous written consent, has duly (a) determined that this Agreement and the
Mergers are fair to and in the best interests of the Company and its
stockholders, (b) approved this Agreement and the Mergers and declared
their advisability, and (c) recommended that the stockholders of the Company
approve and adopt this Agreement and approve the Mergers and directed that
this Agreement and the Transactions (including the Mergers) be submitted for
consideration by the Company Stockholders. The Requisite Approval (the "
_Company Stockholder Approval_ ") is the only vote of the holders of any
class or series of capital stock of the Company necessary to adopt this
Agreement and approve the Transactions. The Written Consent, if executed and
delivered by the Key Company Stockholders, would qualify as the
Company Stockholder Approval and no additional approval or vote from any
holders of any class or series of capital stock of the Company would then be
necessary to adopt this Agreement and approve the Transactions.

  



  

Section 4.20 _Sanctions and International Trade Compliance_.

  



  

(a) The Company and each Company Subsidiary (i) is, and has since January 1,
2017, in compliance with all applicable International Trade Laws and
Sanctions, and (ii) have obtained all required licenses, consents, notices,
waivers, approvals, orders, registrations, declarations, or other
authorizations from, and have made material filings with, any Governmental
Authority for the import, export, re-export, deemed export, deemed re-export,
or transfer of its products as required under applicable International Trade
Laws and Sanctions (the " _Export Approvals_ "), except as would not
reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. There are no pending or, to the knowledge of the
Company, threatened, claims, complaints, charges, investigations, voluntary
disclosures or legal proceedings against the Company or any Company
Subsidiaries related to any applicable International Trade Laws or Sanctions
or any Export Approvals, except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect.

  



  

(b) Neither the Company nor any Company Subsidiary nor any of its or their
respective directors, officers, employees or, to the knowledge of the
Company, any of the Company's or any Company Subsidiary's respective agents,
representatives or other persons acting on behalf of the Company or any
Company Subsidiaries (i) is, or at any time since January 1, 2017 been, a
Sanctioned Person; (ii) has, to the knowledge of the Company, engaged in
unauthorized transactions or dealings directly or indirectly with any
Sanctioned Person or in any Sanctioned Country; or (iii) has, to the
knowledge of the Company, been the subject of or otherwise involved
in investigations or enforcement actions by any Governmental Authority or
other legal proceedings with respect to any actual or alleged violations of
International Trade Laws or Sanctions, and has not been notified of any such
pending or threatened actions, except in each case, as would not reasonably
be expected to have, individually or in the aggregate, a Company Material
Adverse Effect.

  



  

   

55

 



    



  

Section 4.21 _Customers and Suppliers_.

  



  

(a) _Section 4.21(a)_ of the Company Disclosure Schedule sets forth a
complete and correct list, as of the date of this Agreement, of the ten
largest customers of the Products based on annual recurring revenue contract
value based on subscription and maintenance revenues (each a " _Material
Customer_ "), during the 12 month period ended as of June 30, 2020. Except as
set forth on _Section 4.21(a)_ of the Company Disclosure Schedule, as of the
date hereof, no Company Group Member has received any written, or to the
knowledge of the Company, oral notice that any Material Customer has
cancelled, materially decreased or otherwise materially modified, or intends
to cancel, materially decrease or otherwise materially modify, its
relationship with any Company Group Member or its purchase of Products.

  



  

(b) _Section 4.21(b)_ of the Company Disclosure Schedule sets forth a
complete and correct list, as of the date of this Agreement, of the ten
largest vendors, suppliers, service providers and other similar business
relations of the Company and the Company Subsidiaries (each a " _Material
Vendor_ ") during the 12 month period ended as of June 30, 2020, in each case
measured by the expenditure by any Company Group Member during such period.
Except as set forth in _Section 4.21(b)_ of the Company Disclosure Schedule,
as of the date hereof, no Company Group Member has received any written, or to
the knowledge of the Company, oral notice that any Material Vendor has
cancelled, terminated or otherwise materially modified, or intends to cancel,
terminate or otherwise materially modify its relationship with any Company
Group Member.

  



  

Section 4.22 _Certain Business Practices_. Since January 1, 2017, (i) no
Company Group Member or, to the Company's knowledge, any directors or
officers, agents or employees of any Company Group Member, while acting on
behalf of any Company Group Member, has directly or indirectly: (a) used any
funds for unlawful contributions, gifts, entertainment or other unlawful
expenses related to political activity; (b) made any unlawful payment
to foreign or domestic government officials or employees or to foreign or
domestic political parties or campaigns, (c) or violated any applicable
provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or
any other applicable anti-corruption or anti-bribery laws (collectively, the
" _Anti-Bribery Laws_ "); or (d) made any payment in the nature of criminal
bribery and (ii) each Company Group Member has instituted and maintained
policies and procedures reasonably designed to ensure compliance in all
material respects with the Anti-Bribery Laws.

  



  

Section 4.23 _Interested Party Transactions_. Except for
employment relationships and the payment of compensation, benefits and
expense reimbursements and advances in the ordinary course of business, no
director, officer, any person owning 1% of the outstanding capital stock of
the Company or other affiliate of any Company Group Member, to the Company's
knowledge, has or has had, directly or indirectly: (a) an economic interest in
any person that has furnished or sold, or furnishes or sells, services or
Products that any Company Group Member furnishes or sells, or proposes to
furnish or sell; (b) an economic interest in any person that purchases from or
sells or furnishes to, any Company Group Member, any goods or services; (c) a
beneficial interest in any contract or agreement disclosed in _Section
4.17(a)_ of the Company Disclosure Schedule; or (d) any contractual or other
arrangement with any Company Group Member, other than customary
indemnity arrangements; _provided_ , _however_ , that ownership of no more
than 5% of the outstanding voting stock of a publicly traded corporation
shall not be deemed an "economic interest in any person" for purposes of this
_Section 4.23_. No Company Group Member has, in the past three years, (i)
extended or maintained credit, arranged for the extension of credit or
renewed an extension of credit in the form of a personal loan to or for any
director or executive officer (or equivalent thereof) of any Company Group
Member, or (ii) materially modified any term of any such extension or
maintenance of credit. There are no contracts or arrangements between any
Company Group Member and any family member of any director, officer or other
affiliate of any Company Group Member.

  



  

   

56

 



    



  

Section 4.24 _Exchange Act_. No Company Group Member is currently (nor has
it previously been) subject to the requirements of Section 12 of the Exchange
Act.

  



  

Section 4.25 _Brokers_. Except for the Company Financial Advisors, no
broker, finder or investment banker is entitled to any brokerage, finder's or
other fee or commission in connection with the Transactions based upon
arrangements made by or on behalf of any Company Group Member. The Company has
provided Apex with a true and complete copy of all contracts, agreements and
arrangements including its engagement letter, between the Company and the
Company Financial Advisors, other than those that have expired or terminated
and as to which no further services are contemplated thereunder to be
provided in the future. All of the agreements pursuant to which the Company is
obligated to pay Company Transaction Expenses as of the date of this
Agreement are set forth on Section 4.25 of the Company Disclosure Schedule.

  



  

Section 4.26 _Exclusivity of Representations and Warranties_. Except as
otherwise expressly provided in this _Article IV _(as modified by the Company
Disclosure Schedule), the Company hereby expressly disclaims and negates, any
other express or implied representation or warranty whatsoever (whether at Law
or in equity) with respect to the Company Group, its affiliates, and any
matter relating to any of them, including their affairs, the condition, value
or quality of the assets, liabilities, financial condition or results of
operations, or with respect to the accuracy or completeness of any other
information made available to Apex, its affiliates or any of their respective
Representatives by, or on behalf of, any Company Group Member, and any such
representations or warranties are expressly disclaimed. Without limiting the
generality of the foregoing, except as expressly set forth in this Agreement
(as modified by the Company Disclosure Schedule) or in any certificate
delivered by the Company pursuant to this Agreement, neither Company nor any
other person on behalf of Company has made or makes, any representation or
warranty, whether express or implied, with respect to any projections,
forecasts, estimates or budgets made available to Apex, its affiliates or any
of their respective Representatives of future revenues, future results of
operations (or any component thereof), future cash flows or future financial
condition (or any component thereof) of the Company (including the
reasonableness of the assumptions underlying any of the foregoing), whether or
not included in any management presentation or in any other information made
available to Apex, its affiliates or any of their respective Representatives
or any other person, and any such representations or warranties are expressly
disclaimed.

  



  

   

57

 



    



  

Article V. 
 REPRESENTATIONS AND WARRANTIES OF Apex AND MERGER SUBs

  



  

Except as set forth in (i) the correspondingly numbered Section of the Apex's
disclosure schedule delivered by Apex in connection with this Agreement (the
" _Apex Disclosure Schedule_ ") ( _provided_ , that such disclosure shall be
deemed to qualify or provide disclosure in response to the section of this
_Article V_ under which such disclosure is made and any other section of this
_Article V_ to the extent its relevance is reasonably apparent from the face
of such disclosure) or (ii) the Apex SEC Reports (to the extent the
qualifying nature of such disclosure is readily apparent from the content of
such Apex SEC Reports, but excluding disclosures referred to in "Forward-
Looking Statements", "Risk Factors" and any other disclosures therein to the
extent they are of a predictive or cautionary nature or related to forward-
looking statements) (it being acknowledged that nothing disclosed in such a
Apex SEC Report will be deemed to modify or qualify the representations and
warranties set forth in _Section 5.01_ ( _Corporate Organization_.), _Section
5.03_ ( _Capitalization_.) and _Section 5.04_ ( _Authority Relative to This
Agreement._ )), Apex hereby represents and warrants to the Company as
follows:

  



  

Section 5.01 _Corporate Organization_.

  



  

(a) Each of Apex and First Merger Sub is a corporation, and Second Merger Sub
is a limited liability company, in each case, duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
incorporation and has the requisite corporate or limited liability company,
as applicable, power and authority and all necessary governmental approvals to
own, lease and operate its properties and to carry on its business as it is
now being conducted, except where the failure to have such power,
authority and governmental approvals would not be a Apex Material Adverse
Effect.

  



  

(b) The Merger Subs are the only subsidiaries of Apex. Except for Merger
Subs, Apex does not directly or indirectly own any equity or similar interest
in, or any interest convertible into or exchangeable or exercisable for any
equity or similar interest in, any corporation, partnership, joint venture or
business association or other person.

  



  

Section 5.02 _Organizational Documents_. Each of Apex and Merger Subs has
heretofore furnished to the Company complete and correct copies of the Apex
Organizational Documents and the Merger Subs Organizational Documents. The
Apex Organizational Documents and the Merger Subs Organizational Documents are
in full force and effect. Neither Apex nor either Merger Sub is in violation
of any of the provisions of the Apex Organizational Documents or the Merger
Subs Organizational Documents. Each of First Merger Sub and Second Merger Sub
is directly and wholly owned by Apex.

  



  

   

58

 



    



  

Section 5.03 _Capitalization_.

  



  

(a) As of the date hereof, the authorized capital stock of Apex consists of
(i) 100,000,000 shares of Apex Class A Common Stock, (ii) 10,000,000 shares
of Apex Sponsor Common Stock and (iii) 1,000,000 shares of preferred stock,
par value $0.0001 per share (" _Apex Preferred Stock_ "). As of the date of
this Agreement (i) 35,810,000 shares of Apex Class A Common Stock are
issued and outstanding, (ii) 8,750,000 shares of Apex Sponsor Common Stock
are issued and outstanding, all of which outstanding shares under clauses (i)
and (ii) are validly issued, fully paid and non-assessable and not subject to
any preemptive rights, (iii) no shares of Apex Class A Common Stock or Apex
Sponsor Common Stock are held in the treasury of Apex, (iv) 17,905,000 Apex
Warrants are issued and outstanding, and (v) 17,905,000 shares of Apex Class
A Common Stock are reserved for future issuance pursuant to the Apex
Warrants. As of the date of this Agreement, there are no shares of Apex
Preferred Stock issued and outstanding. Each Apex Warrant is exercisable for
one share of Apex Class A Common Stock at an exercise price of $11.50.

  



  

(b) Immediately prior to the closing of the transactions contemplated in the
Subscription Agreements and the completion of the First Merger, (i) the
authorized capital stock of Apex will consist of (x) 1,000,000,000 shares of
Apex Common Stock, and (y) 20,000,000 shares of Apex Preferred Stock, and
(ii) 17,905,000 Apex Warrants will be issued and outstanding.

  



  

(c) As of the date of this Agreement, the authorized capital stock of First
Merger Sub consists of 1,000 shares of common stock, par value $0.00001 per
share (the " _Merger Sub Common Stock_ "). As of the date hereof, 1,000 shares
of Merger Sub Common Stock are issued and outstanding. All outstanding shares
of Merger Sub Common Stock have been duly authorized, validly issued, fully
paid and are non-assessable, were issued free and clear of all Liens other
than transfer restrictions under applicable securities laws and the Merger
Subs Organizational Documents, and are not subject to nor have been issued in
violation of, any applicable securities laws and other applicable Laws, and
are not subject to nor have been issued in violation of, any purchase option,
call option, right of first refusal, preemptive right, subscription right or
any similar rights, and are held by Apex free and clear of all Liens, other
than transfer restrictions under applicable securities laws and the Merger
Subs Organizational Documents.

  



  

(d) As of the date of this Agreement, the authorized capital stock of Second
Merger Sub consists of 1,000 units (the " _Merger Sub Units_ "). As of the
date hereof, 1,000 Merger Sub Units are issued and outstanding. All
outstanding Merger Sub Units have been duly authorized, validly issued, fully
paid and are non-assessable, were issued free and clear of all Liens
other than transfer restrictions under applicable securities laws and the
Merger Subs Organizational Documents, and are not subject to nor have been
issued in violation of, any applicable securities laws and other applicable
Laws, any purchase option, call option, right of first refusal, preemptive
right, subscription right or any similar rights, and are held by Apex free and
clear of all Liens, other than transfer restrictions under applicable
securities laws and the Merger Subs Organizational Documents.

  



  

   

59

 



    



  

(e) All outstanding Apex Units, shares of Apex Common Stock and Apex Warrants
have been issued and granted in compliance with all applicable securities
laws and other applicable Laws and were issued free and clear of all Liens
other than transfer restrictions under applicable securities laws and the
Apex Organizational Documents and are non-assessable and are not subject to,
nor have been issued in violation of, any purchase option, call option, right
of first refusal, preemptive right, subscription right or any similar rights.
All shares of Apex Common Stock when issued pursuant to _Section 3.01(a)_
will be issued in compliance with all applicable securities laws and other
applicable Laws and free and clear of all Liens other than transfer
restrictions under applicable securities laws and the Apex Organizational
Documents, and will be non-assessable and not subject to, nor be issued in
violation of, any purchase option, call option, right of first refusal,
preemptive right, subscription right or any similar rights.

  



  

(f) The Aggregate Stock Consideration and the Contingent Consideration (if
any) being delivered by Apex hereunder shall be duly and validly issued,
fully paid and non-assessable, and each such share or other security shall be
issued free and clear of preemptive rights and all Liens, other than transfer
restrictions under applicable securities laws and the Apex Organizational
Documents. The Aggregate Stock Consideration and the Contingent Consideration
(if any) will be issued in compliance with all applicable securities Laws and
other applicable Laws and without contravention of any other person's rights
therein or with respect thereto.

  



  

(g) Except for securities set forth in _Section 5.03(a)_ , securities issued
pursuant to the Subscription Agreements, securities issued by Apex as
permitted by this Agreement and the Apex Warrants, Apex has not issued any
options, warrants, preemptive rights, calls, convertible securities or other
rights, agreements, arrangements or commitments of any character relating to
the issued or unissued capital stock of Apex or obligating Apex to issue or
sell any shares of capital stock of, or other equity interests in, Apex.
All shares of Apex Common Stock subject to issuance as aforesaid, upon
issuance on the terms and conditions specified in the instruments pursuant to
which they are issuable, will be duly authorized, validly issued, fully paid
and non-assessable and will not be subject to, or be issued in violation of,
any purchase option, call option, right of first refusal, preemptive right,
subscription right or any similar rights. Neither Apex nor any subsidiary of
Apex is a party to, or otherwise bound by, and neither Apex nor any
subsidiary of Apex has granted, any equity appreciation rights,
participations, phantom equity or similar rights. Other than the Sponsor
Support Agreement, Apex is not a party to any voting trusts, voting
agreements, proxies, shareholder agreements or other agreements with respect
to the voting or transfer of Apex Common Stock or any of the equity interests
or other securities of Apex or any of its subsidiaries. Except with respect
to the Apex Warrants and the Redemption Rights, there are no outstanding
contractual obligations of Apex to repurchase, redeem or otherwise acquire
any shares of Apex Common Stock. The Apex Warrants have been validly
issued, and constitute valid and binding obligations of Apex, enforceable
against Apex in accordance with their terms, subject to the
Remedies Exceptions. There are no outstanding contractual obligations of Apex
to make any investment (in the form of a loan, capital contribution or
otherwise) in, any person.

  



  

(h) There are no securities or instruments issued by or to which Apex or the
Sponsor is a party containing anti-dilution or similar provisions that will
be triggered by the consummation of the Transactions or the Private
Placements, in each case, that have not been or will be waived on or prior to
the Closing Date.

  



  

   

60

 



    



  

Section 5.04 _Authority Relative to This Agreement_. Each of Apex and
Merger Subs have all necessary power and authority to execute and deliver this
Agreement and the Ancillary Agreements to which it is a party, to perform its
obligations hereunder and thereunder and to consummate the Transactions. The
execution and delivery of this Agreement and the Ancillary Agreements to
which it is a party by each of Apex and Merger Subs and the consummation
by each of Apex and Merger Subs of the Transactions, have been duly and
validly authorized by all necessary corporate action, and no other corporate
proceedings on the part of Apex or Merger Subs are necessary to authorize this
Agreement, the Ancillary Agreements to which it is party or to consummate the
Transactions (other than (a) with respect to the Mergers, the approval and
adoption of this Agreement by the holders of a majority of the then-
outstanding shares of Apex Capital Stock and by the holders of a majority of
the then outstanding shares of Merger Sub Common Stock, and the filing and
recordation of appropriate merger documents as required by the DGCL and the
DLLCA, and (b) with respect to the issuance of Apex Common Stock and the
Amended and Restated Apex Certificate of Incorporation pursuant to this
Agreement, the approval of a majority of the then-outstanding shares of Apex
Capital Stock). This Agreement and the Ancillary Agreements to which it is a
party has been duly and validly executed and delivered by Apex and Merger
Subs and, assuming due authorization, execution and delivery by the Company,
constitutes a legal, valid and binding obligation of Apex and each Merger
Sub, enforceable against Apex and each Merger Sub in accordance with its terms
subject to the Remedies Exceptions.

  



  

Section 5.05 _No Conflict; Required Filings and Consents_.

  



  

(a) Subject to the approval by the stockholders of Apex of the Apex
Proposals, neither execution and delivery of this Agreement and the
Ancillary Agreements to which it is a party by each of Apex and Merger Subs
do not, and the performance of this Agreement and the Ancillary Agreements to
which it is a party by each of Apex and Merger Subs will not, (i) conflict
with or violate the Apex Organizational Documents or the Merger Subs
Organizational Documents, (ii) assuming that all consents, approvals,
authorizations, expiration or termination of waiting periods and other
actions described in _Section 5.05(b)_ have been obtained and all filings
and obligations described in _Section 5.05(b)_ have been made, conflict with
or violate any Law, rule, regulation, order, judgment or decree applicable to
each of Apex or either Merger Sub or by which any of their property or assets
is bound or affected, or (iii) result in any breach of, or constitute a
default (or an event which, with notice or lapse of time or both, would
become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, or result in the creation of a
Lien on any property or asset of each of Apex or either Merger Sub pursuant
to, any note, bond, mortgage, indenture, contract, agreement, lease, license,
permit, franchise or other instrument or obligation to which any of Apex or
Merger Subs is a party or by which any of Apex or Merger Subs or any of their
property or assets is bound or affected, except, with respect to
_clause (iii)_ , for any such conflicts, violations, breaches, defaults or
other occurrences which would not have or reasonably be expected to have a
Apex Material Adverse Effect.

  



  

   

61

 



    



  

(b) The execution and delivery of this Agreement and the Ancillary Agreements
to which it is a party by each of Apex and Merger Subs do not, and the
performance of this Agreement and the Ancillary Agreements to which it is a
party by each of Apex and Merger Subs will not, require any consent,
approval, authorization or permit of, or filing with or notification to, or
expiration or termination of any waiting period by, any Governmental
Authority, except (i) for applicable requirements, if any, of the Exchange
Act, Blue Sky Laws and state takeover laws, the pre-merger notification
requirements of the HSR Act, and filing and recordation of appropriate merger
documents as required by the DGCL and DLLCA and (ii) where the failure to
obtain such consents, approvals, authorizations or permits, or to make such
filings or notifications, would not, individually or in the aggregate, prevent
or materially delay consummation of any of the Transactions or otherwise
prevent Apex or either Merger Sub from performing its material
obligations under this Agreement.

  



  

Section 5.06 _Compliance_. Neither Apex nor either Merger Sub is or has
been in conflict with, or in default, breach or violation of, (a) any Law
applicable to Apex or either Merger Sub or by which any property or asset of
Apex or either Merger Sub is bound or affected, or (b) any note, bond,
mortgage, indenture, contract, agreement, lease, license, permit, franchise
or other instrument or obligation to which Apex or either Merger Sub is a
party or by which Apex or either Merger Sub or any property or asset of Apex
or either Merger Sub is bound, except, in each case, for any such conflicts,
defaults, breaches or violations that would not have or reasonably be expected
to have a Apex Material Adverse Effect. Each of Apex and Merger Subs is in
possession of all material franchises, grants, authorizations, licenses,
permits, easements, variances, exceptions, consents, certificates, approvals
and orders of any Governmental Authority necessary for Apex or such
Merger Sub to own, lease and operate its properties or to carry on its
business as it is now being conducted. Apex is not an "investment company" or
a person directly or indirectly "controlled" by or acting on behalf of an
"investment company", in each case within the meaning of the Investment
Company Act. Apex constitutes an "emerging growth company" within the meaning
of the Securities Act, as modified by the Jumpstart Our Business Startups Act
of 2012.

  



  

Section 5.07 _SEC Filings; Financial Statements; Sarbanes-Oxley_.

  



  

(a) Apex has filed all forms, reports, schedules, statements and other
documents, including any exhibits thereto, required to be filed by it with
the Securities and Exchange Commission (the " _SEC_ ") since its
incorporation, together with any amendments, restatements or supplements
thereto (collectively, the " _Apex SEC Reports_ "). Apex has
heretofore furnished to the Company true and correct copies of all amendments
and modifications that have not been filed by Apex with the SEC to all
agreements, documents and other instruments that previously had been filed by
Apex with the SEC and are currently in effect. As of their respective dates,
the Apex SEC Reports (i) complied in all material respects with the applicable
requirements of the Securities Act of 1933, as amended (the " _Securities
Act_ "), the Exchange Act and the Sarbanes-Oxley Act, and the rules and
regulations promulgated thereunder, and (ii) did not, at the time they were
filed, or, if amended, as of the date of such amendment, contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein not
misleading, in the case of any Apex SEC Report that is a
registration statement, or include any untrue statement of a material fact or
omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading, in the case of any other Apex SEC Report. Each director
and executive officer of Apex has filed with the SEC on a timely basis all
documents required with respect to Apex by Section 16(a) of the Exchange Act
and the rules and regulations thereunder.

  



  

   

62

 



    



  

(b) Each of the financial statements (including, in each case, any notes
thereto) contained in the Apex SEC Reports was prepared in accordance with
GAAP (applied on a consistent basis) and Regulation S-X and Regulation S-K, as
applicable, throughout the periods indicated (except as may be indicated in
the notes thereto or, in the case of unaudited financial statements, as
permitted by Form 10-Q of the SEC) and each fairly presents, in all material
respects, the financial position, results of operations, changes in
stockholders equity and cash flows of Apex as at the respective dates thereof
and for the respective periods indicated therein, (subject, in the case of
unaudited statements, to normal and recurring year-end adjustments which have
not had, and would not reasonably be expected to individually or in the
aggregate be material). Apex has no off-balance sheet arrangements that are
not disclosed in the Apex SEC Reports. No financial statements other than
those of Apex are required by GAAP to be included in the
consolidated financial statements of Apex.

  



  

(c) Except as and to the extent set forth in the Apex SEC Reports, neither
Apex nor either Merger Sub has any liability or obligation of a nature
(whether accrued, absolute, contingent or otherwise) required to be reflected
on a balance sheet prepared in accordance with GAAP, except for liabilities
and obligations arising in the ordinary course of Apex's and Merger Subs'
business.

  



  

(d) Apex is in compliance in all material respects with the applicable
listing and corporate governance rules and regulations of the Nasdaq Capital
Market.

  



  

(e) Apex has established and maintains disclosure controls and procedures (as
defined in Rule 13a-15 under the Exchange Act). Such disclosure controls and
procedures are designed to ensure that material information relating to Apex
and other material information required to be disclosed by Apex in the
reports and other documents that it files or furnishes under the Exchange Act
is recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the SEC, and that all such material
information is accumulated and communicated to Apex's principal executive
officer and its principal financial officer as appropriate to allow timely
decisions regarding required disclosure and to make the certifications
required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act. Such
disclosure controls and procedures are effective in timely alerting Apex's
principal executive officer and principal financial officer to material
information required to be included in Apex's periodic reports required under
the Exchange Act.

  



  

(f) Apex maintains systems of internal control over financial reporting that
are sufficient to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, including policies and procedures
sufficient to provide reasonable assurance: (i) that Apex maintains records
that in reasonable detail accurately and fairly reflect, in all material
respects, its transactions and dispositions of assets; (ii) that transactions
are recorded as necessary to permit the preparation of financial statements
in conformity with GAAP; (iii) that receipts and expenditures are being made
only in accordance with authorizations of management and its board of
directors; and (iv) regarding prevention or timely detection of unauthorized
acquisition, use or disposition of its assets that could have a material
effect on its financial statements. Apex has delivered to the Company a true
and complete copy of any disclosure (or, if unwritten, a summary thereof) by
any representative of Apex to Apex's independent auditors relating to any
material weaknesses in internal controls and any significant deficiencies in
the design or operation of internal controls that would adversely affect the
ability of Apex to record, process, summarize and report financial data. Apex
has no knowledge of any fraud or whistle-blower allegations, whether or not
material, that involve management or other employees or consultants who have
or had a significant role in the internal control over financial reporting of
Apex. Since June 30, 2020, there have been no material changes in Apex's
internal control over financial reporting.

  



  

   

63

 



    



  

(g) There are no outstanding loans or other extensions of credit made by Apex
to any executive officer (as defined in Rule 3b-7 under the Exchange Act) or
director of Apex has not taken any action prohibited by Section 402 of the
Sarbanes-Oxley Act.

  



  

(h) Neither Apex (including any employee thereof) nor Apex's independent
auditors has identified or been made aware of (i) any significant deficiency
or material weakness in the system of internal accounting controls utilized by
Apex, (ii) any fraud, whether or not material, that involves Apex's
management or other employees who have a role in the preparation of financial
statements or the internal accounting controls utilized by Apex or (iii) any
claim or allegation regarding any of the foregoing.

  



  

(i) As of the date hereof, there are no outstanding SEC comments from the SEC
with respect to the Apex SEC Reports. To the knowledge of Apex, none of the
Apex SEC Reports filed on or prior to the date hereof is subject to ongoing
SEC review or investigation as of the date hereof.

  



  

Section 5.08 _Absence of Certain Changes or Events_. Since June 30, 2020
and prior to the date of this Agreement, except as expressly contemplated by
this Agreement, (a) each of Apex and Merger Subs has conducted its business
in the ordinary course and in a manner consistent with past practice, other
than due to any actions taken due to a "shelter in place," "non-essential
employee" or similar direction of any Governmental Authority, (b) neither
Apex nor either Merger Sub has sold, assigned, transferred, permitted to
lapse, abandoned, or otherwise disposed of any right, title, or interest in
or to any of its material assets, (c) there has not been a Apex Material
Adverse Effect, and (d) neither Apex or either Merger Sub has not taken any
action that, if taken after the date of this Agreement, would constitute a
material breach of any of the covenants set forth in _Section 6.02_.

  



  

Section 5.09 _Absence of Litigation_. There is no Action pending or, to the
knowledge of Apex, threatened against Apex, either Merger Sub, or any property
or asset of Apex or either Merger Sub, before any Governmental Authority.
Neither Apex nor either Merger Sub, nor any material property or asset of Apex
or either Merger Sub is subject to any continuing order of, consent decree,
settlement agreement or other similar written agreement with, or, to the
knowledge of Apex, continuing investigation by, any Governmental Authority.

  



  

   

64

 



    



  

Section 5.10 _Board Approval; Vote Required_.

  



  

(a) The Apex Board, by resolutions duly adopted by majority vote of those
voting at a meeting duly called and held and not subsequently rescinded or
modified in any way, has duly (i) determined that this Agreement and the
transactions contemplated by this Agreement are fair to and in the best
interests of Apex and its stockholders, (ii) approved this Agreement and the
transactions contemplated by this Agreement and declared their advisability,
(iii) recommended that the stockholders of Apex approve and adopt this
Agreement and Mergers, and directed that this Agreement and the Mergers, be
submitted for consideration by the stockholders of Apex at the Apex
Stockholders' Meeting.

  



  

(b) The only vote of the holders of any class or series of capital stock of
Apex necessary to approve the Apex Proposals is the affirmative vote of the
holders of (i) a majority of the outstanding shares of Apex Capital Stock,
voting together as a single class, (ii) a majority of the outstanding shares
of Apex Class A Common Stock and Apex Sponsor Common Stock, voting together as
a single class and (iii) a majority of the outstanding shares of Apex Sponsor
Common Stock, voting separately as a single class.

  



  

(c) The First Merger Sub Board, by resolutions duly adopted by written
consent and not subsequently rescinded or modified in any way, has duly (i)
determined that this Agreement and the First Merger are fair to and in the
best interests of First Merger Sub and its sole stockholder, (ii) approved
this Agreement and the First Merger and declared their advisability, (iii)
recommended that the sole stockholder of First Merger Sub approve and adopt
this Agreement and approve the First Merger and directed that this
Agreement and the transactions contemplated hereby be submitted for
consideration by the sole stockholder of First Merger Sub.

  



  

(d) The only vote of the holders of any class or series of capital stock of
First Merger Sub is necessary to approve this Agreement, the First Merger and
the other transactions contemplated by this Agreement is the affirmative vote
of the holders of a majority of the outstanding shares of Merger Sub Common
Stock.

  



  

(e) Apex, as the sole member and manager of Second Merger Sub, has approved
this Agreement and the Second Merger. No other approval of Second Merger Sub
or its member or manager is necessary to approve this Agreement, the Second
Merger and the other transactions contemplated by this Agreement.

  



  

Section 5.11 _No Prior Operations_

  



  

(a) Each Merger Sub was formed solely for the purpose of engaging in the
transactions contemplated by this Agreement. Since its formation, none of
Apex or any Merger Sub has engaged in any business activities or conducted any
operations or incurred any obligation or liability, other than activities
related to Apex's initial public offering and other activities directed toward
the accomplishment of a Business Combination or as contemplated by this
Agreement.

  



  

   

65

 



    



  

(b) Except for Merger Subs and the transactions contemplated by this
Agreement and the Ancillary Agreements, Apex does not own or have a right to
acquire, directly or indirectly, any interest or investment (whether equity or
debt) in any corporation, partnership, joint venture, business, trust or
other entity. Except for this Agreement and the Ancillary Agreements and the
transactions contemplated hereby and thereby, Apex has no material interests,
rights, obligations or liabilities with respect to, and is not party to,
bound by or has its assets or property subject to, in each case whether
directly or indirectly, any contract or transaction which is, or would
reasonably be interpreted as constituting, a Business Combination. Except for
the transactions contemplated by this Agreement and the Ancillary Agreements,
no Merger Sub owns or has a right to acquire, directly or indirectly, any
interest or investment (whether equity or debt) in any corporation,
partnership, joint venture, business, trust or other entity.

  



  

(c)  As of the date hereof and except for this Agreement, the Ancillary
Agreements and the other documents and transactions contemplated hereby and
thereby (including with respect to expenses and fees incurred in connection
therewith), none of Apex or the Merger Subs is party to any contract with any
other person that would require payments by Apex or any of its subsidiaries
after the date hereof in excess of $1,000,000 in the aggregate with respect
to any individual contract, other than Working Capital Loans. As of the
date hereof, there are no amounts outstanding under any Working Capital
Loans.

  



  

Section 5.12 _Brokers_. Other than the Apex IPO Financial Advisors, no
broker, finder or investment banker is entitled to any brokerage, finder's or
other fee or commission in connection with the Transactions based upon
arrangements made by or on behalf of Apex or either Merger Sub. Apex has
provided the Company with a true and complete copy of all outstanding
contracts, agreements and arrangements (including engagement letters) with the
Apex IPO Financial Advisors as of the date of this Agreement, other than
those that have expired or terminated with no further liability to Apex, and
as to which no further services are contemplated thereunder to be provided in
the future. All of the agreements pursuant to which Apex is obligated to pay
Apex Transaction Expenses or Apex IPO Underwriting Fees as of the date of this
Agreement are set forth on _Section 5.12_ of the Apex Disclosure Schedule.

  



  

Section 5.13 _Apex Trust Fund_. As of the date of this Agreement, Apex has
no less than $351,500,000 in the trust fund established by Apex for the
benefit of its public stockholders (the " _Trust Fund_ ") maintained in a
trust account (the " _Trust Account_ "). The monies of such Trust Account are
invested in United States Government securities or money market funds meeting
certain conditions under Rule 2a-7 promulgated under the Investment
Company Act of 1940, as amended, and held in trust by Continental (the "
_Trustee_ ") pursuant to the Investment Management Trust Account Agreement,
dated as of September 16, 2019, between Apex and the Trustee (the " _Trust
Agreement_ "). The Trust Agreement has not been amended or modified and is
valid and in full force and effect and is enforceable in accordance with its
terms, subject to the Remedies Exceptions. Apex has complied in all material
respects with the terms of the Trust Agreement and is not in breach thereof
or default thereunder and there does not exist under the Trust Agreement any
event which, with the giving of notice or the lapse of time, would constitute
such a breach or default by Apex or the Trustee. There are no
separate contracts, agreements, side letters or other understandings (whether
written or unwritten, express or implied): (i) between Apex and the Trustee
that would cause the description of the Trust Agreement in the Apex SEC
Reports to be inaccurate in any material respect; or (ii) to the knowledge of
Apex, that would entitle any person (other than stockholders of Apex who shall
have elected to redeem their shares of Apex Class A Common Stock pursuant to
the Apex Organizational Documents) to any portion of the proceeds in the
Trust Account. Prior to the Closing, none of the funds held in the Trust
Account may be released except: (A) to pay income and franchise taxes from
any interest income earned in the Trust Account; and (B) upon the exercise of
Redemption Rights in accordance with the provisions of the Apex
Organizational Documents. As of the date hereof, there are no Actions pending
or, to the knowledge of Apex, threatened in writing with respect to the Trust
Account. Upon consummation of the Mergers and notice thereof to the
Trustee pursuant to the Trust Agreement, Apex shall cause the Trustee to, and
the Trustee shall thereupon be obligated to, release to Apex as promptly as
practicable, the Trust Funds in accordance with the Trust Agreement at which
point the Trust Account shall terminate; _provided_ , _however_ , that the
liabilities and obligations of Apex due and owing or incurred at or prior to
the Effective Time shall be paid as and when due, including all amounts
payable (a) to stockholders of Apex who shall have exercised their Redemption
Rights, (b) with respect to filings, applications or other actions taken
pursuant to this Agreement required under Law, (c) to the Trustee for fees
and costs incurred in accordance with the Trust Agreement; and (d) for
unpaid Apex Transaction Expenses. As of the date hereof, assuming the
accuracy of the representations and warranties of the Company herein and the
compliance by the Company with its respective obligations hereunder, Apex has
no reason to believe that any of the conditions to the use of funds in the
Trust Account will not be satisfied or funds available in the Trust Account
will not be available to Apex at the Effective Time.

  

   

66

 



    



  

Section 5.14 _Employees_. Other than any officers as described in the Apex
SEC Reports, Apex and Merger Subs have never employed any employees or
retained any contractors, other than consultants and advisors in the ordinary
course of business. Other than reimbursement of any out-of-pocket expenses
incurred by Apex's officers and directors in connection with activities on
Apex's behalf in an aggregate amount not in excess of the amount of cash held
by Apex outside of the Trust Account, Apex has no unsatisfied material
liability with respect to any employee, officer or director. Apex and Merger
Subs have never and do not currently maintain, sponsor, contribute to or have
any direct or material liability under any Employee Benefit Plan.

  



  

Section 5.15 _Taxes_.

  



  

(a) Apex and Merger Subs (i) have duly and timely filed all income and other
material Tax Returns required to be filed by any of them (taking into account
validly obtained extensions of the due date for filing a Tax Return), and all
such filed Tax Returns are complete and accurate in all material respects;
(ii) have paid all material Taxes that are required to have been paid by Apex
or either Merger Sub; (iii) have not waived (or requested a waiver of) any
statute of limitations with respect to Taxes or agreed to any extension of
time with respect to a Tax assessment or deficiency; and (iv) do not have any
deficiency, assessment, claim, audit, examination, investigation, litigation
or other proceeding in respect of Taxes or Tax matters pending, asserted,
proposed or threatened in writing.

  



  

(b) Neither Apex nor either Merger Sub is a party to, is bound by or has an
obligation under any Tax sharing agreement, Tax indemnification agreement,
Tax allocation agreement or similar contract or arrangement (including any
agreement, contract or arrangement providing for the sharing or ceding of
credits or losses), or has a liability or obligation to any person as a result
of or pursuant to any such agreement, contract, arrangement or commitment (in
each case, other than customary indemnification provisions in
commercial agreements the primary subject matter of which is not Taxes).

  



  

   

67

 



    



  

(c) Each of Apex and Merger Subs has withheld and paid to the appropriate Tax
authority all material Taxes required to have been withheld and paid in
connection with amounts paid or owing to any current or former employee,
independent contractor, creditor, shareholder or other third party.

  



  

(d) Neither Apex nor either Merger Sub has been a member of an affiliated
group filing a consolidated, combined or unitary U.S. federal, state, local
or non-U.S. income Tax Return, other than a group the common parent of which
was or is Apex.

  



  

(e) Neither Apex nor either Merger Sub has any liability for the Taxes of any
other person under Treasury Regulation Section 1.1502-6 (or any similar
provision of state, local or non-U.S. law), as a transferee or successor, or
otherwise by operation of law.

  



  

(f) No Taxing authority or agency has asserted in writing or, to the
knowledge of Apex and Merger Subs, has threatened to assert against Apex or
either Merger Sub, any deficiency or claim for any Taxes or interest thereon
or penalties in connection therewith.

  



  

(g) There are no Tax Liens upon any assets of Apex or either Merger Sub
except for Permitted Liens.

  



  

(h) Neither Apex nor either Merger Sub is currently the beneficiary of any
extension of time within which to file any Tax Return other than customary
extensions of the due date for filing a Tax Return obtained in the ordinary
course of business.

  



  

(i) Neither Apex nor either Merger Sub (i) has any request for a ruling in
respect of Taxes pending between the Company and any Tax authority, and (ii)
has not entered into any closing agreements, private letter rulings, technical
advice memoranda or similar agreements with a Taxing authority.

  



  

(j) Neither Apex nor either Merger Sub has distributed stock of another
person, or had its stock distributed by another person, in a transaction that
was purported or intended to be governed in whole or in part by Section 355 or
Section 361 of the Code.

  



  

(k) Neither Apex nor either Merger Sub has engaged in or entered into a
"listed transaction" within the meaning of Treasury Regulation Section
1.6011-4(b)(2).

  



  

(l) Neither Apex nor either Merger Sub has been a United States real property
holding corporation within the meaning of Section 897(c)(2) of the Code
during the applicable period specified in Section 897(c)(1)(A)(ii) of the
Code. Neither Apex nor either Merger Sub has a permanent establishment
(within the meaning of an applicable Tax treaty) or an agency, office or fixed
place of business or other Tax presence in a country other than the country
in which it is organized.

  



  

   

68

 



    



  

(m) No written claim has ever been received by Apex from a Taxing authority
in a jurisdiction in which Apex or either Merger Sub does not file Tax
Returns that Apex or either Merger Sub, as applicable, is or may be subject to
taxation in such jurisdiction.

  



  

(n) Apex and the Merger Subs, after consultation with their tax advisors, are
not aware of the existence of any fact, or any action Apex or either Merger
Sub has taken (or failed to take) or agreed to take, that would reasonably be
expected to prevent or impede the Mergers from qualifying for the Intended
Tax-Free Treatment.

  



  

(o) The Transactions shall not be the direct or indirect cause of any amount
paid or payable by Apex or any of its affiliates being classified as an
"excess parachute payment" under Section 280G of the Code.

  



  

Section 5.16 _Listing_. The issued and outstanding Apex Units are registered
pursuant to Section 12(b) of the Exchange Act and are listed for trading on
the Nasdaq Capital Market under the symbol "APXTU". The issued
and outstanding shares of Apex Class A Common Stock are registered pursuant
to Section 12(b) of the Exchange Act and are listed for trading on the Nasdaq
Capital Market under the symbol "APXTX". The issued and outstanding Apex
Warrants are registered pursuant to Section 12(b) of the Exchange Act and are
listed for trading on the Nasdaq Capital Market under the symbol "APXTW". As
of the date of this Agreement, there is no Action pending or, to the knowledge
of Apex, threatened in writing against Apex by the Nasdaq Capital Market or
the SEC with respect to any intention by such entity to deregister the Apex
Units, the shares of Apex Common Stock, or Apex Warrants or terminate the
listing of Apex on the Nasdaq Capital Market. None of Apex or any of
its affiliates has taken any action in an attempt to terminate the
registration of the shares of Apex Common Stock, or the Apex Warrants under
the Exchange Act.

  



  

Section 5.17 _PIPE Investment_. Apex has delivered to the Company true,
correct and complete copies of each of the Subscription Agreements entered
into by Apex with the applicable investors named therein (collectively, the "
_PIPE Investors_ "), pursuant to which the PIPE Investors have committed to
purchase shares of Apex Common Stock at a purchase price of $10.00 per share
in the Private Placement solely for purposes of consummating the transactions
contemplated hereby in an aggregate amount equal to $140,000,000 (the " _PIPE
Commitment_ "). As of the date hereof, the Subscription Agreement with each
PIPE Investor is in full force and effect and has not been withdrawn or
terminated, or otherwise amended or modified, in any respect, and no
withdrawal, termination, amendment or modification is contemplated by Apex.
Each Subscription Agreement is a legal, valid and binding obligation of Apex,
enforceable against Apex in accordance with its terms subject to the Remedies
Exceptions and, to the knowledge of Apex, is a legal, valid and binding
obligation of each PIPE Investor, enforceable against each PIPE Investor in
accordance with its terms subject to the Remedies Exceptions. There are no
other agreements, side letters, or arrangements between Apex and any PIPE
Investor relating to any Subscription Agreement or the Private Placement
that could affect the obligation of such PIPE Investors to purchase the
shares of Apex Common Stock in the Private Placement equal to the commitment
amount set forth in the Subscription Agreement of such PIPE Investor. As of
the date hereof, no event has occurred that, with or without notice, lapse of
time or both, would constitute a default or breach on the part of Apex under
any material term or condition of any Subscription Agreement and, as of the
date hereof, Apex has no reason to believe that it will be unable to satisfy
in all material respects on a timely basis any term or condition of closing to
be satisfied by it contained in any Subscription Agreement. The Subscription
Agreements contain all of the conditions precedent (other than the conditions
contained in the other Ancillary Agreements) to the obligations of the PIPE
Investors to purchase the shares of Apex Common Stock in the Private
Placement in commitment amount set forth in the Subscription Agreements on the
terms therein.

  



  

   

69

 



    



  

Section 5.18 _Apex 's and Merger Subs' Investigation and Reliance_. Each of
Apex and Merger Subs is a sophisticated purchaser and has made its own
independent investigation, review and analysis regarding the Company, the
Company Subsidiaries, and the Transactions, which investigation, review and
analysis were conducted by Apex and Merger Subs together with expert
advisors, including legal counsel, that they have engaged for such purpose.
Apex, Merger Subs and their Representatives have been provided with full and
complete access to the Representatives, properties, offices, plants and other
facilities, books and records of the Company and the Company Subsidiaries and
other information that they have requested in connection with
their investigation of the Company, the Company Subsidiaries, and the
Transactions. Neither Apex nor either Merger Sub is relying on any statement,
representation or warranty, oral or written, express or implied, made by any
Company Group Member or any of their Representatives, except as expressly set
forth in _Article IV_ (as modified by the Company Disclosure Schedule) or
in any certificate delivered by any Company Group Member pursuant to this
Agreement. No Company Group Member, nor any of their respective stockholders,
affiliates or Representatives shall have any liability to Apex, Merger Subs or
any of their respective stockholders, affiliates or Representatives resulting
from the use of any information, documents or materials made available to Apex
or either Merger Sub or any of their Representatives, whether orally or in
writing, in any confidential information memoranda, "data rooms," management
presentations, due diligence discussions or in any other form in expectation
of the Transactions. Apex and Merger Subs acknowledge that no Company Group
Member, nor any of their stockholders, affiliates or Representatives is
making, directly or indirectly, any representation or warranty with respect
to any estimates, projections or forecasts involving any Company Group
Member.

  



  

Section 5.19 _Exclusivity of Representations and Warranties_. Except as
otherwise expressly provided in this _Article V_ (as modified by the Apex
Disclosure Schedule and the Apex SEC Reports), Apex and Merger Subs hereby
expressly disclaim and negate, any other express or implied representation or
warranty whatsoever (whether at Law or in equity) with respect to Apex or
either Merger Sub, their affiliates, and any matter relating to any of them,
including their affairs, the condition, value or quality of the assets,
liabilities, financial condition or results of operations, or with respect to
the accuracy or completeness of any other information made available to any
Company Group Member, its affiliates or any of their respective
Representatives by, or on behalf of, Apex or either Merger Sub, and any such
representations or warranties are expressly disclaimed.

  



  

   

70

 



     

  

Article VI. 
  _CONDUCT OF BUSINESS PENDING THE MERGERs_

  



  

Section 6.01 _Conduct of Business by the Company Pending the Mergers._

  



  

(a) The Company agrees that, between the date of this Agreement and the
Effective Time or the earlier termination of this Agreement (the " _Interim
Period_ "), except as (1) expressly contemplated by any other provision of
this Agreement or any Ancillary Agreement, (2) as set forth in _Section 6.01_
of the Company Disclosure Schedule, and (3) as required by applicable Law
(including as may be requested or compelled by any Governmental Authority),
unless Apex shall otherwise consent in writing (which consent shall not be
unreasonably conditioned, withheld or delayed):

  



  

(i) the Company shall, and shall cause the Company Subsidiaries to, conduct
their business in the ordinary course of business and in a manner consistent
with past practice; and

  



  

(ii) the Company shall, and shall cause the Company Subsidiaries to, use
their reasonable best efforts to (A) preserve substantially intact the
business organization of the Company and the Company Subsidiaries, (B) keep
available the services of the current executive officers of the Company and
the Company Subsidiaries and (C) preserve the current relationships of the
Company and the Company Subsidiaries with customers, suppliers and other
persons with which the Company and the Company Subsidiaries have significant
business relations.

  



  

(b) By way of amplification and not limitation, except as (1) expressly
contemplated by any other provision of this Agreement or any
Ancillary Agreement, (2) as set forth in _Section 6.01_ of the Company
Disclosure Schedule, and (3) as required by applicable Law (including as may
be requested or compelled by any Governmental Authority), no Company Group
Member shall, during the Interim Period, directly or indirectly, do any of
the following without the prior written consent of Apex (which consent shall
not be unreasonably conditioned, withheld or delayed):

  



  

(i) amend or otherwise change its Company Group Organizational Documents;

  



  

(ii) issue, sell, pledge, dispose of, grant or encumber, or authorize the
issuance, sale, pledge, disposition, grant or encumbrance of, (A) any shares
of any class of capital stock of any Company Group Member, or any options,
warrants, convertible securities or other rights of any kind to acquire any
shares of such capital stock, or any other ownership interest (including,
without limitation, any phantom interest), of any Company Group Member,
_provided_ , that the consent of Apex shall not be required with respect to
(1) the grant of any Company Options to employees of the Company in the
ordinary course of business and in a manner consistent with past practice,
(2) exercise of any Company Options and (3) the issuance of shares of Company
Common Stock pursuant to the terms of the Company Preferred Stock or any
Company Options; or (B) any material assets of any Company Group Member
(including Company Personal Information);

  



  

   

71

 



    



  

(iii) form any subsidiary or acquire any equity interest or other interest in
any other entity or enter into a joint venture with any other entity;

  



  

(iv) declare, set aside, make or pay any dividend or other distribution,
payable in cash, stock, property or otherwise, with respect to any of its
capital stock;

  



  

(v) reclassify, combine, split, subdivide or redeem, or purchase or otherwise
acquire, directly or indirectly, any of its capital stock, other than
redemptions of equity securities from former employees upon the terms set
forth in the underlying agreements governing such equity securities;

  



  

(vi) enter into any agreement, understanding or arrangement with respect to
the voting of equity securities of the Company, except for the Ancillary
Agreements;

  



  

(vii) purchase, repurchase, redeem or otherwise acquire any issued and
outstanding share capital, outstanding shares of capital stock,
membership interests or other equity interests of the Company or the Company
Subsidiaries, except for (i) the acquisition by the Company or the Company
Subsidiaries of any shares of capital stock, membership interests or other
equity interests (other than the Company Options) of the Company or the
Company Subsidiaries in connection with the forfeiture or cancellation of such
interests, (ii) transactions between the Company and any wholly owned Company
Subsidiary of the Company or between wholly owned Company Subsidiaries and
(iii) the transactions contemplated by the Named Executive Equity Agreements;

  



  

(viii)  (A) acquire (including, without limitation, by merger, consolidation,
or acquisition of stock or any assets or any other business combination) any
corporation, partnership, other business organization or any division thereof,
other than the acquisition of inventory and up to $1,000,000 of fixed assets
in the ordinary course of business consistent with past practice; or (B) incur
any indebtedness for borrowed money, other than an aggregate drawdown of up
to $10,000,000 under the Company Loan Agreement, or issue any debt
securities or assume, guarantee or endorse, or otherwise become responsible
for, the obligations of any person, or make any loans or advances, or
intentionally grant any security interest in any of its assets;

  



  

(ix) (A) grant any increase in the compensation, incentives or benefits
payable or to become payable to any current or former director, officer,
employee or consultant of any Company Group Member (or their respective
beneficiaries or dependents) as of the date of this Agreement, (B) enter into
any new, or amend in any material respect any existing employment or severance
or termination agreement with any current or former director, executive
officer or employee with an annual salary in excess of $250,000 or (C)
accelerate or commit to accelerate the funding, payment, or vesting of any
compensation or benefits to any current or former director, officer, employee
or consultant (except that the Company Group may (1) increase base
compensation of current directors, officers, employees or consultants in the
ordinary course of business consistent with past practice, (2) provide
increases in salary, wages, bonuses or benefits to employees as required
under any employment or consulting agreement in effect on the date of this
Agreement in the ordinary course of business consistent with past practice,
(3) change the title of its employees in the ordinary course of
business consistent with past practice, and (4) make annual or quarterly
bonus or commission payments in the ordinary course of business and in
accordance with the bonus or commission plans existing on the date of this
Agreement and reflected on _Section 4.10(a)_  of the Company Disclosure
Schedule);

  



  

   

72

 



    



  

(x) other than as required by Law or pursuant to the terms of an agreement
entered into prior to the date of this Agreement and reflected on _Section
4.10(a)_ of the Company Disclosure Schedule or that any Company Group Member
is not prohibited from entering into after the date hereof, grant any
severance or termination pay to, any director or officer of any Company Group
Member;

  



  

(xi) adopt, amend or terminate any material Plan except as may be required by
applicable Law, is necessary in order to consummate the Transactions, or
health and welfare plan renewals in the ordinary course of business;

  



  

(xii) materially amend other than reasonable and usual amendments in the
ordinary course of business, with respect to accounting policies or
procedures, other than as required by GAAP;

  



  

(xiii) (A) amend any income, franchise or other material Tax Return, (B)
change any material method of Tax accounting, (C) make, change or rescind any
material election relating to Taxes, or (D) settle or compromise any U.S.
federal, state, local or non-U.S. Tax audit, assessment, Tax claim or other
controversy relating to Taxes;

  



  

(xiv) materially amend, or modify or consent to the termination (excluding
any expiration in accordance with its terms) of any Material Contract or
amend, waive, modify or consent to the termination (excluding any expiration
in accordance with its terms) of the Company's material rights thereunder, or
enter into a contract or agreement that if entered into prior to the date of
this Agreement would be a Material Contract, in each case in a manner that is
adverse to any Company Group Member, except in the ordinary course
of business, other than the termination of any agreement with any affiliate
of the Company;

  



  

(xv) materially amend, or modify or consent to the termination (excluding any
expiration in accordance with its terms) of any contracts, agreements and
arrangements (including engagement letters) with the Company Financial
Advisors in a manner adverse to the Company or that would increase, add or
supplement any Company Transaction Expenses or enter into a contract or
agreement that if entered into prior to the date of this Agreement would
require the payment of amounts that would constitute Company Transaction
Expenses;

  



  

(xvi) enter into, amend, waive or terminate (other than terminations in
accordance with their terms or in accordance with this Agreement)
any transaction with any affiliate of the Company (other than (x)
transactions by and among the Company and the Company Subsidiaries, (y)
compensation and benefits and advancement of expenses, in each case, provided
in the ordinary course of business consistent with past practice and (z) the
termination of any Affiliate Agreement in accordance with _Section 7.18_ );

  



  

   

73

 



    



  

(xvii) enter into any contract, agreement or arrangement that obligates any
Company Group Member to develop any Intellectual Property related to the
business of any Company Group Member or the Products, other than where the
results of the Company's or any Company Subsidiary's performance would be
Company-Owned IP;

  



  

(xviii) (A) intentionally permit any registered Company-Owned IP to lapse or
to be abandoned, invalidated, dedicated to the public, or disclaimed, or
otherwise become unenforceable or fail to perform or make any applicable
filings, recordings or other similar actions or filings, or fail to pay all
required fees and Taxes required or advisable to maintain and protect its
interest in each and every of registered Company-Owned IP or (B) disclose any
trade secrets of any Company Group Member other than in the ordinary course of
business consistent with past practice pursuant to a non-disclosure agreement
protecting the use and confidentiality thereof; or

  



  

(xix) waive, release, settle or compromise any claim, action or proceeding
(including any suit, action, claim, proceeding or investigation relating to
this Agreement or the transactions contemplated hereby) in excess of
$1,000,000 (individually or in the aggregate) or that otherwise impose non-
monetary obligations that are material to the business or operations of any
Company Group Member;

  



  

(xx) adopt a plan of, or otherwise enter into or effect a, complete or
partial liquidation, dissolution, restructuring, recapitalization or other
reorganization of any Company Group Member (other than the Mergers);

  



  

(xxi) terminate without replacement or amend in a manner materially
detrimental to the Company and the Company Subsidiaries, taken as a
whole, any insurance policy insuring the business of the Company or any of
the Company Subsidiaries; or

  



  

(xxii) enter into any formal or informal agreement or otherwise make a
binding commitment to do any of the foregoing.

  



  

Nothing herein shall require any Company Group Member to obtain consent from
Apex to do any of the foregoing if obtaining such consent might reasonably be
expected to violate applicable Law, and nothing contained in this _Section
6.01_ shall give to Apex, directly or indirectly, the right to control or
direct the operations of any Company Group Member prior to the Closing Date.
Prior to the Closing Date, each of Apex and the Company shall exercise,
consistent with the terms and conditions hereof, complete control and
supervision of its respective operations, as required by Law.

  



  

Section 6.02 _Conduct of Business by Apex and Merger Subs Pending the
Mergers._

  



  

(a) Except as expressly contemplated by any other provision of this Agreement
or any Ancillary Agreement (including entering into various Subscription
Agreements and consummating the Private Placements), except as set forth on
_Section 6.02_ of the Apex Disclosure Schedule and as required by applicable
Law (including as may be requested or compelled by any Governmental
Authority), Apex agrees that during the Interim Period, unless the Company
shall otherwise consent in writing (which consent shall not be
unreasonably withheld, delayed or conditioned), the businesses of Apex and
Merger Subs shall be conducted in the ordinary course of business and in a
manner consistent with past practice.

  



  

   

74

 



    



  

(b) By way of amplification and not limitation, except as expressly
contemplated by any other provision of this Agreement or any
Ancillary Agreement (including entering into various Subscription Agreements
and consummating the Private Placements), or in connection with the terms and
conditions of, any Subscription Agreement, as set forth on _Section 6.02_ of
the Company Disclosure Schedule or and as required by applicable Law
(including as may be requested or compelled by any Governmental Authority),
neither Apex nor Merger Subs shall, during the Interim Period, directly or
indirectly, do any of the following without the prior written consent of the
Company, which consent shall not be unreasonably withheld, delayed or
conditioned:

  



  

(i) amend or otherwise change the Apex Organizational Documents (except as
contemplated by the Apex Proposals) or the Merger Subs
Organizational Documents or form any subsidiary of Apex other than Merger
Subs;

  



  

(ii) declare, set aside, make or pay any dividend or other distribution,
payable in cash, stock, property or otherwise, with respect to any of its
capital stock, other than redemptions from the Trust Fund that are required
pursuant to the Apex Organizational Documents;

  



  

(iii) reclassify, combine, split, subdivide or redeem, or purchase or
otherwise acquire, directly or indirectly, any of the Apex Common Stock
or Apex Warrants except for redemptions from the Trust Fund;

  



  

(iv) issue, sell, pledge, dispose of, grant or encumber, or authorize the
issuance, sale, pledge, disposition, grant or encumbrance of, any shares of
any class of capital stock or other securities of Apex or Merger Subs, or any
options, warrants, convertible securities or other rights of any kind to
acquire any shares of such capital stock, or any other ownership interest
(including, without limitation, any phantom interest), of Apex or Merger
Subs, except (A) in connection with a Working Capital Loan to finance Apex
Transaction Expenses, (B) the issuance of shares of Apex Common Stock
pursuant to the Subscription Agreements solely in accordance with
Subscription Agreements as of the date hereof or as amended in accordance
with _Section 7.10(c)_ , or (C) pursuant to the exercise of Apex Warrants, or
(D) pursuant to the conversion of Apex Sponsor Common Stock;

  



  

(v) acquire (including, without limitation, by merger, consolidation, or
acquisition of stock or assets or any other business combination) any
corporation, partnership, other business organization or enter into any
strategic joint ventures, partnerships or alliances with any other person;

  



  

(vi) incur any indebtedness for borrowed money or guarantee any such
indebtedness of another person or persons, issue or sell any debt
securities or options, warrants, calls or other rights to acquire any debt
securities of Apex, as applicable, enter into any "keep well" or other
agreement to maintain any financial statement condition or enter into any
arrangement having the economic effect of any of the foregoing, in each case,
except in the ordinary course of business consistent with past practice or
except Working Capital Loans in an aggregate amount not to exceed $1,000,000;

  



  

   

75

 



    



  

(vii) make any change in any method of financial accounting or financial
accounting principles, policies, procedures or practices, except as required
by a concurrent amendment in GAAP or applicable Law made subsequent to the
date hereof, as agreed to by its independent accountants;

  



  

(viii) (A) amend any income, franchise or other material Tax Return, (B)
change any material method of Tax accounting, (C) make, change or rescind any
material election relating to Taxes, or (D) settle or compromise any U.S.
federal, state, local or non-U.S. Tax audit, assessment, Tax claim or other
controversy relating to Taxes;

  



  

(ix) liquidate, dissolve, reorganize or otherwise wind up the business and
operations of Apex or either Merger Sub;

  



  

(x) amend the Trust Agreement or any other agreement related to the Trust
Account;

  



  

(xi) amend, modify or waive any of the terms or rights set forth in any Apex
Warrant or the Apex Warrant Agreement, including any amendment, modification
or reduction of the warrant price set forth therein;

  



  

(xii) amend the Subscription Agreements, except as permitted in accordance
with Section 7.10(c);

  



  

(xiii) materially amend, or modify or consent to the termination (excluding
any expiration in accordance with its terms) of any contracts, agreements and
arrangements (including engagement letters) with the Apex IPO Financial
Advisors in a manner adverse to Apex or that would increase, add or
supplement any Apex Transaction Expenses or Apex IPO Underwriting Fees or
enter into a contract or agreement that if entered into prior to the date of
this Agreement would require the payment of amounts that would constitute Apex
Transaction Expenses or Apex IPO Underwriting Fees other than any services
providers engaged by Apex for printing, mailing and solicitation services
with respect to the Proxy Statement and the Registration Statement; or

  



  

(xiv) except the Sponsor Support Agreement, the Registration Rights
Agreement, the Lock-Up Agreements and any Working Capital Loan enter
into, renew or amend any contract with an affiliate of the Sponsor or any
Apex Initial Stockholder; or enter into any formal or informal agreement or
otherwise make a binding commitment to do any of the foregoing.

  



  

Nothing herein shall require Apex to obtain consent from the Company to do
any of the foregoing if obtaining such consent might reasonably be
expected to violate applicable Law, and nothing contained in this _Section
6.02_ shall give to the Company, directly or indirectly, the right to control
or direct the operations of Apex prior to the Closing Date. Prior to the
Closing Date, each of Apex and the Company shall exercise, consistent with
the terms and conditions hereof, complete control and supervision of its
respective operations, as required by Law.

  



  

   

76

 



    



  

Section 6.03 _Claims Against Trust Account_. The Company acknowledges that
Apex is a blank check company with the powers and privileges to effect a
Business Combination. The Company further acknowledges that, as described in
the prospectus of Apex dated September 16, 2019 (the " _Prospectus_ ")
available at www.sec.gov, substantially all of Apex assets consist of the
cash proceeds of Apex's initial public offering and substantially all of those
proceeds have been deposited in the Trust Account for the benefit of Apex,
certain of its public stockholders and the underwriters of Apex's initial
public offering. The Company acknowledges that it has been advised by Apex
that, except with respect to interest earned on the funds held in the Trust
Account that may be released to Apex to pay its franchise tax, income tax and
similar obligations, the Trust Agreement provides that cash in the Trust
Account may be disbursed only (i) if Apex completes the transactions
which constitute a Business Combination, then to those persons and in such
amounts as described in the Prospectus; (ii) if Apex fails to complete a
Business Combination within the allotted time period and liquidates, subject
to the terms of the Trust Agreement, to Apex in limited amounts to permit
Apex to pay the costs and expenses of its liquidation and dissolution, and
then to Apex's public stockholders; and (iii) if Apex holds a stockholder
vote to amend the Apex Organizational Documents to modify the substance or
timing of the obligation to redeem 100% of Apex Class A Common Stock if Apex
fails to complete a Business Combination within the allotted time period,
then for the redemption of any Apex Class A Common Stock properly tendered in
connection with such vote. For and in consideration of Apex entering into
this Agreement, the receipt and sufficiency of which are hereby acknowledged,
the Company hereby irrevocably waives any right, title, interest or claim of
any kind they have or may have in the future in or to any monies in the Trust
Account or any distributions therefrom and agree not to seek recourse against
the Trust Account or any funds distributed therefrom as a result of, or
arising out of, this Agreement and any negotiations, contracts or agreements
with Apex; _provided_ , that (x) nothing herein shall serve to limit or
prohibit the Company's right to pursue a claim against Apex for legal relief
against monies or other assets held outside the Trust Account, for specific
performance or other equitable relief in connection with the consummation of
the transactions (including a claim for Apex to specifically perform its
obligations under this Agreement and cause the disbursement of the balance of
the cash remaining in the Trust Account (after giving effect to the
Redemption Rights) to the Company Stockholders in accordance with the terms of
this Agreement and the Trust Agreement) so long as such claim would not
affect Apex's ability to fulfil its obligation to effectuate the Redemption
Rights, or for Fraud and (y) nothing herein shall serve to limit or prohibit
any claims that the Company may have in the future against Apex's assets or
funds that are not held in the Trust Account (including any funds that have
been released from the Trust Account and any assets that have been purchased
or acquired with any such funds).

  



  

   

77

 



    



  

Article VII. 
  _ADDITIONAL AGREEMENTS_

  



  

Section 7.01 _Proxy Statement; Registration Statement._

  



  

(a) As promptly as practicable after the execution of this Agreement and
Apex's receipt of the Annual Financial Statements and the Interim Financial
Statements, subject to the terms of this _Section 7.01_, Apex (with the
assistance and cooperation of the Company as reasonably requested by Apex)
shall prepare and file with the SEC (i) a joint prospectus/proxy statement
(as amended or supplemented, the " _Proxy Statement_ ") to be sent to the
stockholders of Apex relating to the meeting of Apex's stockholders
(including any adjournment or postponement thereof, the " _Apex Stockholders
' Meeting_") to be held to consider (1) approval of this Agreement and the
transactions contemplated by this Agreement, including the Mergers, (2)
approval of the issuance of Apex Common Stock in connection with the Private
Placements pursuant to the Subscription Agreements and Apex Common Stock as
contemplated by this Agreement, in accordance with the DGCL, the Apex
Organizational Documents and the rules and regulations of the Nasdaq Capital
Market, (3) the approval and adoption of the Amended and Restated Apex
Certificate of Incorporation, (4) the approval and adoption of an equity
incentive plan (the " _Apex Equity Incentive Plan_ "), in form and substance
reasonably acceptable to Apex and the Company that provides for grant of
awards to employees and other service providers of Apex and its subsidiaries
in the form of options, restricted shares, restricted share units or other
equity-based awards based on Apex Class A Common Stock with a total pool of
awards of Apex Class A Common Stock not exceeding (A) twelve percent (12%) of
the aggregate number of the sum of (x) shares of Apex Common Stock outstanding
at the Closing and (y) securities convertible into Apex Common Stock, _plus_
(B) an amount equal to the product (rounded down to the nearest whole number)
of (I) the number of shares of Company Common Stock subject to the PRC Options
immediately prior to the Effective Time and (II) the Exchange Ratio, with an
annual "evergreen" increase of not more than five percent (5%) of the shares
of Apex Common Stock outstanding as of the day prior to such increase, (5) the
approval and adoption of an employee stock purchase plan, in form and
substance reasonably acceptable to Apex and the Company, that provides for
grant of purchase rights with respect to Apex Class A Common Stock to
employees of Apex and its subsidiaries with a total pool of shares of Apex
Class A Common Stock not exceeding one and one half percent (1.5%) of the
aggregate number of the sum of (x) shares of Apex Common Stock outstanding at
the Closing and (y) securities convertible into Apex Common Stock, with an
annual "evergreen" increase of one percent 1% of the shares of Apex Common
Stock outstanding as of the day prior to such increase (the proposals in
clauses (4) and (5), the " _Equity Proposals_ "), (6) the appointment, and
designation of classes, of the members of the Apex Board as set forth on
_Exhibit K_ and (7) any other proposals the parties deem necessary to
effectuate the Transactions (collectively, the " _Apex Proposals_ "); and
(ii) a registration statement on Form S-4 (together with all amendments
thereto, the " _Registration Statement_ ") in which the Proxy Statement shall
be included as a prospectus, in connection with the registration under the
Securities Act of the shares of Apex Common Stock to be issued to
the stockholders of the Company pursuant to this Agreement, including the
Contingent Consideration. Apex and the Company shall each pay one half of all
registration and filing fees and printing and mailing costs due in connection
with the Registration Statement. Notwithstanding the foregoing, the Equity
Proposals are subject to approval by each of the Company Board and the Apex
Board (the " _Board Approvals_ ") following the receipt of a report from a
compensation consulting firm of national reputation (the " _Compensation
Report_ ") and prior to the filing of the Proxy Statement. As promptly
as practicable following the date hereof, and in any event within ten
Business Days, the Company shall deliver to Apex the Compensation Report. In
the absence of obtaining the Board Approvals for the Equity Proposals as set
forth herein, the Company and Apex shall discuss reasonable modifications to
the Equity Proposals to obtain such Board Approvals.

  



  

   

78

 



    



  

(b) Each of Apex and the Company shall furnish all information concerning
such party as may reasonably be requested by the other party in connection
with such actions and the preparation of the Registration Statement and the
Proxy Statement. Apex and the Company each shall use their reasonable best
efforts to (i) cause the Proxy Statement and the Registration Statement, when
filed with the SEC, to comply in all material respects with all legal
requirements applicable thereto, (ii) respond as promptly as reasonably
practicable to, and resolve all comments received from, the SEC concerning
the Proxy Statement or the Registration Statement, (iii) to cause the
Registration Statement to be declared effective under the Securities Act as
promptly as practicable and (iv) to keep the Registration Statement effective
as long as is necessary to consummate the Transactions. Prior to the effective
date of the Registration Statement, Apex shall use commercially reasonable
efforts to take any action required under any applicable federal or state
securities laws in connection with the issuance of shares of Apex Common
Stock to the stockholders of the Company pursuant to this Agreement.
As promptly as practicable following the clearance of the Proxy Statement by
the SEC, Apex shall mail the Proxy Statement to its stockholders.

  



  

(c) No filing of, or amendment or supplement to the Proxy Statement or the
Registration Statement will be made by Apex or the Company without the
approval of the other party (such approval not to be unreasonably withheld,
conditioned or delayed). Apex and the Company each will advise the other,
promptly after they receive notice thereof, of the time when the Registration
Statement has become effective or any supplement or amendment has been filed,
of the issuance of any stop order, of the suspension of the qualification of
the Apex Common Stock to be issued or issuable to the stockholders of the
Company in connection with this Agreement for offering or sale in any
jurisdiction, or of any request by the SEC for amendment of the Proxy
Statement or the Registration Statement or comments thereon and responses
thereto or requests by the SEC for additional information. Each of Apex and
the Company shall cooperate in the preparation of, and mutually agree upon
(such agreement not to be unreasonably withheld or delayed), any response to
comments of the SEC or its staff with respect to the Registration Statement
and any amendment to the Registration Statement filed in response thereto.

  



  

(d) Apex represents that the information supplied by Apex for inclusion in
the Registration Statement and the Proxy Statement shall not, at (i) the time
the Registration Statement is declared effective, (ii) the time the Proxy
Statement (or any amendment thereof or supplement thereto) is first mailed to
the stockholders of Apex, (iii) the time of the Apex Stockholders' Meeting,
and (iv) the Effective Time, contain any untrue statement of a material fact
or fail to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. If, at any time prior to the Effective
Time, any event or circumstance relating to Apex or Merger Subs, or their
respective officers or directors, should be discovered by Apex which should
be set forth in an amendment or a supplement to the Registration Statement or
the Proxy Statement, Apex shall promptly inform the Company. All documents
that Apex is responsible for filing with the SEC in connection with the
Mergers or the other transactions contemplated by this Agreement will comply
as to form and substance in all material respects with the applicable
requirements of the Securities Act and the rules and regulations thereunder
and the Exchange Act and the rules and regulations thereunder.

  



  

   

79

 



    



  

(e) The Company represents that the information supplied by the Company for
inclusion in the Registration Statement and the Proxy Statement shall not, at
(i) the time the Registration Statement is declared effective, (ii) the time
the Proxy Statement (or any amendment thereof or supplement thereto) is first
mailed to the stockholders of Apex, (iii) the time of Apex Stockholders'
Meeting, and (iv) the Effective Time, contain any untrue statement of a
material fact or fail to state any material fact required to be stated
therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. If, at any time
prior to the Effective Time, any event or circumstance relating to any Company
Group Member, or their respective officers or directors, should be discovered
by the Company which should be set forth in an amendment or a supplement to
the Registration Statement or the Proxy Statement, the Company shall promptly
inform Apex. All documents that the Company is responsible for filing with
the SEC in connection with the Mergers or the other transactions contemplated
by this Agreement will comply as to form and substance in all material
respects with the applicable requirements of the Securities Act and the rules
and regulations thereunder and the Exchange Act and the rules and regulations
thereunder.

  



  

Section 7.02 _Apex Stockholders ' Meeting; and First Merger Sub
Stockholder's Approval_.

  



  

(a) Apex shall call and hold the Apex Stockholders' Meeting as promptly as
practicable following the effectiveness of the registration of the Proxy
Statement by the SEC for the purpose of voting solely upon the Apex Proposals,
and Apex shall use its reasonable best efforts to hold the Apex Stockholders'
Meeting as soon as practicable following the clearance of the Proxy Statement
by the SEC; _provided_ , that Apex may postpone or adjourn the Apex
Stockholders' Meeting on one or more occasions for up to 30 days in the
aggregate upon the good faith determination by the Apex Board that such
postponement or adjournment is necessary to solicit additional proxies to
obtain approval of the Apex Proposals or otherwise take actions consistent
with Apex's obligations pursuant to _Section 7.10_ of this Agreement. Apex
shall use its reasonable best efforts to obtain the approval of the Apex
Proposals at the Apex Stockholders' Meeting, including by soliciting from its
stockholders proxies as promptly as possible in favor of the Apex Proposals,
and shall take all other action necessary or advisable to secure the required
vote or consent of its stockholders. The Apex Board shall recommend to its
stockholders that they approve the Apex Proposals and shall include
such recommendation in the Proxy Statement.

  



  

(b) Promptly following the execution of this Agreement, Apex shall approve
and adopt this Agreement and approve the First Merger and the
other transactions contemplated by this Agreement, as the sole stockholder of
First Merger Sub.

  



  

   

80

 



    



  

Section 7.03 _Company Stockholders ' Written Consent_. Upon the terms set
forth in this Agreement, the Company shall (a) distribute the Registration
Statement to the Company Stockholders, accompanied by any such additional
disclosure to the Company Stockholders as the Company and its outside counsel
determine is necessary or appropriate and seek the irrevocable written
consent, in form and substance reasonably acceptable to Apex, of holders of
the Requisite Approval (including the Key Company Stockholders) in favor of
the approval and adoption of this Agreement and the Mergers and all other
transactions contemplated by this Agreement (the " _Written Consent_ ") as
soon as reasonably practicable after the Registration Statement becomes
effective, and in any event within 48 hours after the Registration Statement
becomes effective and deliver a copy of the Written Consent to Apex and (b)
in the event the Company determines it is not able to obtain the Written
Consent, the Company shall call and hold a meeting of holders of Company
Common Stock and Company Preferred Stock for the purpose of voting
solely upon the adoption of this Agreement and the Mergers and all other
transactions contemplated by this Agreement (the " _Company Stockholder
Meeting_ ") as soon as reasonably practicable after the Registration Statement
becomes effective, and in any event within ten days after the Registration
Statement becomes effective. The Company shall use its best efforts to
obtain the Company Stockholder Approval at the Company Stockholder Meeting,
including by soliciting from its stockholders proxies as promptly as possible
in favor of this Agreement and the Mergers, and shall take all other action
necessary or advisable to secure the Company Stockholder Approval. Within ten
Business Days of the of the receipt of the Written Consent, the Company shall
prepare and deliver a notice (the " _Stockholder Notice_ ") to every Company
Stockholder that did not execute the Written Consent in accordance with
Section 228 of the DGCL. Within ten Business Days of the earlier of the
receipt of the Written Consent or the Company Stockholder Approval, the
Company shall notify the Company Stockholders of their appraisal and
dissenter rights pursuant to the DGCL. All materials sent to the Company
Stockholders in accordance with this _Section 7.03_ shall be subject to
Apex's advance review and reasonable approval, and such materials shall be
provided by the Company to Apex at least five Business Days prior to the
effectiveness of the Registration Statement for Apex's advance review and
reasonable approval.

  



  

Section 7.04 _Access to Information; Confidentiality_.

  



  

(a) During the Interim Period, the Company and Apex shall (and shall cause
their respective subsidiaries to): (i) provide to the other party (and the
other party's officers, directors, employees, accountants, consultants, legal
counsel, agents and other representatives, collectively, " _Representatives_
") reasonable access at reasonable times upon prior notice to the
officers, employees, agents, properties, offices and other facilities of such
party and its subsidiaries and to the books and records thereof; and (ii)
furnish promptly to the other party such information concerning the business,
properties, contracts, assets, liabilities, personnel, Taxes and other
aspects of such party and its subsidiaries as the other party or its
Representatives may reasonably request, including in connection with any Tax
disclosure in any statement, filing, notice or application relating to the
Intended Tax-Free Treatment. Notwithstanding the foregoing, neither the
Company nor Apex shall be required to provide access to or
disclose information where the access or disclosure would jeopardize the
protection of attorney-client privilege or contravene applicable Law (it
being agreed that the parties shall use their reasonable best efforts to cause
such information to be provided in a manner that would not result in such
jeopardy or contravention).

  



  

(b) All information obtained by the parties pursuant to this _Section 7.04_
shall be kept confidential in accordance with the confidentiality agreement,
between Apex and the Company, dated as of September 1, 2020 and the
confidentiality agreement, between Apex and the Company, dated as of October
7, 2020 (collectively, the " _Confidentiality Agreements_ ").

  



  

(c) Notwithstanding anything in this Agreement to the contrary, each party
(and its respective Representatives) may consult any tax advisor as is
reasonably necessary regarding the tax treatment and tax structure of the
Transactions and may disclose to such advisor as if reasonably necessary, the
tax treatment and tax structure of the Transactions and all materials
(including any tax analysis) that are provided relating to such treatment or
structure, in each case in accordance with the Confidentiality Agreements.

  



  

   

81

 



    



  

Section 7.05 _Exclusivity_.

  



  

(a) During the Interim Period, the Company shall not take, nor shall it
permit any of its controlled affiliates or direct any of its
Representatives to take, whether directly or indirectly, any action to
solicit, initiate, continue or engage in discussions or negotiations with, or
enter into any agreement with, or encourage, respond, provide information to
or commence due diligence with respect to, any person (other than Apex, its
stockholders or any of their affiliates or Representatives), concerning,
relating to or which is intended or is reasonably likely to give rise to or
result in, any offer, inquiry, proposal or indication of interest, written or
oral relating to any merger, initial public offering, sale of ownership
interests or assets (other than asset sales in the ordinary course
of business) of the Company, recapitalization or similar transaction, in each
case other than (i) the Transactions or (ii) any purchase of shares of Apex
Common Stock in any Private Placement (a " _Company Business Combination
Proposal_ ") other than with Apex, its stockholders and their respective
affiliates and Representatives or the PIPE Investors with respect to
the Private Placement. In addition, the Company shall, and shall cause its
controlled affiliates to, and shall cause their respective Representatives
to, immediately cease any and all existing discussions or negotiations with
any person with respect to any Company Business Combination Proposal.

  



  

(b) During the Interim Period, Apex shall not, nor shall Apex permit any of
its controlled affiliates or direct any of its Representatives to, solicit,
initiate, continue or engage in discussions or negotiations with, or enter
into any agreement with, or encourage, respond, provide information to or
commence due diligence with respect to, any person (other than the Company,
its stockholders or any of their affiliates or Representatives), concerning
any merger, purchase of ownership interests or assets of Apex,
recapitalization or similar business combination transaction or any other
Business Combination, in each case, other than (i) the Transactions or (ii)
any purchase of shares of Apex Common Stock in any Private Placement (an "
_Apex Business Combination Proposal_ "). In addition, Apex shall, and shall
cause its controlled affiliates to, and shall cause their respective
Representatives to, immediately cease any and all existing discussions or
negotiations with any person with respect to any Apex Business Combination
Proposal.

  



  

Section 7.06 _Employee Benefits Matters_.

  



  

(a) The parties shall cooperate to establish an equity incentive plan and a
tax-qualified employee stock purchase plan under Section 423 of the Code that
will allow the parties to effectuate the actions set forth in _Section
7.01(a)_. The parties shall cooperate to effectuate the assumption of certain
Company Options in accordance with _Section 3.01(a)(vi)_ , and to ensure that
the terms and conditions of the assumed Company Options will be governed by
the applicable Company Option Plans and award agreements, except for any
changes that are necessary to effectuate the transactions contemplated by this
Agreement.

  



  

(b) The Company shall cause all notices to be timely provided to each
optionee under the Company Option Plans as required by the Company Option
Plans.

  



  

   

82

 



    



  

(c) For a period of not less than one year following the Closing, Apex shall,
or shall cause the Surviving Entity and each of its subsidiaries, as
applicable, to provide the employees of the Company and any Company Subsidiary
who remain employed by Apex, the Surviving Entity or any Company Subsidiary
immediately after the Effective Time (the " _Continuing Employees_ "), for
all purposes under the employee benefit plans of Apex, the Surviving Entity
and each Company Subsidiary providing benefits to Continuing Employees after
the Closing, credit for purposes of eligibility to participate, vesting and
determining the level of benefits, as applicable, under any employee benefit
plan, program or arrangement established or maintained by the Surviving Entity
or any of its subsidiaries (excluding any retiree health plans or programs,
or defined benefit retirement plans or programs, nonqualified deferred
compensation arrangements, equity or equity-related compensation) for service
accrued or deemed accrued prior to the Effective Time with any Company Group
Member; _provided_ , _however_ , that such crediting of service shall not
operate to duplicate any benefit or the funding of any such benefit. In
addition, subject to the terms of all governing documents, Apex shall use
reasonable best efforts to (i) cause to be waived any eligibility waiting
periods, any evidence of insurability requirements and the application of any
pre-existing condition limitations under each of the employee benefit plans
established or maintained by the Surviving Entity or any of its subsidiaries
that cover the Continuing Employees or their dependents, and (ii) cause
any eligible expenses incurred by any Continuing Employee and his or her
covered dependents, during the portion of the plan year in which the Closing
occurs, under those health and welfare benefit plans in which such Continuing
Employee currently participates to be taken into account under those health
and welfare benefit plans in which such Continuing Employee participates
subsequent to the Closing Date for purposes of satisfying all deductible,
coinsurance, and maximum out-of-pocket requirements applicable to such
Continuing Employee and his or her covered dependents for the applicable plan
year. Following the Closing, Apex, the Surviving Entity and each Company
Subsidiary will honor all accrued but unused vacation and other paid time off
of the Continuing Employees that existed immediately prior to the Closing
with respect to the calendar year in which the Closing occurs.

  



  

(d) The provisions of this _Section 7.06_ are solely for the benefit of the
parties to the Agreement, and nothing contained in this Agreement, express or
implied, shall confer upon any Continuing Employee or legal representative or
beneficiary or dependent thereof, or any other person, any rights or remedies
of any nature or kind whatsoever under or by reason of this Agreement,
whether as a third-party beneficiary or otherwise, including, without
limitation, any right to employment or continued employment for any specified
period, or level of compensation or benefits. Nothing contained in this
Agreement, express or implied, shall constitute an amendment or modification
of any employee benefit plan of the Company or shall require the Company,
Apex, the Surviving Entity and each of its subsidiaries to continue any Plan
or other employee benefit arrangements, or prevent their amendment,
modification or termination.

  



  

Section 7.07 _Adoption of Equity Plan and ESPP_. Prior to the effectiveness
of the Proxy Statement and Registration Statement, Apex will adopt a
customary equity incentive plan and customary employee stock purchase plan,
each of which is reasonably acceptable to the Company, in accordance with
_Section 7.01(a)_.

  



  

   

83

 



    



  

Section 7.08 _Directors ' and Officers' Indemnification_.

  



  

(a) The certificate of incorporation and bylaws of the Surviving Corporation
and the operating agreement of the Surviving Entity shall contain provisions
no less favorable with respect to indemnification, advancement or expense
reimbursement than are set forth in the bylaws of the Company, which
provisions shall not be amended, repealed or otherwise modified for a period
of six years from the Effective Time in any manner that would affect
adversely the rights thereunder of individuals who, at or prior to the
Effective Time, were directors, officers, employees, fiduciaries or agents of
the Company, unless such modification shall be required by applicable Law.
From and after the Effective Time, Apex agrees that it shall indemnify and
hold harmless each present and former director and officer of the Company and
Apex against any costs or expenses (including reasonable attorneys' fees),
judgments, fines, losses, claims, damages or liabilities incurred in
connection with any claim, action, suit, proceeding or investigation, whether
civil, criminal, administrative or investigative, arising out of or pertaining
to matters existing or occurring at or prior to the Effective Time, whether
asserted or claimed prior to, at or after the Effective Time, to the fullest
extent that the Company or Apex would have been permitted under applicable
Law, the Company Group Organizational Documents or any director
indemnification agreement or employment agreement in effect on the date of
this Agreement to indemnify such person (including the advancing of expenses
as incurred to the fullest extent permitted under applicable Law). Apex
further agrees that with respect to the provisions of the Company Group
Organizational Documents relating to indemnification, advancement or expense
reimbursement, such provisions shall not be amended, repealed or otherwise
modified for a period of six years from the Effective Time in any manner that
would affect adversely the rights thereunder of individuals who, at or prior
to the Effective Time, were directors, officers, employees, fiduciaries or
agents of any Company Group Member, unless such modification shall be required
by applicable Law.

  



  

(b) Prior to the Effective Time, Apex shall purchase and obtain as of the
Closing Date "tail" insurance policies extending coverage for an aggregate
period of six years providing directors' and officers' liability insurance
with respect to claims arising from facts or events that occurred on or
before the Closing covering (as direct beneficiaries) those persons who are
currently covered by the Company's, Apex's and Merger Subs' directors' and
officers' liability insurance policies, in each case of the type and with the
amount of coverage no less favorable than those of the directors' and
officers' liability insurance maintained as of the date hereof by, or for the
benefit of, the Company, Apex and Merger Subs, as applicable.

  



  

(c) On the Closing Date, Apex shall enter into customary indemnification
agreements reasonably satisfactory to each of the Company and Apex with the
post-Closing directors and officers of Apex, which indemnification agreements
shall continue to be effective following the Closing.

  



  

   

84

 



    



  

Section 7.09 _Notification of Certain Matters_. During the Interim Period,
the Company shall give prompt notice to Apex, and Apex shall give prompt
notice to the Company, of (a) any event which a party becomes aware of between
the date of this Agreement and the Closing (or the earlier termination of
this Agreement in accordance with _Article IX_), the occurrence, or non-
occurrence of which causes or would reasonably be expected to cause any of the
conditions set forth in _Article VIII _to fail, (b) any notice or other
communication from any person alleging that the consent of such person is
required in connection with the transactions contemplated by this Agreement,
except any consent the failure of which to obtain would not reasonably
be expected to be material to the Company Group, taken as a whole, or (c) any
Actions that, if pending on the date of this Agreement, would have been
required to have been disclosed pursuant to _Section 4.09_ or _Section 5.09_.

  



  

Section 7.10 _Further Action; Reasonable Best Efforts_.

  



  

(a) Upon the terms and subject to the conditions of this Agreement, during
the Interim Period, each of the parties hereto shall use its reasonable best
efforts to take, or cause to be taken, appropriate action, and to do, or cause
to be done, such things as are necessary, proper or advisable under
applicable Laws or otherwise, and each shall cooperate with the other, to
consummate and make effective the Transactions, including, without
limitation, using its reasonable best efforts to obtain all permits, consents,
approvals, authorizations, qualifications and orders of, and the expiration
or termination of waiting periods by, Governmental Authorities and parties to
contracts with the Company and the Company Subsidiaries as set forth in
_Section 4.05_ necessary for the consummation of the Transactions and to
fulfill the conditions to the Mergers. In case, at any time after the
Effective Time, any further action is necessary or desirable to carry out the
purposes of this Agreement, the proper officers and directors of each party
shall use their reasonable best efforts to take all such action.

  



  

(b) During the Interim Period, each of the parties shall keep each other
apprised of the status of matters relating to the Transactions,
including promptly notifying the other parties of any communication it or any
of its affiliates receives from any Governmental Authority relating to the
matters that are the subject of this Agreement and permitting the other
parties to review in advance, and to the extent practicable consult about,
any proposed communication by such party to any Governmental Authority in
connection with the Transactions. No party to this Agreement shall agree to
participate in any meeting, or video or telephone conference, with
any Governmental Authority in respect of any filings, investigation or other
inquiry unless it consults with the other parties in advance and, to the
extent permitted by such Governmental Authority, gives the other parties the
opportunity to attend and participate at such meeting or conference. Subject
to the terms of the Confidentiality Agreements, the parties will coordinate
and cooperate fully with each other in exchanging such information and
providing such assistance as the other parties may reasonably request in
connection with the foregoing. Subject to the terms of the Confidentiality
Agreements, the parties will provide each other with copies of all material
correspondence, filings or communications, including any documents,
information and data contained therewith, between them or any of their
Representatives, on the one hand, and any Governmental Authority, on the other
hand, with respect to this Agreement and the Transactions contemplated
hereby. No party shall take or cause to be taken any action before any
Governmental Authority that is inconsistent with or intended to delay its
action on requests for a consent or the consummation of the Transactions.

  



  

   

85

 



    



  

(c) Notwithstanding the generality of the foregoing, Apex shall use its
reasonable best efforts to consummate the Private Placement in accordance
with the Subscription Agreements, and the Company shall cooperate with Apex
in such efforts. Apex acknowledges and agrees that the Company shall be
entitled to specifically enforce the obligations of the PIPE Investors to fund
the subscription amounts set forth in the Subscription Agreements executed by
such PIPE Investors and the provisions of each such Subscription Agreement of
which the Company is an express third party beneficiary, in each case, on the
terms and subject to the conditions set forth in each such
Subscription Agreement. Apex shall not, without the prior written consent of
the Company (such consent not to be unreasonably withheld, delayed or
conditioned), and except for any of the following actions that would not
increase conditionality or impose any new obligation on the Company or Apex,
increase, decrease or otherwise modify any PIPE Commitment or the subscription
amount under any Subscription Agreement or reduce or impair the rights of
Apex under any Subscription Agreement, permit or consent to any amendment,
supplement or modification to any Subscription Agreement, any waiver (in
whole or in part) of, or provide consent to modify (including consent to
terminate), any provision or remedy under, or any replacements of, any of the
Subscription Agreements, in each case, other than any assignment or transfer
contemplated therein or expressly permitted thereby (without any further
amendment, modification or waiver to such assignment or transfer provision);
_provided_ , that, in the case of any such assignment or transfer, the
initial party to such Subscription Agreement remains bound by its obligations
with respect thereto in the event that the transferee or assignee, as
applicable, does not comply with its obligations to consummate the purchase of
shares of Apex Common Stock contemplated thereby. Subject to the immediately
preceding sentence and in the event that all conditions in the Subscription
Agreements have been satisfied, Apex shall use its reasonable best efforts to
take, or to cause to be taken, all actions required, necessary or that it
otherwise deems to be proper or advisable to consummate the transactions
contemplated by the Subscription Agreements on or prior to the Closing on the
terms described therein, including using its reasonable best efforts to
satisfy on a timely basis all conditions and covenants applicable to Apex in
the Subscription Agreements and otherwise comply with its obligations
thereunder and to enforce the rights of Apex under the Subscription
Agreements to cause the PIPE Investors to pay to (or as directed by) Apex the
applicable purchase price under each PIPE Investor's applicable Subscription
Agreement in accordance with its terms.

  



  

(d) Without limiting the generality of _Section 7.10(c)_ , Apex shall give
the Company prompt written notice: (i) of any amendment to any Subscription
Agreement (other than as a result of any assignments or transfers contemplated
therein or otherwise permitted thereby) entered into by Apex that Apex was
permitted to make without the prior written consent of the Company in
accordance with _Section 7.10(c)_ , (ii) to the knowledge of Apex, of any
breach or default (or any event or circumstance that, with or without
notice, lapse of time or both, would give rise to any breach or default) by
any party to any Subscription Agreement; (iii) of the receipt of any written
notice or other written communication from any party to any Subscription
Agreement with respect to any actual, potential, threatened, or claimed
expiration, lapse, withdrawal, breach, default, termination or repudiation by
any party to any Subscription Agreement or any provisions of any Subscription
Agreement; and (iv) if, to the knowledge of Apex, any portion of the PIPE
Commitment pursuant to the Subscription Agreements will not be funded in
accordance with the terms of the applicable Subscription Agreement.

  



  

(e) The Company shall give Apex prompt written notice: (i) to the knowledge
of the Company, of any breach or default (or any event or circumstance that,
with or without notice, lapse of time or both, would give rise to any breach
or default) by any party to any Subscription Agreement; and (ii) if, to the
knowledge of the Company, any portion of the PIPE Commitment pursuant to the
Subscription Agreements will not be funded in accordance with the terms of
the applicable Subscription Agreement.

  



  

   

86

 



    



  

Section 7.11 _Public Announcements_. The initial press release relating to
this Agreement shall be a joint press release, the text of which has been
agreed to by each of Apex and the Company. Thereafter, between the date of
this Agreement and the Closing Date (or the earlier termination of this
Agreement in accordance with _Article IX_) unless otherwise prohibited by
applicable Law or the requirements of Nasdaq Capital Market, each of Apex and
the Company shall each use its reasonable best efforts to consult with each
other before issuing any press release or otherwise making any public
statements (including through social media platforms) with respect to this
Agreement, the Mergers or any of the other Transactions, and shall not
issue any such press release or make any such public statement (including
through social media platforms) without the prior written consent of the
other party. Furthermore, nothing contained in this Section 7.11 shall prevent
Apex or the Company or its respective affiliates from furnishing customary or
other reasonable information concerning the Transactions to their investors
and prospective investors that is substantively consistent with public
statements previously consented to by the other party in accordance with this
_Section 7.11_.

  



  

Section 7.12 _Stock Exchange Listing_. Apex will use its reasonable best
efforts to cause the shares of Apex Common Stock issuable upon conversion of
the Aggregate Stock Consideration to be approved for listing on Nasdaq Capital
Market at Closing subject to notice of issuance. Apex and the Company shall
each pay one half of all filing fees and out-of-pocket expenses due in
connection with any such listing in connection with the Transactions
(excluding, for the avoidance of doubt, expenses of such party's legal
counsel). During the Interim Period, Apex shall use its reasonable best
efforts to keep the Apex Common Stock and Apex Warrants listed for trading on
Nasdaq Capital Market.

  



  

Section 7.13 _Antitrust_.

  



  

(a) To the extent required under any Laws that are designed to prohibit,
restrict or regulate actions having the purpose or effect of monopolization
or restraint of trade, including the HSR Act (" _Antitrust Laws_ "), each
party hereto agrees to promptly make any required filing or application under
Antitrust Laws, as applicable, and no later than ten Business Days after the
date of this Agreement, the Company and Apex each shall file with the
Antitrust Division of the U.S. Department of Justice and the U.S. Federal
Trade Commission a Notification and Report Form as required by the HSR Act.
Apex and the Company shall each pay one half of all administrative filing
fees and out-of-pocket expenses due in connection with any such required
filing (excluding, for the avoidance of doubt, expenses of such party's legal
counsel). The parties hereto agree to supply as promptly as
reasonably practicable any additional information and documentary material
that may be requested pursuant to Antitrust Laws and to take all other
actions necessary, proper or advisable to cause the expiration or termination
of the applicable waiting periods or obtain required approvals, as applicable
under Antitrust Laws as soon as practicable, including by requesting early
termination of the waiting period provided for under the HSR Act.

  



  

   

87

 



    



  

(b) Apex and the Company each shall, in connection with its efforts to obtain
all requisite approvals and expiration or termination of waiting periods for
the Transactions under any Antitrust Laws, use its reasonable best efforts to:
(i) cooperate in all respects with each other party or its affiliates in
connection with any filing or submission and in connection with any
investigation or other inquiry, including any proceeding initiated by a
private person; (ii) timely keep the other reasonably informed of any
communication received by such party from, or given by such party to, any
Governmental Authority and of any communication received or given in
connection with any proceeding by a private person, in each case regarding
any of the Transactions, and promptly furnish the other with copies of all
such written communications; (iii) permit the other to review in advance any
written communication to be given by it to, and consult with each other in
advance of any meeting or video or telephonic conference with, any
Governmental Authority or, in connection with any proceeding by a private
person, with any other person, and to the extent permitted by such
Governmental Authority or other person, give the other the opportunity to
attend and participate in such in person, video or telephonic meetings and
conferences; (iv) in the event a party is prohibited from participating in or
attending any in person, video or telephonic meetings or conferences, the
other shall keep such party promptly and reasonably apprised with respect
thereto; and (v) cooperate in the filing of any memoranda, white papers,
filings, submissions, correspondence or other written communications
explaining or defending the Transactions, articulating any regulatory or
competitive argument, or responding to requests or objections made by any
Governmental Authority, permitting the other party to view in advance,
considering and in good faith incorporating the other party's reasonable
comments; _provided_ , that materials required to be provided pursuant to
this _Section 7.13(b)_ may be restricted to outside counsel and may be
redacted (i) to remove references concerning the valuation of the Company, and
(ii) as necessary to comply with contractual arrangements, and (iii) to
remove references to privileged information.

  



  

(c) No party hereto shall take any action that could reasonably be expected
to adversely affect or materially delay the approval of any Governmental
Authority, or the expiration or termination of any waiting period under
Antitrust Laws, including by agreeing to merge with or acquire any other
person or acquire a substantial portion of the assets of or equity in any
other person. The parties hereto further covenant and agree, with respect to
a threatened or pending preliminary or permanent injunction or other order,
decree or ruling or statute, rule, regulation or executive order that would
adversely affect the ability of the parties to consummate the Transactions,
to use reasonable best efforts to prevent or lift the entry, enactment or
promulgation thereof, as the case may be.

  



  

Section 7.14 _Trust Account_. As of the Effective Time, the obligations of
Apex to dissolve or liquidate within a specified time period as contained in
the Apex Certificate of Incorporation will be terminated and Apex shall have
no obligation whatsoever to dissolve and liquidate the assets of Apex by
reason of the consummation of the Mergers or otherwise, and no stockholder of
Apex shall be entitled to receive any amount from the Trust Account. At least
48 hours prior to the Effective Time, Apex shall provide notice to the
Trustee in accordance with the Trust Agreement and shall deliver any other
documents, opinions or notices required to be delivered to the Trustee
pursuant to the Trust Agreement and cause the Trustee prior to the Effective
Time to, and the Trustee shall thereupon be obligated to, transfer all funds
held in the Trust Account to Apex to pay as and when due all amounts payable
to Apex Public Stockholders pursuant to the Redemption Rights, and with
respect to all remaining amounts then available in the Trust Account to Apex
to be used in accordance with this Agreement and thereafter shall cause the
Trust Account and the Trust Agreement to terminate.

  



  

Section 7.15 _Tax Matters_.

  



  

(a) After the Closing, each of Apex, Merger Subs, the Company and their
respective affiliates and Representatives shall (A) file all Tax Returns
consistent with the Intended Tax-Free Treatment (including attaching the
statement described in Treasury Regulations Section 1.368-3(a), on or with
the U.S. federal income Tax Returns of the Company and Apex for the taxable
year that includes the Mergers), and (B) except to the extent otherwise
required by a "determination" as such term is used in Section 1313 of the
Code, take no position or action inconsistent with the Intended Tax-Free
Treatment (whether in audits, Tax Returns or otherwise).

  



  

   

88

 



    



  

(b) Each of Apex, Merger Subs, and the Company and their respective
affiliates and Representatives shall cooperate and use its
respective reasonable best efforts to cause the Mergers to qualify for the
Intended Tax-Free Treatment, and not to take any action or fail to take any
action, in either case, that could reasonably be expected to prevent or impede
the Mergers from qualifying for the Intended Tax-Free Treatment. Such
cooperation and reasonable best efforts shall include (but not be limited to):
(i) taking actions (and not failing to take actions) to cause the Mergers to
qualify for the Intended Tax-Free Treatment, and not taking actions
(or failing to take actions) that could reasonably be expected to prevent or
impede the Mergers from qualifying for the Intended Tax-Free Treatment; (ii)
a party promptly notifying the other party that such party knows or has reason
to believe that the Mergers may not qualify for the Intended Tax-Free
Treatment; and (iii) in the event either Apex or the Company seeks a tax
opinion from its respective tax advisor regarding the Intended Tax-Free
Treatment, or the SEC requests or requires a tax opinion regarding the
Intended Tax-Free Treatment, each party shall execute and delivery customary
tax representation letters to the applicable tax advisor in form and
substance reasonably satisfactory to such advisor upon which such advisor
shall be entitled to rely. Notwithstanding anything in this Agreement to the
contrary, no party shall be required to undertake any of the following in
order to cause the Mergers to qualify for the Intended Tax-Free Treatment:
(x) modify the Per Share Amount; or (y) surrender, undermine or alter any of
its other economic or legal rights pursuant to this Agreement to an extent
that materially and adversely affects the benefits intended to be conferred
upon Apex and its shareholders, the Apex Initial Stockholders, or any
affiliates thereof (as contemplated by this Agreement prior to giving effect
to any surrendering, undermining or alteration of such rights).

  



  

(c) For U.S. federal income Tax purposes, each of Apex, the Company and their
respective affiliates intend that this Agreement, including any amendments
thereto, be, and is hereby adopted as, the "plan of reorganization" involving
the Mergers within the meaning of Section 368 of the Code and Treasury
Regulations Sections 1.368-2(g) and 1.368-3(a).

  



  

(d) For the avoidance of doubt, and notwithstanding anything to the contrary,
each party acknowledges that it (and its respective Representatives and
owners): (i) has had a reasonable opportunity to consult with tax advisors of
its own choosing regarding this Agreement, the Transactions, and the tax
structure of the Transactions, in each case, in accordance with the
Confidentiality Agreements; (ii) is aware of the Tax consequences of the
Transactions; (iii) is relying solely upon its own Representatives and is not
relying upon any other party or its Representatives for tax advice regarding
the Transactions; and (iv) other than representations and
warranties explicitly provided pursuant to this Agreement (including pursuant
to _Section 7.15(a)_), is not relying upon any representation or warranty
from any party in determining the Tax treatment of the Transactions.

  



  

Section 7.16 _Directors_. Apex and the Company shall take all necessary
action so that immediately after the Effective Time, the board of directors
of Apex is comprised of the individuals designated on _Exhibit K_. Apex shall
enter into the Board Observer Agreement at or prior to the Closing.

  



  

   

89

 



    



  

Section 7.17 _Audited Financial Statements_.

  



  

(a) The Company shall use reasonable best efforts to deliver to Apex, as soon
as reasonably practicable following the date hereof, but in no event later
than December 28, 2020, (i) audited consolidated balance sheets and statements
of operations, comprehensive loss, stockholders' equity and cash flows of the
Company and Company Subsidiaries as of and for the years ended December 31,
2019 and December 31, 2018, together with the auditor's reports thereon, which
comply in all material respects with all applicable accounting requirements
and with the rules and regulations of the SEC, the Exchange Act and the
Securities Act as required to be included in the Proxy Statement (the "
_Updated Annual Financial Statements_ "); _provided_ , that upon delivery of
such Updated Annual Financial Statements, such financial statements shall be
deemed " _Annual Financial Statements_ " for the purposes of this Agreement
and the representation and warranties set forth in _Section 4.07_  shall be
deemed to apply to such Updated Annual Financial Statements with the same
force and effect as if made as of the date of this Agreement.

  



  

(b) The Company shall use reasonable best efforts to deliver to Apex on or
before December 28, 2020, the audited consolidated balance sheets and
statements of operations, comprehensive loss, stockholders' equity, and cash
flows of the Company and Company Subsidiaries as of and for the nine-month
period ending September 30, 2020 (the " _Updated Audited Interim Financial
Statements_ "), which comply in all material respects with all applicable
accounting requirements and with the rules and regulations of the SEC, the
Exchange Act and the Securities Act as required to be included in the Proxy
Statement; _provided_ , that upon delivery of such Updated Audited Interim
Financial Statements, the representations and warranties set forth in _Section
4.07_ shall be deemed to apply to the Updated Audited Interim Financial
Statements in the same manner as the Interim Financial Statements, mutatis
mutandis, with the same force and effect as if made as of the date of this
Agreement.

  



  

(c) If the Effective Time has not occurred prior to February 28, 2021, and
this Agreement has not been earlier terminated pursuant to  _Section 9.01_ ,
the Company shall use reasonable best efforts to deliver to Apex on or before
February 28, 2021, the audited consolidated balance sheets and statements of
operations and comprehensive loss, cash flow and change in stockholders'
equity of the Company and Company Subsidiaries as of and for the year ended
December 31, 2020, together with the auditor's reports thereon (the " _2020
Audited Financial Statements_ "), which comply in all material respects with
all applicable accounting requirements and with the rules and regulations of
the SEC, the Exchange Act and the Securities Act; _provided_ , that upon
delivery of such 2020 Audited Financial Statements, the representation and
warranties set forth in _Section 4.07_  shall be deemed to apply to the 2020
Audited Financial Statements in the same manner as the Annual Financial
Statements, mutatis mutandis, with the same force and effect as if made as of
the date of this Agreement.

  



  

Section 7.18 _Affiliate Agreements_. All agreements set forth on _Section
4.23_ of the Company Disclosure Schedule (each an " _Affiliate Agreement_ ")
shall be terminated or settled at or prior to the Closing without further
liability to Apex, Merger Subs, the Company or Company Subsidiaries, in each
case, except as otherwise set forth on _Section 7.18_ of the Company
Disclosure Schedule.

  



  

Section 7.19 _280G Approval_. To the extent that the execution of this
Agreement and the consummation of the transactions contemplated hereby may
entitle any "disqualified individual" of the Company Group to a "parachute
payment" (as such terms are defined in Section 280G of the Code), then, prior
to the Closing, the Company shall submit to its stockholders, for approval
(in a manner and with a disclosure document reasonably satisfactory to Apex)
by a vote of such stockholders as is required pursuant to Section
280G(b)(5)(B) of the Code and the Treasury Regulations thereunder (the "
_Requisite 280G Vote_ "), any such payments or other benefits payable to any
person who has provided the waiver described in the succeeding sentence that
may, separately or in the aggregate, constitute "parachute payments" (within
the meaning of Section 280G of the Code and the Treasury Regulations
thereunder), such that, if the Requisite 280G Vote is received approving such
payments and benefits, such payments and benefits shall not be deemed to be
"parachute payments" under Section 280G of the Code and the Treasury
Regulations thereunder. Prior to such Requisite 280G Vote (if any), the
Company shall obtain, from each person who is a "disqualified individual"
(within the meaning of Section 280G of the Code and the Treasury Regulations
thereunder) and who might otherwise have, receive or have the right or
entitlement to receive a parachute payment under Section 280G of the Code, a
written waiver (in form and substance reasonably satisfactory to Apex)
pursuant to which such person agrees to waive any and all right or
entitlement to receive or retain any such payment, to the extent (i) the
value thereof equals or exceeds three times such person's base amount
determined in accordance with Section 280G of the Code and the Treasury
Regulations thereunder and (ii) such payments are not approved pursuant to the
Requisite 280G Vote.

  



  

Section 7.20 _Trust Account Proceeds and Related Available Equity_. If,
after the Apex Stockholders' Meeting the Available Apex Cash is less than the
Minimum Cash Amount, then, at or prior to the Closing, Apex shall,
notwithstanding anything contained herein to the contrary, have the right
(but not the obligation) to purchase or sell to any other person additional
shares of Apex Common Stock (a) that have the same rights, privileges and
preferences as the shares of Apex Common Stock to be issued to the
stockholders of the Company pursuant to the terms of this Agreement (with no
additional securities or economic inducements, except or as otherwise
expressly consented to by the Company in advance of such issuance) and (b) at
a price per share not less than $10.00 (such additional shares, the "
_Additional Equity Amount_ ") up to the Minimum Cash Amount.

  



  

Section 7.21 _Employment Agreements_. Apex shall use commercially reasonable
efforts to enter into employment agreements with the executives of the
Company set forth on _Schedule E_ as promptly as practicable, and in any event
within seven Business Days following the delivery of the Compensation Report
to Apex.

  



  

   

90

 



    



  

Article VIII. 
  _CONDITIONS TO THE MERGERs_

  



  

Section 8.01 _Conditions to the Obligations of Each Party_. The obligations
of the Company, Apex and Merger Subs to consummate the Transactions, including
the Mergers, are subject to the satisfaction or waiver (where permissible) at
or prior to the Closing of the following conditions:

  



  

(a) _Company Stockholder Approval_. The Company Stockholder Approval shall
have been obtained.

  



  

(b) _Apex Stockholders ' Approval_. The Apex Proposals shall have been
approved and adopted by the requisite affirmative vote of the stockholders of
Apex in accordance with the Proxy Statement, the DGCL, the Apex Organizational
Documents and the rules and regulations of the Nasdaq Capital Market.

  



  

(c) _Effectiveness of Registration Statement_. The Registration Statement
shall have become effective under the Securities Act and no stop
order suspending the effectiveness of the Registration Statement shall be in
effect and no proceedings for that purpose shall be pending before or
threatened by the SEC.

  



  

(d) _No Order_. No Governmental Authority shall have enacted, issued,
promulgated, enforced or entered any Law, rule, regulation, judgment, decree,
executive order or award which is then in effect and has the effect of making
the Transactions, including the Mergers, illegal or otherwise prohibiting
consummation of the Transactions, including the Mergers.

  



  

(e) _HSR_. All required filings under the HSR Act shall have been completed
and any applicable waiting period (and any extension thereof) applicable to
the consummation of the Transactions under the HSR Act shall have expired or
been terminated.

  



  

(f) _Consents_. All consents, approvals and authorizations set forth on
_Section 8.01(f)_ of the Company Disclosure Schedule shall have been obtained
from and made with all Governmental Authorities.

  



  

(g) _PIPE Closing_. The sale and issuance by Apex of Apex Common Stock shall
have been consummated in accordance with the terms of the Subscription
Agreements.

  



  

(h) _Apex Net Tangible Assets_. Apex shall have at least $5,000,001 of net
tangible assets following the exercise of Redemption Rights in accordance
with the Apex Organizational Documents.

  



  

(i) _Stock Exchange Listing_. Apex shall have submitted the supplemental
listing application to the Nasdaq Capital Market for the shares of Apex
Common Stock represented by the Aggregate Stock Consideration and the
Contingent Consideration.

  

   

91

 



    



  

Section 8.02 _Conditions to the Obligations of Apex and Merger Subs_. The
obligations of Apex and Merger Subs to consummate the Transactions, including
the Mergers, are subject to the satisfaction or waiver (where permissible) at
or prior to the Closing of the following additional conditions:

  



  

(a) _Representations and Warranties_. The representations and warranties of
the Company contained in (i) _Section 4.01_, _Section 4.03_ (other than
clauses (a) and (b) thereof, which are subject to clause (iii) below),
_Section 4.04_, _Section 4.05(a)(i)_  and (ii), _Section 4.19_ and _Section
4.25_ shall each be true and correct in all material respects as of the date
hereof and the Effective Time (except, in the case of _Section 4.03(c)_ , to
the extent of any changes that reflect actions permitted in accordance with
_Section 6.01_ of this Agreement) (except to the extent that any such
representation or warranty expressly is made as of an earlier date, in which
case such representation and warranty shall be true and correct as of such
specified date), (ii) _Section 4.08(c)_ shall be true and correct in all
respects as of the date hereof and the Effective Time, (iii)  _Section
4.03(a)_ and _Section 4.03(b)_ shall be true and correct in all respects as of
the date hereof and as of the Effective Time as though made on and as of such
date (except to the extent that any such representation or warranty
expressly is made as of an earlier date, in which case such representation
and warranty shall be true and correct as of such specified date), except
where the failure of such representations and warranties to be so true and
correct would not, individually or in the aggregate, be reasonably expected
to result in more than _de minimis_ additional cost, expense or liability to
the Company, Apex, Merger Sub or their affiliates and (iv) the other
provisions of _Article IV_ shall be true and correct in all respects (without
giving effect to any "materiality," "Company Material Adverse Effect" or
similar qualifiers contained in any such representations and warranties) as
of the date hereof and as of the Effective Time as though made on and as of
such date (except to the extent that any such representation or warranty
expressly is made as of an earlier date, in which case such
representation and warranty shall be true and correct as of such earlier
date), except where the failures of any such representations and
warranties to be so true and correct, individually or in the aggregate, would
not reasonably be expected to have a Company Material Adverse Effect.

  



  

(b) _Agreements and Covenants_. The Company shall have performed or complied
in all material respects with all agreements and covenants required by this
Agreement to be performed or complied with by it on or prior to the Effective
Time.

  



  

(c) _Officer Certificate_. The Company shall have delivered to Apex a
certificate, dated the date of the Closing, signed by an officer of the
Company, certifying as to the satisfaction of the conditions specified in
_Section 8.02(a)_ , _Section 8.02(b)_ and  _Section 8.02(d)_.

  



  

(d) _Material Adverse Effect_. No Company Material Adverse Effect shall have
occurred between the date of this Agreement and the Closing Date that is
continuing. 

  



  

Section 8.03 _Conditions to the Obligations of the Company_. The obligations
of the Company to consummate the Transactions, including the Mergers, are
subject to the satisfaction or waiver (where permissible) at or prior to
Closing of the following additional conditions:

  



  

(a) _Representations and Warranties_. The representations and warranties of
Apex and Merger Sub contained in (i) _Section 5.01_, _Section 5.03_ (other
than clause (a) thereof, which is subject to clause (iii) below), _Section
5.04_, _Section 5.05(a)(i)_ and  _(ii)_ , _Section 5.10_ and Section 5.12
shall each be true and correct in all material respects as of as of the
date hereof and the Effective Time (except to the extent that any such
representation or warranty expressly is made as of an earlier date, in which
case such representation and warranty shall be true and correct as of such
specified date), (ii) _Section 5.08(c)_  shall be true and correct in all
respects as of the date hereof and the Effective Time, (iii) _Section
5.03(a)_,  _Section 5.03(f)_ and _Section 5.03(g)_ shall be true and correct
in all respects as of the date hereof and as of the Effective Time as though
made on and as of such date (except to the extent that any such representation
or warranty expressly is made as of an earlier date, in which case such
representation and warranty shall be true and correct as of such specified
date), except where the failure of such representations and warranties to be
so true and correct would not, individually or in the aggregate, be
reasonably expected to result in more than de minimis additional cost, expense
or liability to the Company, Apex, Merger Subs or their affiliates and (iv)
the other provisions of _Article V_ shall be true and correct in all respects
(without giving effect to any "materiality," "Apex Material Adverse Effect"
or similar qualifiers contained in any such representations and warranties)
as of the date hereof and as of the Effective Time as though made on and as of
such date (except to the extent that any such representation or warranty
expressly is made as of an earlier date, in which case such
representation and warranty shall be true and correct as of such earlier
date), except where the failures of any such representations and
warranties to be so true and correct, individually or in the aggregate, would
not reasonably be expected to have a Apex Material Adverse Effect.

  



  

   

92

 



    



  

(b) _Agreements and Covenants_. Apex and Merger Subs shall have performed or
complied in all material respects with all agreements and covenants required
by this Agreement to be performed or complied with by it on or prior to the
Effective Time.

  



  

(c) _Officer Certificate_. Apex shall have delivered to the Company a
certificate, dated the date of the Closing, signed by the Chief
Executive Officer of Apex, certifying as to the satisfaction of the
conditions specified in _Section 8.03(a)_ , _Section 8.03(b)_ and  _Section
8.03(d)_.

  



  

(d) _Material Adverse Effect_. No Apex Material Adverse Effect shall have
occurred between the date of this Agreement and the Closing Date that is
continuing.

  



  

(e) _Minimum Cash_. The Available Apex Cash shall be no less than the
Minimum Cash Amount.

  



  

Section 8.04 _Frustration of Conditions_. None of Apex, Merger Subs or the
Company may rely on the failure of any condition set forth in this _Article
VIII_ to be satisfied if such failure was caused by such party's failure to
act in good faith or to take such actions as may be necessary to cause the
conditions of the other party to be satisfied, as required by _Section
7.10_.

  



  

Article IX. 
  _TERMINATION, AMENDMENT AND WAIVER_

  



  

Section 9.01 _Termination_. This Agreement may be terminated and the Mergers
and the other Transactions may be abandoned at any time prior to the
Effective Time, notwithstanding any requisite approval and adoption of this
Agreement and the Transactions by the stockholders of the Company or Apex, as
follows:

  



  

(a) by mutual written consent of Apex and the Company; or

  



  

(b) by either Apex or the Company if the Effective Time shall not have
occurred prior to the date that is 180 days after the date hereof (the "
_Outside Date_ "); _provided_ , _however_ , that this Agreement may not be
terminated under this _Section 9.01(b)_ by or on behalf of any party that is
in breach or violation of any representation, warranty, covenant, agreement
or obligation contained herein and such breach or violation is the principal
cause of the failure of a condition set forth in _Article VIII_ on or prior
to the Outside Date; and _provided_ , _further_ , that in the event that any
Law is enacted after the date hereof extending the applicable waiting period
under the HSR Act, the Outside Date shall automatically be extended by the
length of any such extension; or

  



  

   

93

 



    



  

(c) by either Apex or the Company if any Governmental Authority in the United
States shall have enacted, issued, promulgated, enforced or entered any
injunction, order, decree or ruling (whether temporary, preliminary or
permanent) which has become final and non-appealable and has the effect of
making consummation of the Transactions, including the Mergers, illegal or
otherwise preventing or prohibiting consummation of the Transactions, the
Mergers; or

  



  

(d) by either Apex or the Company if any of the Apex Proposals shall fail to
receive the requisite vote for approval at the Apex Stockholders' Meeting; or

  



  

(e) by Apex if the Company shall have failed to obtain the Company
Stockholder Approval within 48 hours after the Registration Statement becomes
effective; or

  



  

(f) by Apex upon a breach of any representation, warranty, covenant or
agreement on the part of the Company set forth in this Agreement, or if any
representation or warranty of the Company shall have become untrue, in either
case such that the conditions set forth in _Sections 8.02(a)_ and _8.02(b)_
would not be satisfied (" _Terminating Company Breach_ ");  _provided_ , that
Apex has not waived such Terminating Company Breach and Apex and Merger Subs
are not then in breach of their representations, warranties, covenants or
agreements in this Agreement such that the conditions set forth in _Sections
8.03(a)_ and _8.03(b)_ would not be satisfied; _provided_ , _further_ , that,
if such Terminating Company Breach is curable by the Company, Apex may not
terminate this Agreement under this _Section 9.01(f)_ for so long as the
Company continues to exercise its reasonable efforts to cure such breach,
unless such breach is not cured within 30 days after notice of such breach is
provided by Apex to the Company; or

  



  

(g) by the Company upon a breach of any representation, warranty, covenant or
agreement on the part of Apex or either Merger Sub set forth in this
Agreement, or if any representation or warranty of Apex or Merger Subs shall
have become untrue, in either case such that the conditions set forth in
_Sections 8.03(a)_ and _8.03(b)_ would not be satisfied (" _Terminating
Apex Breach_ "); _provided_ , that the Company has not waived such
Terminating Apex Breach and the Company is not then in breach of its
representations, warranties, covenants or agreements in this Agreement such
that the conditions set forth in _Sections 8.02(a)_ and _8.02(b)_ would not
be satisfied; _provided_ , _however_ , that, if such Terminating Apex Breach
is curable by Apex and Merger Subs, the Company may not terminate this
Agreement under this _Section 9.01(g) _for so long as Apex and Merger Subs
continue to exercise their reasonable efforts to cure such breach, unless such
breach is not cured within 30 days after notice of such breach is provided by
the Company to Apex.

  



  

Section 9.02 _Effect of Termination_. In the event of the termination of
this Agreement pursuant to _Section 9.01_, this Agreement shall forthwith
become void, and there shall be no liability under this Agreement on the part
of any party hereto, except (a) as set forth in _Section 7.04(b)_, this
_Section 9.02_, _Section 9.03_, _Article X _(collectively, the "
_Surviving Provisions_ "), and any corresponding definitions set forth in
_Article I _and any other Section or Article of this Agreement referenced in
such Surviving Provisions or (b) with respect to Fraud or a willful material
breach of this Agreement by a party hereto prior to such termination. The
Surviving Provisions and the Confidentiality Agreements shall in each case
survive any termination of this Agreement.

  



  

   

94

 



    



  

Section 9.03 _Expenses_. Except as set forth in this _Section 9.03_ or
elsewhere in this Agreement, all expenses incurred in connection with this
Agreement and the Transactions shall be paid by the party incurring such
expenses, whether or not the Mergers or any other Transaction is consummated.
For avoidance of doubt, the filing and registration fees and mailing and
printing costs contemplated by _Section 7.01_, the listing fees contemplated
by _Section 7.12_ and the filing fees and expenses contemplated by _Section
7.13 _shall be paid one half by each of the parties hereto;  _provided_ ,
that each party further acknowledges that such party shall be responsible for
the fees and expenses payable by such party to its respective Representatives
with respect to such matters. On the Closing Date, Apex shall pay any unpaid
Company Transaction Expenses and Apex Transaction Expenses; _provided_ , that
any Ineligible Apex IPO Underwriting Fees shall be paid by Sponsor, and not
at the expense of Apex or any of its subsidiaries.

  



  

Section 9.04 _Amendment_. This Agreement may be amended in writing by the
parties hereto at any time prior to the Effective Time. This Agreement may not
be amended except by an instrument in writing signed by each of the parties
hereto.

  



  

Section 9.05 _Waiver_. At any time prior to the Effective Time, (i) Apex
may (a) extend the time for the performance of any obligation or other act of
the Company, (b) waive any inaccuracy in the representations and warranties
of the Company contained herein or in any document delivered by the Company
pursuant hereto and (c) waive compliance with any agreement of the Company or
any condition to its own obligations contained herein and (ii) the Company
may (a) extend the time for the performance of any obligation or other act of
Apex or either Merger Sub, (b) waive any inaccuracy in the representations
and warranties of Apex or Merger Subs contained herein or in any document
delivered by Apex or either Merger Sub pursuant hereto and (c) waive
compliance with any agreement of Apex or either Merger Sub or any
condition to its own obligations contained herein. Any such extension or
waiver shall be valid if set forth in an instrument in writing signed by the
party or parties to be bound thereby.

  



  

   

95

 



    



  

Article X. 
  _GENERAL PROVISIONS_

  



  

Section 10.01 _Notices_. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be
deemed to have been duly given (a) when delivered by hand (with written
confirmation of receipt); (b) when received by the addressee if sent by a
nationally recognized overnight courier (receipt requested); (c) on the date
sent by e-mail (with confirmation of transmission) if sent during
normal business hours of the recipient, and on the next Business Day if sent
after normal business hours of the recipient, except, in each case, if an
undelivered message is received by the sender; or (d) on the third day after
the date mailed, by certified or registered mail, return receipt requested,
postage prepaid) by delivery in person, by email or by registered or certified
mail (postage prepaid, return receipt requested) to the respective parties at
the following addresses (or at such other address for a party as shall be
specified in a notice given in accordance with this _Section 10.01_):

  



  

if to Apex or either Merger Sub:

  



  

Apex Technology Acquisition Corp.

  

533 Airport Blvd., Suite 400

  

Burlingame, California 94010

   | Attention:| Steve Fletcher  
---|---|--- 
   | Email:| ########  
---|---|--- 
  



  

with a copy to (which will not constitute notice):

  



  

Latham and Watkins LLP

  

140 Scott Drive

  

Menlo Park, California 94025

   | Attention:| Josh M. Dubofsky; Brian Paulson; Saad Khanani  
---|---|--- 
   | Email:| ######## 
---|---|--- 
  



  

if to the Company:

  



  

AvePoint, Inc.

  

901 East Byrd Street

  

Suite 900

  

Richmond, VA 23219

   | Attention:| General Counsel  
---|---|--- 
   | Email:| ########  
---|---|--- 
  



  

with a copy to (which will not constitute notice):

  



  

Cooley LLP 
 55 Hudson Yards 
 New York, NY 10001

   | Attention:| Mike Lincoln, John McKenna, David I. Silverman  
---|---|--- 
   | Email:| ########  
---|---|--- 
  



  

   

96

 



    



  

Section 10.02 _Nonsurvival of Representations, Warranties and
Covenants_. None of the representations, warranties, covenants, obligations
or other agreements in this Agreement or in any certificate, statement or
instrument delivered pursuant to this Agreement, including any rights arising
out of any breach of such representations, warranties, covenants,
obligations, agreements and other provisions, shall survive the Closing and
all such representations, warranties, covenants, obligations or other
agreements shall terminate and expire upon the occurrence of the Closing (and
there shall be no liability after the Closing in respect thereof), except for
(a) those covenants and agreements contained herein that by their terms
expressly apply in whole or in part after the Closing and then only with
respect to any breaches occurring after the Closing and (b) this  _Article
X_ and any corresponding definitions set forth in _Article I_.

  



  

Section 10.03 _Severability_. If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any rule of
law, or public policy, all other conditions and provisions of this Agreement
shall nevertheless remain in full force and effect so long as the economic or
legal substance of the Transactions is not affected in any manner materially
adverse to any party. Upon such determination that any term or
other provision is invalid, illegal or incapable of being enforced, the
parties hereto shall negotiate in good faith to modify this Agreement so as
to effect the original intent of the parties as closely as possible in a
mutually acceptable manner in order that the Transactions be consummated as
originally contemplated to the fullest extent possible.

  



  

Section 10.04 _Entire Agreement; Assignment_. This Agreement and the
Ancillary Agreements constitute the entire agreement among the parties with
respect to the subject matter hereof and supersede, except as set forth in
_Section 7.04(b)_, all prior agreements and undertakings, both written and
oral, among the parties, or any of them, with respect to the subject matter
hereof, except for the Confidentiality Agreements. This Agreement shall
not be assigned (whether pursuant to a merger, by operation of law or
otherwise) by any party without the prior express written consent of the
other parties hereto.

  



  

Section 10.05 _Parties in Interest_. This Agreement shall be binding upon
and inure solely to the benefit of each party hereto, and nothing in this
Agreement, express or implied, is intended to or shall confer upon any other
person any right, benefit or remedy of any nature whatsoever under or by
reason of this Agreement, other than _Section 7.08_ (which is intended to be
for the benefit of the persons covered thereby and may be enforced by such
persons).

  



  

Section 10.06 _Governing Law_. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of Delaware applicable to
contracts executed in and to be performed in that State. All Actions arising
out of or relating to this Agreement shall be heard and determined exclusively
in any Delaware Chancery Court; _provided_ , that if jurisdiction is not then
available in the Delaware Chancery Court, then any such Action may be brought
in any federal court located in the State of Delaware or any other Delaware
state court. The parties hereto hereby (a) irrevocably submit to the
exclusive jurisdiction of the aforesaid courts for themselves and with respect
to their respective properties for the purpose of any Action arising out of
or relating to this Agreement brought by any party hereto, and (b) agree not
to commence any Action relating thereto except in the courts described above
in Delaware, other than Actions in any court of competent jurisdiction to
enforce any judgment, decree or award rendered by any such court in Delaware
as described herein. Each of the parties further agrees that notice as
provided herein shall constitute sufficient service of process and the
parties further waive any argument that such service is insufficient. Each of
the parties hereby irrevocably and unconditionally waives, and agrees not to
assert, by way of motion or as a defense, counterclaim or otherwise, in any
Action arising out of or relating to this Agreement or the transactions
contemplated hereby, (a) any claim that it is not personally subject to the
jurisdiction of the courts in Delaware as described herein for any reason,
(b) that it or its property is exempt or immune from jurisdiction of any such
court or from any legal process commenced in such courts (whether through
service of notice, attachment prior to judgment, attachment in aid of
execution of judgment, execution of judgment or otherwise) and (c) that (i)
the Action in any such court is brought in an inconvenient forum, (ii) the
venue of such Action is improper or (iii) this Agreement, or the subject
matter hereof, may not be enforced in or by such courts.

  



  

   

97

 



    



  

Section 10.07 _Waiver of Jury Trial_. Each of the parties hereto hereby
waives to the fullest extent permitted by applicable Law any right it may have
to a trial by jury with respect to any litigation directly or indirectly
arising out of, under or in connection with this Agreement or the
Transactions. Each of the parties hereto (a) certifies that no
representative, agent or attorney of any other party has represented,
expressly or otherwise, that such other party would not, in the event of
litigation, seek to enforce that foregoing waiver and (b) acknowledges that it
and the other hereto have been induced to enter into this Agreement and the
Transactions, as applicable, by, among other things, the mutual waivers and
certifications in this _Section 10.07_.

  



  

Section 10.08 _Headings_. The descriptive headings contained in this
Agreement are included for convenience of reference only and shall not affect
in any way the meaning or interpretation of this Agreement.

  



  

Section 10.09 _Counterparts_. This Agreement may be executed and delivered
(including by facsimile or portable document format (pdf) transmission) in one
or more counterparts, and by the different parties hereto in separate
counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement.

  



  

Section 10.10 _Specific Performance_.

  



  

(a)  The parties acknowledge and agree that irreparable damage would occur in
the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached, and that
monetary damages, even if available, would not be an adequate remedy
therefor. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent breaches or threatened breaches of this
Agreement and to enforce specifically the performance of the terms and
provisions of this Agreement, including the right of a party to cause the
other parties to consummate the Transactions. It is agreed that the parties
are entitled to enforce specifically the performance of terms and provisions
of this Agreement, without proof of actual damages (and each such party
hereby waives any requirement for the securing or posting of any bond in
connection with such remedy), this being in addition to any other remedy to
which they are entitled at law or in equity. Such Action shall be brought in
the Court of Chancery of the State of Delaware or, if that court does not
have jurisdiction, any court of the United States located in the State of
Delaware.

  



  

(b) The parties further agree not to assert that a remedy of specific
enforcement is unenforceable, invalid, contrary to any applicable Law or
inequitable for any reason, nor to assert that a remedy of monetary damages
would provide an adequate remedy for any such breach. Each of the parties
hereby further waives any defense in any action for specific performance that
a remedy at law would be adequate.

  



  

Section 10.11 _No Recourse_. All claims, obligations, liabilities, or causes
of action (whether in contract or in tort, in law or in equity, or granted by
statute) that may be based upon, in respect of, arise under, out or by reason
of, be connected with, or relate in any manner to this Agreement, or the
negotiation, execution, or performance of this Agreement (including any
representation or warranty made in, in connection with, or as an inducement
to, this Agreement), may be made only against (and such representations and
warranties are those solely of) the persons that are expressly identified as
parties in the preamble to this Agreement (the " _Contracting Parties_ ")
except as set forth in this _Section 10.11_. No person who is not a
Contracting Party, including any current, former or future director, officer,
employee, incorporator, member, partner, manager, stockholder, affiliate,
agent, attorney, Representative or assignee of, and any financial advisor or
lender to, any Contracting Party, or any current, former or future director,
officer, employee, incorporator, member, partner, manager, stockholder,
affiliate, agent, attorney, Representative or assignee of, and any financial
advisor or lender to, any of the foregoing (collectively, the " _Nonparty
Affiliates_ "), shall have any liability (whether in contract or in tort, in
law or in equity, or granted by statute) for any claims, causes of action,
obligations, or liabilities arising under, out of, in connection with, or
related in any manner to this Agreement or based on, in respect of, or by
reason of this Agreement or its negotiation, execution, performance, or
breach, except with respect to willful and material breach or actual and
intentional common law fraud under the laws of the State of Delaware ("
_Fraud_ ") against the person who committed such willful and material breach
or Fraud, and, to the maximum extent permitted by applicable Law, each
Contracting Party hereby waives and releases all such liabilities, claims,
causes of action, and obligations against any such Nonparty Affiliates.

  



  

   

98

 



    



  

Section 10.12 _Conflicts and Privilege_.

  



  

(a) Apex and the Company, on behalf of their respective successors and
assigns (including, after the Closing, the Surviving Corporation and the
Surviving Entity), hereby agree that, in the event a dispute with respect to
this Agreement or the transactions contemplated hereby arises after the
Closing between or among (i) the Sponsor, the stockholders or holders of other
equity interests of Apex or the Sponsor or any of their respective directors,
members, partners, officers, employees or affiliates (other than
the Surviving Corporation and the Surviving Entity) (collectively, the "
_Apex Group_ "), on the one hand, and (ii) the Surviving Corporation, the
Surviving Entity or any member of the AvePoint Group, on the other hand, any
legal counsel, including Lathan and Watkins LLP (" _Latham_ "), that
represented Apex or the Sponsor prior to the Closing may represent the
Sponsor or any other member of the Apex Group, in such dispute even though the
interests of such persons may be directly adverse to Apex, the Surviving
Corporation or the Surviving Entity, and even though such counsel may have
represented Apex in a matter substantially related to such dispute, or may be
handling ongoing matters for Apex, the Surviving Corporation, the Surviving
Entity or the Sponsor. Apex and the Company, on behalf of their respective
successors and assigns (including, after the Closing, the Surviving
Corporation and the Surviving Entity), further agree that, as to all legally
privileged communications prior to the Closing (made in connection with the
negotiation, preparation, execution, delivery and performance under, or any
dispute or Action arising out of or relating to, this Agreement, any
Ancillary Agreements or the transactions contemplated hereby or
thereby) between or among Apex, the Sponsor or any other member of the Apex
Group, on the one hand, and Latham, on the other hand, the
attorney/client privilege and the expectation of client confidence shall
survive the Mergers and belong to the Apex Group after the Closing, and shall
not pass to or be claimed or controlled by Apex following the Closing, the
Surviving Corporation or the Surviving Entity. Notwithstanding the foregoing,
any privileged communications or information shared by the Company prior to
the Closing with Apex or the Sponsor under a common interest agreement shall
remain the privileged communications or information of the Surviving
Corporation and the Surviving Entity, and not the Apex Group.

  



  

(b) Apex and the Company, on behalf of their respective successors and
assigns (including, after the Closing, the Surviving Corporation and the
Surviving Entity), hereby agree that, in the event a dispute with respect to
this Agreement or the transactions contemplated hereby arises after the
Closing between or among (i) the stockholders or holders of other equity
interests of the Company and any of their respective directors, members,
partners, officers, employees or affiliates (other than the Surviving
Corporation and the Surviving Entity) (collectively, the " _AvePoint Group_
"), on the one hand, and (y) the Surviving Corporation, the Surviving Entity
or any member of the Apex Group, on the other hand, any legal counsel,
including Cooley LLP (" _Cooley_ ") that represented the Company prior to the
Closing may represent any member of the AvePoint Group in such dispute even
though the interests of such persons may be directly adverse to the Surviving
Corporation or the Surviving Entity, and even though such counsel may have
represented Apex or the Company in a matter substantially related to such
dispute, or may be handling ongoing matters for the Surviving Corporation or
the Surviving Entity, further agree that, as to all legally privileged
communications prior to the Closing (made in connection with the negotiation,
preparation, execution, delivery and performance under, or any dispute
or Action arising out of or relating to, this Agreement, any Ancillary
Agreements or the transactions contemplated hereby or thereby) between or
among the Company or any member of the AvePoint Group, on the one hand, and
Cooley, on the other hand, the attorney/client privilege and the expectation
of client confidence shall survive the Mergers and belong to the AvePoint
Group after the Closing, and shall not pass to or be claimed or controlled by
the Surviving Corporation or the Surviving Entity. Notwithstanding the
foregoing, any privileged communications or information shared by Apex prior
to the Closing with the Company under a common interest agreement shall be
and remain the privileged communications or information of the Apex Group, and
not Apex.

  



  

[ _Signature Page Follows_.]

  



    

99

 



    



  

IN WITNESS WHEREOF, Apex, Merger Subs, and the Company have caused this
Agreement to be executed as of the date first written above by their
respective officers thereunto duly authorized.

  



       |  

APEX TECHNOLOGY ACQUISITION CORP. 

---|--- 
     | 
     | By  | /s/ Jeff Epstein 
     | Name:   | Jeff Epstein 
     | Title:  | Co-Chief Executive Officer, 
 Chief Financial Officer and Secretary 
     | 
     |  

ATHENA TECHNOLOGY MERGER SUB, INC. 

     | 
     | By  | /s/ Kimberly Kit 
     | Name:  | Kimberly Kit 
     | Title:  | President and Secretary 
     | 
     |  

ATHENA TECHNOLOGY MERGER SUB 2, LLC 

     | 
     | By  | /s/ Kimberly Kit 
     | Name:  | Kimberly Kit 
     | Title:  | President and Secretary 
     |   | 
     |  

AVEPOINT, INC. 

     | 
     | By  | /s/ Brian Brown 
     | Name:  | Brian Brown 
     | Title:  | Chief Legal Counsel and 
 Chief Operating Officer 
   



  

[ _Signature Page to Business Combination Agreement and Plan of
Reorganization_ ]

  



  



  



  



  

     '

